{
  "usdmVersion": "4.0",
  "generatedAt": "2026-01-23T03:36:47.841551",
  "generator": "Protocol2USDM v6.5.0",
  "study": {
    "id": "99c0b4f4-cc53-429d-924f-849511efac6b",
    "instanceType": "Study",
    "versions": [
      {
        "id": "19dc67dd-2dbe-4964-924f-5b33dc493def",
        "instanceType": "StudyVersion",
        "versionIdentifier": "1.0",
        "studyDesigns": [
          {
            "id": "126ecff2-fbf8-469c-ba5a-18812c6f0169",
            "name": "Study Design",
            "rationale": "Protocol-defined study design for investigating efficacy and safety",
            "instanceType": "InterventionalStudyDesign",
            "blindingSchema": {
              "id": "fd9de8dc-7f13-420b-b777-b548d441e17b",
              "standardCode": {
                "id": "a6f23bfe-797a-4238-84db-99d2bbd02c0d",
                "code": "Open Label",
                "codeSystem": "http://www.cdisc.org",
                "codeSystemVersion": "2024-09-27",
                "decode": "Open Label",
                "instanceType": "Code"
              },
              "instanceType": "AliasCode"
            },
            "randomizationType": {
              "code": "Randomized"
            },
            "arms": [
              {
                "id": "15b94bbd-6e82-4aab-ab25-4f10672396e5",
                "name": "Axicabtagene Ciloleucel",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Subjects receive a 3-day conditioning chemotherapy regimen (fludarabine 30 mg/m2/day and cyclophosphamide 500 mg/m2/day) followed by a single infusion of axicabtagene ciloleucel at a target dose of 2 x 10^6 anti-CD19 CAR T cells/kg.",
                "type": {
                  "id": "C174266",
                  "code": "C174266",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Investigational Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "b689c718-3135-4f55-bd18-8cb018eb67e6",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              },
              {
                "id": "71c4ff41-223e-4756-a05d-da0371ea4ee8",
                "name": "Standard of Care (SOC)",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Subjects receive investigator's choice of platinum-based salvage combination chemotherapy (R-ICE, R-DHAP, R-ESHAP, or R-GDP). Responding subjects proceed to high-dose therapy (HDT) and autologous stem cell transplant (ASCT).",
                "type": {
                  "id": "C174267",
                  "code": "C174267",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.12e",
                  "decode": "Active Comparator Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "2153fd69-6cda-4a4b-8d81-d0a7c6a84371",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              }
            ],
            "studyCohorts": [],
            "studyCells": [
              {
                "id": "0b440dcd-7b86-42cb-906f-006823aa53d5",
                "armId": "15b94bbd-6e82-4aab-ab25-4f10672396e5",
                "epochId": "42a36ce7-2ce6-4ccc-afc0-0a7d9605190f",
                "elementIds": [
                  "d9d0d235-b7ef-48f2-b7f3-39b66da0b6d3"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "79eead90-86ec-430f-ac88-18fd856d180d",
                "armId": "15b94bbd-6e82-4aab-ab25-4f10672396e5",
                "epochId": "268e1c4d-92e1-401e-afd6-63c53cde04ea",
                "elementIds": [
                  "9104b177-3c0d-4368-9b72-7f17e025d81e"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "838cea13-ad9a-4d31-9266-48199a0c7d10",
                "armId": "15b94bbd-6e82-4aab-ab25-4f10672396e5",
                "epochId": "ac31381d-c74c-4a5d-8dd9-ed49b147aa91",
                "elementIds": [
                  "e60ba79d-7ee9-4c52-ab6a-b63b88e62565"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "02d98a9f-7d94-42ca-adcd-0ef27d0d1fbf",
                "armId": "15b94bbd-6e82-4aab-ab25-4f10672396e5",
                "epochId": "5e453d8c-b48d-465b-9a41-1907c6900c09",
                "elementIds": [
                  "49eb28d1-4891-4cd3-b117-977bc4e509c7"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "42306a5c-5f24-40ea-850b-4e1839f338b6",
                "armId": "15b94bbd-6e82-4aab-ab25-4f10672396e5",
                "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548",
                "elementIds": [
                  "2e6e50e9-85a3-407e-83d4-b02c0728c0cb"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "b00f733c-3c72-46c3-a0d8-5d6eac2c5ee6",
                "armId": "15b94bbd-6e82-4aab-ab25-4f10672396e5",
                "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b",
                "elementIds": [
                  "be55455f-a4e0-4021-b9ec-af797561dc48"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "ac95a6fe-a8bc-441d-8b81-aa4b75891e59",
                "armId": "15b94bbd-6e82-4aab-ab25-4f10672396e5",
                "epochId": "8259b0cd-01b5-426f-a644-025fceb904b5",
                "elementIds": [
                  "b1176443-9ebf-4379-b73e-cb8e822641a5"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "403b8bd0-eef8-4b70-86c0-f3a315e57444",
                "armId": "71c4ff41-223e-4756-a05d-da0371ea4ee8",
                "epochId": "42a36ce7-2ce6-4ccc-afc0-0a7d9605190f",
                "elementIds": [
                  "5cef72b4-7d4c-487a-90ff-853eec1e5e2c"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "5d2b1b65-a907-43d9-9d93-c3a72b48a010",
                "armId": "71c4ff41-223e-4756-a05d-da0371ea4ee8",
                "epochId": "268e1c4d-92e1-401e-afd6-63c53cde04ea",
                "elementIds": [
                  "5c141381-c413-4a64-a0e3-f436ee99ff6a"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "e84ae8f9-8b54-4cd2-a593-06f3c5afe9b4",
                "armId": "71c4ff41-223e-4756-a05d-da0371ea4ee8",
                "epochId": "ac31381d-c74c-4a5d-8dd9-ed49b147aa91",
                "elementIds": [
                  "bfb68133-83ad-40ab-a4b6-7017a61a733c"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "0dc94700-c411-47b8-8f5a-c4fe257bd1cf",
                "armId": "71c4ff41-223e-4756-a05d-da0371ea4ee8",
                "epochId": "5e453d8c-b48d-465b-9a41-1907c6900c09",
                "elementIds": [
                  "4ee62768-7eec-47ca-99b7-33577eb83ae1"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "93be05d2-eb0d-4c10-9f26-c2139fc36da8",
                "armId": "71c4ff41-223e-4756-a05d-da0371ea4ee8",
                "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548",
                "elementIds": [
                  "3bc0d533-3dd0-4dae-b1a7-15a3a07b0ad0"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "ef6f1fec-97ab-4304-9ed1-a06df157d46d",
                "armId": "71c4ff41-223e-4756-a05d-da0371ea4ee8",
                "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b",
                "elementIds": [
                  "868f7ae1-62d1-46d9-9ba1-cb9ee376b2bd"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "28ef3842-c9d8-4bd3-aa06-764f5d201db1",
                "armId": "71c4ff41-223e-4756-a05d-da0371ea4ee8",
                "epochId": "8259b0cd-01b5-426f-a644-025fceb904b5",
                "elementIds": [
                  "d5313059-b136-471e-a724-79d20d425acb"
                ],
                "instanceType": "StudyCell"
              }
            ],
            "studyElements": [
              {
                "id": "d9d0d235-b7ef-48f2-b7f3-39b66da0b6d3",
                "name": "Axicabtagene Ciloleucel - Screening",
                "instanceType": "StudyElement",
                "description": "Treatment period for Axicabtagene Ciloleucel during Screening"
              },
              {
                "id": "9104b177-3c0d-4368-9b72-7f17e025d81e",
                "name": "Axicabtagene Ciloleucel - Randomization",
                "instanceType": "StudyElement",
                "description": "Treatment period for Axicabtagene Ciloleucel during Randomization"
              },
              {
                "id": "e60ba79d-7ee9-4c52-ab6a-b63b88e62565",
                "name": "Axicabtagene Ciloleucel - Leukapheresis",
                "instanceType": "StudyElement",
                "description": "Treatment period for Axicabtagene Ciloleucel during Leukapheresis"
              },
              {
                "id": "49eb28d1-4891-4cd3-b117-977bc4e509c7",
                "name": "Axicabtagene Ciloleucel - Conditioning Chemotherapy",
                "instanceType": "StudyElement",
                "description": "Treatment period for Axicabtagene Ciloleucel during Conditioning Chemotherapy"
              },
              {
                "id": "2e6e50e9-85a3-407e-83d4-b02c0728c0cb",
                "name": "Axicabtagene Ciloleucel - IP Administration",
                "instanceType": "StudyElement",
                "description": "Treatment period for Axicabtagene Ciloleucel during IP Administration"
              },
              {
                "id": "be55455f-a4e0-4021-b9ec-af797561dc48",
                "name": "Axicabtagene Ciloleucel - Post Treatment Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for Axicabtagene Ciloleucel during Post Treatment Follow-up"
              },
              {
                "id": "b1176443-9ebf-4379-b73e-cb8e822641a5",
                "name": "Axicabtagene Ciloleucel - Long-term Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for Axicabtagene Ciloleucel during Long-term Follow-up"
              },
              {
                "id": "5cef72b4-7d4c-487a-90ff-853eec1e5e2c",
                "name": "Standard of Care (SOC) - Screening",
                "instanceType": "StudyElement",
                "description": "Treatment period for Standard of Care (SOC) during Screening"
              },
              {
                "id": "5c141381-c413-4a64-a0e3-f436ee99ff6a",
                "name": "Standard of Care (SOC) - Randomization",
                "instanceType": "StudyElement",
                "description": "Treatment period for Standard of Care (SOC) during Randomization"
              },
              {
                "id": "bfb68133-83ad-40ab-a4b6-7017a61a733c",
                "name": "Standard of Care (SOC) - Leukapheresis",
                "instanceType": "StudyElement",
                "description": "Treatment period for Standard of Care (SOC) during Leukapheresis"
              },
              {
                "id": "4ee62768-7eec-47ca-99b7-33577eb83ae1",
                "name": "Standard of Care (SOC) - Conditioning Chemotherapy",
                "instanceType": "StudyElement",
                "description": "Treatment period for Standard of Care (SOC) during Conditioning Chemotherapy"
              },
              {
                "id": "3bc0d533-3dd0-4dae-b1a7-15a3a07b0ad0",
                "name": "Standard of Care (SOC) - IP Administration",
                "instanceType": "StudyElement",
                "description": "Treatment period for Standard of Care (SOC) during IP Administration"
              },
              {
                "id": "868f7ae1-62d1-46d9-9ba1-cb9ee376b2bd",
                "name": "Standard of Care (SOC) - Post Treatment Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for Standard of Care (SOC) during Post Treatment Follow-up"
              },
              {
                "id": "d5313059-b136-471e-a724-79d20d425acb",
                "name": "Standard of Care (SOC) - Long-term Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for Standard of Care (SOC) during Long-term Follow-up"
              }
            ],
            "maskingRoles": [
              {
                "id": "d185d090-6f82-4132-8245-6881cb1836e3",
                "text": "Outcome Assessor is masked in this Open Label study",
                "isMasked": true,
                "instanceType": "Masking"
              }
            ],
            "eligibilityCriteria": [
              {
                "id": "749c0dd1-79f5-444e-801c-84b051b2dc16",
                "identifier": "101",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "e6a2d0eb-82dd-4d1b-9b7c-7286844e03c4",
                "instanceType": "EligibilityCriterion",
                "name": "Histologically proven large B-cell lymphoma",
                "nextId": "3e408678-46fe-48f1-a61c-5d02e7e3d67b"
              },
              {
                "id": "3e408678-46fe-48f1-a61c-5d02e7e3d67b",
                "identifier": "102",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "8e96dc49-493b-4073-b1bd-bed4bedf18a6",
                "instanceType": "EligibilityCriterion",
                "name": "Relapsed or refractory disease",
                "previousId": "749c0dd1-79f5-444e-801c-84b051b2dc16",
                "nextId": "59da2abe-8a55-4eca-a666-2dd5acb2d8c7"
              },
              {
                "id": "59da2abe-8a55-4eca-a666-2dd5acb2d8c7",
                "identifier": "103",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "2cdb34f3-b1ed-4df8-90ea-5117326a01c6",
                "instanceType": "EligibilityCriterion",
                "name": "Adequate first-line therapy",
                "previousId": "3e408678-46fe-48f1-a61c-5d02e7e3d67b",
                "nextId": "5a73c1d6-adba-4534-9f13-760e4198fbc7"
              },
              {
                "id": "5a73c1d6-adba-4534-9f13-760e4198fbc7",
                "identifier": "104",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "79cc0570-a367-4a08-924f-ce53498ff05a",
                "instanceType": "EligibilityCriterion",
                "name": "Intent to proceed to HDT and ASCT",
                "previousId": "59da2abe-8a55-4eca-a666-2dd5acb2d8c7",
                "nextId": "83758e50-21c2-4e19-9fc8-2584e7bffa5b"
              },
              {
                "id": "83758e50-21c2-4e19-9fc8-2584e7bffa5b",
                "identifier": "105",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "cdf10c44-ad57-4563-9621-de53e16a9f9a",
                "instanceType": "EligibilityCriterion",
                "name": "Radiographically documented disease",
                "previousId": "5a73c1d6-adba-4534-9f13-760e4198fbc7",
                "nextId": "4bd636b2-5baa-41f4-b4a0-6f07f0f68b88"
              },
              {
                "id": "4bd636b2-5baa-41f4-b4a0-6f07f0f68b88",
                "identifier": "106",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "31d2f33c-02c6-499a-9114-42c955d58a56",
                "instanceType": "EligibilityCriterion",
                "name": "No CNS involvement",
                "previousId": "83758e50-21c2-4e19-9fc8-2584e7bffa5b",
                "nextId": "335e52ba-d6f8-4560-b4d2-4e1a87855957"
              },
              {
                "id": "335e52ba-d6f8-4560-b4d2-4e1a87855957",
                "identifier": "107",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "85446d2a-54d7-430a-839a-f2dbc7df9f06",
                "instanceType": "EligibilityCriterion",
                "name": "Prior systemic cancer therapy washout",
                "previousId": "4bd636b2-5baa-41f4-b4a0-6f07f0f68b88",
                "nextId": "edfe2a48-2db8-410f-b26c-cb21b9ab30bd"
              },
              {
                "id": "edfe2a48-2db8-410f-b26c-cb21b9ab30bd",
                "identifier": "108",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "6fe487b1-dbd4-49a3-83cd-e2f5a3e5c94a",
                "instanceType": "EligibilityCriterion",
                "name": "Age requirement",
                "previousId": "335e52ba-d6f8-4560-b4d2-4e1a87855957",
                "nextId": "342887ef-1a56-44b6-96f4-8c6c2916d8bf"
              },
              {
                "id": "342887ef-1a56-44b6-96f4-8c6c2916d8bf",
                "identifier": "109",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "37383cd2-bded-4f3f-b851-fd083c80bb38",
                "instanceType": "EligibilityCriterion",
                "name": "ECOG performance status",
                "previousId": "edfe2a48-2db8-410f-b26c-cb21b9ab30bd",
                "nextId": "8d455e81-f4b7-49d3-86d7-f1aeabffd3b8"
              },
              {
                "id": "8d455e81-f4b7-49d3-86d7-f1aeabffd3b8",
                "identifier": "110",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "099617a7-b6ae-459d-afc3-d31f7b9345b6",
                "instanceType": "EligibilityCriterion",
                "name": "Adequate organ function",
                "previousId": "342887ef-1a56-44b6-96f4-8c6c2916d8bf",
                "nextId": "14977282-30ff-404b-9d3f-f8c4b1e99f51"
              },
              {
                "id": "14977282-30ff-404b-9d3f-f8c4b1e99f51",
                "identifier": "111",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "2a87ad75-199f-481c-bd88-e213ccfe8ecb",
                "instanceType": "EligibilityCriterion",
                "name": "Pregnancy test requirement",
                "previousId": "8d455e81-f4b7-49d3-86d7-f1aeabffd3b8"
              },
              {
                "id": "7b6a3c03-0943-44ac-a610-c16fb9d701d4",
                "identifier": "201",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "11fbd449-f208-4963-bff9-7e5f96589543",
                "instanceType": "EligibilityCriterion",
                "name": "History of other malignancy",
                "nextId": "53c66b3f-06c3-4339-a929-08012d94b087"
              },
              {
                "id": "53c66b3f-06c3-4339-a929-08012d94b087",
                "identifier": "202",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "c9bfff35-16bb-4958-a41c-a6f72ba25675",
                "instanceType": "EligibilityCriterion",
                "name": "Richterâ€™s transformation or PMBCL",
                "previousId": "7b6a3c03-0943-44ac-a610-c16fb9d701d4",
                "nextId": "7d17dc34-57ed-47e2-9143-17acfa033a00"
              },
              {
                "id": "7d17dc34-57ed-47e2-9143-17acfa033a00",
                "identifier": "203",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "b34f946e-3160-45b6-8e28-911dcb68d899",
                "instanceType": "EligibilityCriterion",
                "name": "Prior stem cell transplant",
                "previousId": "53c66b3f-06c3-4339-a929-08012d94b087",
                "nextId": "97e57fb9-26e7-45ee-ab8d-015c2c30c67c"
              },
              {
                "id": "97e57fb9-26e7-45ee-ab8d-015c2c30c67c",
                "identifier": "204",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "40247583-d4c9-407b-a2f5-34d54bfbd828",
                "instanceType": "EligibilityCriterion",
                "name": "Lines of therapy for DLBCL",
                "previousId": "7d17dc34-57ed-47e2-9143-17acfa033a00",
                "nextId": "b3d37f7b-4e4a-4d95-a20f-5dfa00bd07bb"
              },
              {
                "id": "b3d37f7b-4e4a-4d95-a20f-5dfa00bd07bb",
                "identifier": "205",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "47268ba5-b88e-46e7-805d-50b35c390f63",
                "instanceType": "EligibilityCriterion",
                "name": "Prior CD19 targeted therapy",
                "previousId": "97e57fb9-26e7-45ee-ab8d-015c2c30c67c",
                "nextId": "6faa7f2f-8666-47b3-93a0-77671a227d85"
              },
              {
                "id": "6faa7f2f-8666-47b3-93a0-77671a227d85",
                "identifier": "206",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "d027a56c-a92c-4ccf-98a8-ff525754af9e",
                "instanceType": "EligibilityCriterion",
                "name": "Systemic immunostimulatory agents",
                "previousId": "b3d37f7b-4e4a-4d95-a20f-5dfa00bd07bb",
                "nextId": "491f48ed-cdac-4101-b50b-56ee48e66e9b"
              },
              {
                "id": "491f48ed-cdac-4101-b50b-56ee48e66e9b",
                "identifier": "207",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "b94dd332-9e78-4795-b0c7-c7025cd4026f",
                "instanceType": "EligibilityCriterion",
                "name": "Prior CAR T or ZUMA-7 randomization",
                "previousId": "6faa7f2f-8666-47b3-93a0-77671a227d85",
                "nextId": "73d1476f-eb21-4475-aa47-5c9003dfd329"
              },
              {
                "id": "73d1476f-eb21-4475-aa47-5c9003dfd329",
                "identifier": "208",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "75955aed-1c6e-4b5e-9bbc-5558db1dce23",
                "instanceType": "EligibilityCriterion",
                "name": "Aminoglycoside hypersensitivity",
                "previousId": "491f48ed-cdac-4101-b50b-56ee48e66e9b",
                "nextId": "658c202c-873d-4db8-aa4f-f296e052a499"
              },
              {
                "id": "658c202c-873d-4db8-aa4f-f296e052a499",
                "identifier": "209",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "e133a3b5-d747-4f3a-b6fd-1f96b2a0d918",
                "instanceType": "EligibilityCriterion",
                "name": "Uncontrolled infection",
                "previousId": "73d1476f-eb21-4475-aa47-5c9003dfd329",
                "nextId": "71f787fd-5510-436e-917f-df2762bc2693"
              },
              {
                "id": "71f787fd-5510-436e-917f-df2762bc2693",
                "identifier": "210",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "d806c997-d6a3-4c7e-88bd-23e229a91bbb",
                "instanceType": "EligibilityCriterion",
                "name": "HIV, Hepatitis B or C",
                "previousId": "658c202c-873d-4db8-aa4f-f296e052a499",
                "nextId": "bb99f601-8198-4f1e-a3f8-45251e162f1a"
              },
              {
                "id": "bb99f601-8198-4f1e-a3f8-45251e162f1a",
                "identifier": "211",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "9aa6a407-853f-47aa-b875-1b8fe8781e3b",
                "instanceType": "EligibilityCriterion",
                "name": "Active tuberculosis",
                "previousId": "71f787fd-5510-436e-917f-df2762bc2693",
                "nextId": "8665404e-8678-4ec2-ac3f-ba3a428aa58b"
              },
              {
                "id": "8665404e-8678-4ec2-ac3f-ba3a428aa58b",
                "identifier": "212",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "00a91695-0760-4ac8-9425-d5f4996c1f59",
                "instanceType": "EligibilityCriterion",
                "name": "Indwelling line or drain",
                "previousId": "bb99f601-8198-4f1e-a3f8-45251e162f1a",
                "nextId": "b9affbb8-ab5f-4e71-8421-eed649c67011"
              },
              {
                "id": "b9affbb8-ab5f-4e71-8421-eed649c67011",
                "identifier": "213",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "c6a2b12b-8fc9-49ed-913d-4c2cff127869",
                "instanceType": "EligibilityCriterion",
                "name": "CSF malignant cells or brain metastases",
                "previousId": "8665404e-8678-4ec2-ac3f-ba3a428aa58b",
                "nextId": "8b678e31-4dfc-4290-b18b-58499fe531b3"
              },
              {
                "id": "8b678e31-4dfc-4290-b18b-58499fe531b3",
                "identifier": "214",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "802b9c11-3b62-49d8-ac1c-0781ea548956",
                "instanceType": "EligibilityCriterion",
                "name": "Non-malignant CNS disorder",
                "previousId": "b9affbb8-ab5f-4e71-8421-eed649c67011",
                "nextId": "edb4996c-624f-401e-b938-b1cd269eba68"
              },
              {
                "id": "edb4996c-624f-401e-b938-b1cd269eba68",
                "identifier": "215",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "4e52b1c9-c518-4276-bfc9-27e370daad89",
                "instanceType": "EligibilityCriterion",
                "name": "Cardiac lymphoma involvement",
                "previousId": "8b678e31-4dfc-4290-b18b-58499fe531b3",
                "nextId": "50bb8263-7238-4afd-b79c-446b0d47a3b5"
              },
              {
                "id": "50bb8263-7238-4afd-b79c-446b0d47a3b5",
                "identifier": "216",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "c801b52a-485e-4ec9-9543-7c811d175302",
                "instanceType": "EligibilityCriterion",
                "name": "Clinically significant cardiac disease",
                "previousId": "edb4996c-624f-401e-b938-b1cd269eba68",
                "nextId": "791b60b6-b138-4245-98ba-eed877146f87"
              },
              {
                "id": "791b60b6-b138-4245-98ba-eed877146f87",
                "identifier": "217",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "0ddc6d84-c3bf-4283-adc0-f20313c4f3c9",
                "instanceType": "EligibilityCriterion",
                "name": "Urgent therapy requirement",
                "previousId": "50bb8263-7238-4afd-b79c-446b0d47a3b5",
                "nextId": "470b3e2b-bcf4-434c-8ba9-6262287c310c"
              },
              {
                "id": "470b3e2b-bcf4-434c-8ba9-6262287c310c",
                "identifier": "218",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "e0514917-9592-4f92-b95c-5bcde5cef306",
                "instanceType": "EligibilityCriterion",
                "name": "Autoimmune disease history",
                "previousId": "791b60b6-b138-4245-98ba-eed877146f87",
                "nextId": "bc85bbfd-a031-464e-ab10-8dc814a29d21"
              },
              {
                "id": "bc85bbfd-a031-464e-ab10-8dc814a29d21",
                "identifier": "219",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "44576847-1af8-4804-bd6a-822c7894b345",
                "instanceType": "EligibilityCriterion",
                "name": "Pulmonary fibrosis or pneumonitis",
                "previousId": "470b3e2b-bcf4-434c-8ba9-6262287c310c"
              }
            ],
            "population": {
              "id": "99144497-1600-4a13-ae07-b3af9ffb735e",
              "name": "Study Population",
              "includesHealthySubjects": false,
              "criterionIds": [
                "749c0dd1-79f5-444e-801c-84b051b2dc16",
                "3e408678-46fe-48f1-a61c-5d02e7e3d67b",
                "59da2abe-8a55-4eca-a666-2dd5acb2d8c7",
                "5a73c1d6-adba-4534-9f13-760e4198fbc7",
                "83758e50-21c2-4e19-9fc8-2584e7bffa5b",
                "4bd636b2-5baa-41f4-b4a0-6f07f0f68b88",
                "335e52ba-d6f8-4560-b4d2-4e1a87855957",
                "edfe2a48-2db8-410f-b26c-cb21b9ab30bd",
                "342887ef-1a56-44b6-96f4-8c6c2916d8bf",
                "8d455e81-f4b7-49d3-86d7-f1aeabffd3b8",
                "14977282-30ff-404b-9d3f-f8c4b1e99f51",
                "7b6a3c03-0943-44ac-a610-c16fb9d701d4",
                "53c66b3f-06c3-4339-a929-08012d94b087",
                "7d17dc34-57ed-47e2-9143-17acfa033a00",
                "97e57fb9-26e7-45ee-ab8d-015c2c30c67c",
                "b3d37f7b-4e4a-4d95-a20f-5dfa00bd07bb",
                "6faa7f2f-8666-47b3-93a0-77671a227d85",
                "491f48ed-cdac-4101-b50b-56ee48e66e9b",
                "73d1476f-eb21-4475-aa47-5c9003dfd329",
                "658c202c-873d-4db8-aa4f-f296e052a499",
                "71f787fd-5510-436e-917f-df2762bc2693",
                "bb99f601-8198-4f1e-a3f8-45251e162f1a",
                "8665404e-8678-4ec2-ac3f-ba3a428aa58b",
                "b9affbb8-ab5f-4e71-8421-eed649c67011",
                "8b678e31-4dfc-4290-b18b-58499fe531b3",
                "edb4996c-624f-401e-b938-b1cd269eba68",
                "50bb8263-7238-4afd-b79c-446b0d47a3b5",
                "791b60b6-b138-4245-98ba-eed877146f87",
                "470b3e2b-bcf4-434c-8ba9-6262287c310c",
                "bc85bbfd-a031-464e-ab10-8dc814a29d21"
              ],
              "instanceType": "StudyDesignPopulation",
              "description": "Target population defined by eligibility criteria"
            },
            "objectives": [
              {
                "id": "ebdfa41b-9f48-49ca-a023-091d8b7735c8",
                "name": "Primary Objective",
                "text": "To determine if axicabtagene ciloleucel is superior to standard of care (SOC) as measured by event-free survival (EFS), as determined by blinded central review",
                "level": {
                  "id": "C85826",
                  "code": "C85826",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Primary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "46687959-9d71-46e4-abfd-3617c248fb64"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "f5d7de80-0cfe-4657-be01-d5253f19c4f4",
                "name": "Secondary Objective - ORR",
                "text": "To evaluate the effect of axicabtagene ciloleucel compared to SOC on objective response rate (ORR), as determined by blinded central review",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "ce2ffea6-a359-4ac5-8b5a-65520cc47746"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "a345126c-9bd1-4775-85c6-c587ed505ef4",
                "name": "Secondary Objective - OS",
                "text": "To evaluate the effect of axicabtagene ciloleucel compared to SOC on overall survival (OS)",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "8bd8bd7f-93ab-4dda-9e83-63b614b1ed1c"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "65cb8206-a5f8-4992-95b7-5558f16a944b",
                "name": "Secondary Objective - PFS",
                "text": "To evaluate the effect of axicabtagene ciloleucel compared to SOC on progression-free survival (PFS)",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "87a7fdd6-4f51-4e5a-a110-0b22bce1dcae"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "af6cbc33-210f-489a-969e-7b0a9e9334c7",
                "name": "Secondary Objective - DOR",
                "text": "To evaluate the effect of axicabtagene ciloleucel compared to SOC on duration of response (DOR) and duration of complete response among responding subjects, as determined by blinded central review",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "c0035dec-d88d-4cab-b50e-81d6fc9d7aed"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "7368dd2a-dde0-4c7d-9c4a-c00c1e2b6d37",
                "name": "Secondary Objective - Safety",
                "text": "To evaluate the safety of axicabtagene ciloleucel compared to SOC",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "81ecff13-f1d4-41c2-9d9c-979703fd0f89"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "06b31717-4a72-4856-9227-24a98a0415b9",
                "name": "Secondary Objective - PRO/QoL",
                "text": "To evaluate the effect of axicabtagene ciloleucel on patient reported outcomes (PROs) and quality of life (QoL) compared to SOC",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "ad95039d-6fee-4e6f-bb36-ed43422863ba",
                  "10add45c-cdae-4d7b-b80b-4fb093c22b7d"
                ],
                "instanceType": "Objective"
              }
            ],
            "endpoints": [
              {
                "id": "46687959-9d71-46e4-abfd-3617c248fb64",
                "name": "Primary Endpoint - EFS",
                "text": "Event-free Survival (EFS): EFS is defined as the time from randomization to the earliest date of disease progression per the Lugano Classification {Cheson 2014}, commencement of new lymphoma therapy, or death from any cause.",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "ce2ffea6-a359-4ac5-8b5a-65520cc47746",
                "name": "Key Secondary Endpoint - ORR",
                "text": "Objective response rate",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "8bd8bd7f-93ab-4dda-9e83-63b614b1ed1c",
                "name": "Key Secondary Endpoint - OS",
                "text": "Overall survival",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "3bbb4b3a-057e-448a-aa7f-3021f7c327f0",
                "name": "Secondary Endpoint - Investigator EFS",
                "text": "EFS based on investigator disease assessments",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "bf923ba9-8b0a-4b1b-884c-b82fa834fcb4",
                "name": "Secondary Endpoint - Modified EFS",
                "text": "Modified EFS based on blinded central review and on investigator disease assessments",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "87a7fdd6-4f51-4e5a-a110-0b22bce1dcae",
                "name": "Secondary Endpoint - PFS",
                "text": "Progression-free survival",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "c0035dec-d88d-4cab-b50e-81d6fc9d7aed",
                "name": "Secondary Endpoint - DOR/CR",
                "text": "Duration of response and complete response",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "81ecff13-f1d4-41c2-9d9c-979703fd0f89",
                "name": "Secondary Endpoint - Safety",
                "text": "Incidence of adverse events and clinically significant changes in safety lab values, including antibodies to axicabtagene ciloleucel",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Safety"
              },
              {
                "id": "ad95039d-6fee-4e6f-bb36-ed43422863ba",
                "name": "Secondary Endpoint - QoL EORTC",
                "text": "Changes from screening to post baseline in the global health status QoL scale and the physical functioning domain of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Cancer-30 (EORTC QLQ-C30)",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "QualityOfLife"
              },
              {
                "id": "10add45c-cdae-4d7b-b80b-4fb093c22b7d",
                "name": "Secondary Endpoint - QoL EQ-5D-5L",
                "text": "Changes from screening to post baseline in the Euro-QOL, Five Dimensions, Five Levels (EQ-5D-5L) index and visual analog scale (VAS) scores",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "QualityOfLife"
              }
            ],
            "estimands": [
              {
                "id": "e4bc38c8-8b75-40a3-ab01-9286f164df9f",
                "name": "Primary Efficacy Estimand - EFS",
                "populationSummary": "Adult subjects with relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL) after first-line rituximab and anthracycline-based chemotherapy (ITT population) Summary measure: Hazard ratio (stratified log-rank test).",
                "analysisPopulationId": "90eda771-46e5-4e6c-928c-dac05405070d",
                "variableOfInterestId": "46687959-9d71-46e4-abfd-3617c248fb64",
                "interventionIds": [
                  "6a58e8de-5b06-443e-b538-c9f76e391d59"
                ],
                "intercurrentEvents": [
                  {
                    "id": "3040964b-94ec-4058-ae78-4cc8d9a54137",
                    "name": "Commencement of new lymphoma therapy",
                    "text": "Subject starts a new lymphoma therapy before a progression event or death",
                    "strategy": "Composite",
                    "instanceType": "IntercurrentEvent"
                  },
                  {
                    "id": "e09a07bc-e558-48a2-aa7e-0b151fc50e08",
                    "name": "Death",
                    "text": "Death from any cause prior to disease progression",
                    "strategy": "Composite",
                    "instanceType": "IntercurrentEvent"
                  },
                  {
                    "id": "31ca4727-e0c3-4e21-b0c3-95907147d975",
                    "name": "Treatment discontinuation",
                    "text": "Subject discontinues the assigned treatment arm (e.g., fails to receive CAR T infusion or fails to proceed to ASCT)",
                    "strategy": "Treatment Policy",
                    "instanceType": "IntercurrentEvent"
                  }
                ],
                "instanceType": "Estimand",
                "treatment": "Axicabtagene ciloleucel (single infusion of 2 x 10^6 anti-CD19 CAR T cells/kg) vs Standard of Care (SOC) therapy (platinum-based salvage chemotherapy followed by HDT-ASCT for responders)",
                "analysisPopulation": "Adult subjects with relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL) after first-line rituximab and anthracycline-based chemotherapy (ITT population)",
                "variableOfInterest": "Event-free survival (EFS), defined as the time from randomization to the earliest date of disease progression (per Lugano 2014), commencement of new lymphoma therapy, or death from any cause",
                "summaryMeasure": "Hazard ratio (stratified log-rank test)"
              },
              {
                "id": "3b34c5cf-46f3-42a9-9ad0-57831b68f10e",
                "name": "Key Secondary Efficacy Estimand - ORR",
                "populationSummary": "Adult subjects with relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL) (ITT population) Summary measure: Odds ratio (stratified Cochran-Mantel-Haenszel test).",
                "analysisPopulationId": "869e7cfc-17b3-4a20-a47f-0b6188fc83d9",
                "variableOfInterestId": "ce2ffea6-a359-4ac5-8b5a-65520cc47746",
                "interventionIds": [
                  "4f662043-4b2b-4225-8977-0ceb6ff8439f"
                ],
                "intercurrentEvents": [
                  {
                    "id": "c361b190-f6d6-4bd7-9329-65cf8f6d9ca8",
                    "name": "Death prior to response assessment",
                    "text": "Subject dies before the first scheduled disease assessment",
                    "strategy": "Composite",
                    "instanceType": "IntercurrentEvent"
                  },
                  {
                    "id": "52f4dc70-3f2c-4887-bd38-b46fd9da0366",
                    "name": "Treatment switching",
                    "text": "Subject in SOC arm receives CAR T-cell therapy off-protocol",
                    "strategy": "Treatment Policy",
                    "instanceType": "IntercurrentEvent"
                  }
                ],
                "instanceType": "Estimand",
                "treatment": "Axicabtagene ciloleucel vs Standard of Care (SOC)",
                "analysisPopulation": "Adult subjects with relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL) (ITT population)",
                "variableOfInterest": "Objective response rate (ORR), defined as the proportion of subjects achieving a best response of CR or PR",
                "summaryMeasure": "Odds ratio (stratified Cochran-Mantel-Haenszel test)"
              },
              {
                "id": "f8629404-c647-41a0-bbdf-a523241ed9cd",
                "name": "Key Secondary Efficacy Estimand - OS",
                "populationSummary": "Adult subjects with relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL) (ITT population) Summary measure: Hazard ratio (stratified log-rank test).",
                "analysisPopulationId": "789b4359-b7ea-4ae3-92e5-aa5927882a7f",
                "variableOfInterestId": "8bd8bd7f-93ab-4dda-9e83-63b614b1ed1c",
                "interventionIds": [
                  "ee72f6ba-7228-450c-b9e5-5b02fb64126b"
                ],
                "intercurrentEvents": [
                  {
                    "id": "10423912-e8aa-42f7-b60a-104fa4e62335",
                    "name": "Treatment switching/Crossover",
                    "text": "Subjects in the SOC arm receiving subsequent cellular therapy",
                    "strategy": "Treatment Policy",
                    "instanceType": "IntercurrentEvent"
                  }
                ],
                "instanceType": "Estimand",
                "treatment": "Axicabtagene ciloleucel vs Standard of Care (SOC)",
                "analysisPopulation": "Adult subjects with relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL) (ITT population)",
                "variableOfInterest": "Overall survival (OS), defined as the time from randomization to death from any cause",
                "summaryMeasure": "Hazard ratio (stratified log-rank test)"
              }
            ],
            "scheduleTimelines": [
              {
                "id": "95cec188-6bdc-40c1-a8ec-224995596a1e",
                "name": "Main Schedule Timeline",
                "mainTimeline": true,
                "instanceType": "ScheduleTimeline",
                "entryCondition": "Subject enrolled in study",
                "entryId": "96b15122-c944-4cff-ba6a-7c40abafc611",
                "instances": [
                  {
                    "id": "96b15122-c944-4cff-ba6a-7c40abafc611",
                    "activityIds": [
                      "657877e2-0bad-4121-aef7-e857b90be47d"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_1",
                    "encounterId": "62174547-37ae-4535-a8f1-ce0609b7aeaa",
                    "epochId": "42a36ce7-2ce6-4ccc-afc0-0a7d9605190f"
                  },
                  {
                    "id": "30f90a4e-51d3-4a65-ac74-7a381c06b5e9",
                    "activityIds": [
                      "07dbae1d-67c6-4ec2-a8a3-ec3f4b73fa60"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@enc_1",
                    "encounterId": "62174547-37ae-4535-a8f1-ce0609b7aeaa",
                    "epochId": "42a36ce7-2ce6-4ccc-afc0-0a7d9605190f"
                  },
                  {
                    "id": "1d93b55c-2c34-4e11-b6c7-5b3e49a8082f",
                    "activityIds": [
                      "07dbae1d-67c6-4ec2-a8a3-ec3f4b73fa60"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@enc_9",
                    "encounterId": "17568e63-7559-4d6c-910f-120a81c21324",
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "58979c26-bd0e-4da0-a79a-4b00c8a07cf3",
                    "activityIds": [
                      "07dbae1d-67c6-4ec2-a8a3-ec3f4b73fa60"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@enc_11",
                    "encounterId": "e9b883bf-5e58-40ab-a4e6-19e0cb3f1960",
                    "timingId": "30e2c586-d47b-42ac-91f1-c2cb492bcab3",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "d12e577e-4636-4788-97e1-356f5c6fb4d2",
                    "activityIds": [
                      "07dbae1d-67c6-4ec2-a8a3-ec3f4b73fa60"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@enc_12",
                    "encounterId": "79d35e9f-160c-48e8-873b-a9747a912cae",
                    "timingId": "9fc212da-53c6-4306-8208-384c69f4c1a3",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "d8669bb7-41cd-4641-bb10-10230b8eb90f",
                    "activityIds": [
                      "ae842214-6b86-4c56-bf7d-fbef019181f2"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_1",
                    "encounterId": "62174547-37ae-4535-a8f1-ce0609b7aeaa",
                    "epochId": "42a36ce7-2ce6-4ccc-afc0-0a7d9605190f"
                  },
                  {
                    "id": "0f1be09a-9bb1-4242-94c7-24b60511dc7b",
                    "activityIds": [
                      "ae842214-6b86-4c56-bf7d-fbef019181f2"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_9",
                    "encounterId": "17568e63-7559-4d6c-910f-120a81c21324",
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "79cc502e-4eb1-44f9-916e-ab60d0618b8e",
                    "activityIds": [
                      "ae842214-6b86-4c56-bf7d-fbef019181f2"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_10",
                    "encounterId": "fdeed36f-6c32-416d-8f3a-a88c03215771",
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "2757b6e5-a8b6-43d0-8032-646c9dcd62c1",
                    "activityIds": [
                      "ae842214-6b86-4c56-bf7d-fbef019181f2"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_11",
                    "encounterId": "e9b883bf-5e58-40ab-a4e6-19e0cb3f1960",
                    "timingId": "30e2c586-d47b-42ac-91f1-c2cb492bcab3",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "ad30bc29-d348-4f56-b2bf-4820b00b8734",
                    "activityIds": [
                      "7fc4d956-5f86-4c50-955c-b6bb132f1620"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_1",
                    "encounterId": "62174547-37ae-4535-a8f1-ce0609b7aeaa",
                    "epochId": "42a36ce7-2ce6-4ccc-afc0-0a7d9605190f"
                  },
                  {
                    "id": "6eb91347-96ed-44ca-8af3-347e3dafe8ee",
                    "activityIds": [
                      "7fc4d956-5f86-4c50-955c-b6bb132f1620"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_9",
                    "encounterId": "17568e63-7559-4d6c-910f-120a81c21324",
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "4ba42b7d-d2e3-4a1f-8e1d-265c2d803ab3",
                    "activityIds": [
                      "8275f0dc-2f1e-4c07-8c2f-9f033d6eb3fa"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_1",
                    "encounterId": "62174547-37ae-4535-a8f1-ce0609b7aeaa",
                    "epochId": "42a36ce7-2ce6-4ccc-afc0-0a7d9605190f"
                  },
                  {
                    "id": "c5c12cd4-4b4c-4750-afb3-038b1e67db8d",
                    "activityIds": [
                      "8275f0dc-2f1e-4c07-8c2f-9f033d6eb3fa"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_3",
                    "encounterId": "1e55cdb0-fc2d-478e-b392-937f2c457903",
                    "epochId": "ac31381d-c74c-4a5d-8dd9-ed49b147aa91"
                  },
                  {
                    "id": "a5cf40da-436b-498b-9b5a-61044ddd20b6",
                    "activityIds": [
                      "8275f0dc-2f1e-4c07-8c2f-9f033d6eb3fa"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_9",
                    "encounterId": "17568e63-7559-4d6c-910f-120a81c21324",
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "6abb2c9e-07b7-44ab-81c1-d6a263ce3aa3",
                    "activityIds": [
                      "8275f0dc-2f1e-4c07-8c2f-9f033d6eb3fa"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_10",
                    "encounterId": "fdeed36f-6c32-416d-8f3a-a88c03215771",
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "a571b82f-9ef6-4722-a67d-1dceeed87928",
                    "activityIds": [
                      "8275f0dc-2f1e-4c07-8c2f-9f033d6eb3fa"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_11",
                    "encounterId": "e9b883bf-5e58-40ab-a4e6-19e0cb3f1960",
                    "timingId": "30e2c586-d47b-42ac-91f1-c2cb492bcab3",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "584d81f8-1096-4f2c-951a-c1d6c69445d5",
                    "activityIds": [
                      "53bf719f-7170-4a34-9003-8e1f466c50ad"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_6@enc_1",
                    "encounterId": "62174547-37ae-4535-a8f1-ce0609b7aeaa",
                    "epochId": "42a36ce7-2ce6-4ccc-afc0-0a7d9605190f"
                  },
                  {
                    "id": "95ad83df-ca52-44cd-890a-2eca95635bd7",
                    "activityIds": [
                      "1141bcac-6ed0-4cd7-9c4e-b9c41c47fe88"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@enc_1",
                    "encounterId": "62174547-37ae-4535-a8f1-ce0609b7aeaa",
                    "epochId": "42a36ce7-2ce6-4ccc-afc0-0a7d9605190f"
                  },
                  {
                    "id": "671648dc-e7d7-43d7-bd32-fea594732138",
                    "activityIds": [
                      "ce497a62-35b6-41d1-9c3a-b4053097c57e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@enc_1",
                    "encounterId": "62174547-37ae-4535-a8f1-ce0609b7aeaa",
                    "epochId": "42a36ce7-2ce6-4ccc-afc0-0a7d9605190f"
                  },
                  {
                    "id": "78ea20eb-de33-4b8d-9897-efb43b0ff6d2",
                    "activityIds": [
                      "cddfd22b-a39a-45eb-b16b-f59b1dc38d69"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_9@enc_1",
                    "encounterId": "62174547-37ae-4535-a8f1-ce0609b7aeaa",
                    "epochId": "42a36ce7-2ce6-4ccc-afc0-0a7d9605190f"
                  },
                  {
                    "id": "317c7aa9-896a-4f38-b2b2-3e6e26432653",
                    "activityIds": [
                      "cddfd22b-a39a-45eb-b16b-f59b1dc38d69"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_9@enc_11",
                    "encounterId": "e9b883bf-5e58-40ab-a4e6-19e0cb3f1960",
                    "timingId": "30e2c586-d47b-42ac-91f1-c2cb492bcab3",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "a39656c4-df11-4e04-914b-0a34c6a22a4f",
                    "activityIds": [
                      "cddfd22b-a39a-45eb-b16b-f59b1dc38d69"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_9@enc_12",
                    "encounterId": "79d35e9f-160c-48e8-873b-a9747a912cae",
                    "timingId": "9fc212da-53c6-4306-8208-384c69f4c1a3",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "cb615e8f-6e1a-4b2c-a422-6aa4f892c9f8",
                    "activityIds": [
                      "cddfd22b-a39a-45eb-b16b-f59b1dc38d69"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_9@enc_13",
                    "encounterId": "88ddd4c1-25ec-4e8e-9ec0-fd4965490fb9",
                    "timingId": "def0bdef-7278-40f7-9b26-bce57b23acc7",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "644124f5-d084-4f67-82c8-30bf2130b439",
                    "activityIds": [
                      "e1308d60-207a-4ab5-bff2-67c4f4e0bc7e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_10@enc_1",
                    "encounterId": "62174547-37ae-4535-a8f1-ce0609b7aeaa",
                    "epochId": "42a36ce7-2ce6-4ccc-afc0-0a7d9605190f"
                  },
                  {
                    "id": "2548dca0-766a-43f0-8e98-bf5cb732ffc6",
                    "activityIds": [
                      "a8df3d05-22e5-4d67-b8de-314796038b7d"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_11@enc_1",
                    "encounterId": "62174547-37ae-4535-a8f1-ce0609b7aeaa",
                    "epochId": "42a36ce7-2ce6-4ccc-afc0-0a7d9605190f"
                  },
                  {
                    "id": "9528492a-1815-48ba-8c73-37d529ed3bb2",
                    "activityIds": [
                      "a8df3d05-22e5-4d67-b8de-314796038b7d"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_11@enc_4",
                    "encounterId": "c4efbabd-737e-497e-a7bd-bc4870c824a2",
                    "epochId": "5e453d8c-b48d-465b-9a41-1907c6900c09"
                  },
                  {
                    "id": "b27ab2ab-4f3d-4f29-9b1a-404199b84466",
                    "activityIds": [
                      "4d7306fa-9334-491d-bcb4-68e10f61f0e0"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_12@enc_1",
                    "encounterId": "62174547-37ae-4535-a8f1-ce0609b7aeaa",
                    "epochId": "42a36ce7-2ce6-4ccc-afc0-0a7d9605190f"
                  },
                  {
                    "id": "33d81500-4fbe-4326-8ce4-7a3394ddffcd",
                    "activityIds": [
                      "4d7306fa-9334-491d-bcb4-68e10f61f0e0"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_12@enc_4",
                    "encounterId": "c4efbabd-737e-497e-a7bd-bc4870c824a2",
                    "epochId": "5e453d8c-b48d-465b-9a41-1907c6900c09"
                  },
                  {
                    "id": "94526fed-c18d-4234-b45f-6c405e1dac00",
                    "activityIds": [
                      "4d7306fa-9334-491d-bcb4-68e10f61f0e0"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_12@enc_9",
                    "encounterId": "17568e63-7559-4d6c-910f-120a81c21324",
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "ce7b6bcc-04f4-4da8-9041-828cb912f2dd",
                    "activityIds": [
                      "4d7306fa-9334-491d-bcb4-68e10f61f0e0"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_12@enc_10",
                    "encounterId": "fdeed36f-6c32-416d-8f3a-a88c03215771",
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "85e1b65b-3afd-4360-a307-bcf211939e74",
                    "activityIds": [
                      "4d7306fa-9334-491d-bcb4-68e10f61f0e0"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_12@enc_11",
                    "encounterId": "e9b883bf-5e58-40ab-a4e6-19e0cb3f1960",
                    "timingId": "30e2c586-d47b-42ac-91f1-c2cb492bcab3",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "908dc8db-a32c-4360-8c69-7cbe79df0ec9",
                    "activityIds": [
                      "4d7306fa-9334-491d-bcb4-68e10f61f0e0"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_12@enc_12",
                    "encounterId": "79d35e9f-160c-48e8-873b-a9747a912cae",
                    "timingId": "9fc212da-53c6-4306-8208-384c69f4c1a3",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "e6fbac21-7d6b-4f06-93c0-b214aa5e12f1",
                    "activityIds": [
                      "4d7306fa-9334-491d-bcb4-68e10f61f0e0"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_12@enc_13",
                    "encounterId": "88ddd4c1-25ec-4e8e-9ec0-fd4965490fb9",
                    "timingId": "def0bdef-7278-40f7-9b26-bce57b23acc7",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "8911dcdc-0217-4f78-bd40-34c286e70850",
                    "activityIds": [
                      "371d27c8-8dbf-4d8e-8f6e-004bbf5ced41"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_13@enc_1",
                    "encounterId": "62174547-37ae-4535-a8f1-ce0609b7aeaa",
                    "epochId": "42a36ce7-2ce6-4ccc-afc0-0a7d9605190f"
                  },
                  {
                    "id": "5d5b5b4f-2a00-4db1-a2ee-e78e944bb272",
                    "activityIds": [
                      "371d27c8-8dbf-4d8e-8f6e-004bbf5ced41"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_13@enc_4",
                    "encounterId": "c4efbabd-737e-497e-a7bd-bc4870c824a2",
                    "epochId": "5e453d8c-b48d-465b-9a41-1907c6900c09"
                  },
                  {
                    "id": "c9b53e5b-d858-4dd5-bf66-0c34dad4af31",
                    "activityIds": [
                      "371d27c8-8dbf-4d8e-8f6e-004bbf5ced41"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_13@enc_9",
                    "encounterId": "17568e63-7559-4d6c-910f-120a81c21324",
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "c3a3494d-649f-4789-88cc-6aea11b3c812",
                    "activityIds": [
                      "371d27c8-8dbf-4d8e-8f6e-004bbf5ced41"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_13@enc_10",
                    "encounterId": "fdeed36f-6c32-416d-8f3a-a88c03215771",
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "08d36f05-c647-41c4-a081-bf3741ecb954",
                    "activityIds": [
                      "371d27c8-8dbf-4d8e-8f6e-004bbf5ced41"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_13@enc_11",
                    "encounterId": "e9b883bf-5e58-40ab-a4e6-19e0cb3f1960",
                    "timingId": "30e2c586-d47b-42ac-91f1-c2cb492bcab3",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "899ee0d9-f2e9-4def-8cc9-858dcfb4793d",
                    "activityIds": [
                      "371d27c8-8dbf-4d8e-8f6e-004bbf5ced41"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_13@enc_12",
                    "encounterId": "79d35e9f-160c-48e8-873b-a9747a912cae",
                    "timingId": "9fc212da-53c6-4306-8208-384c69f4c1a3",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "b292dd8d-0d83-4476-9399-d9f692ce2ca3",
                    "activityIds": [
                      "371d27c8-8dbf-4d8e-8f6e-004bbf5ced41"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_13@enc_13",
                    "encounterId": "88ddd4c1-25ec-4e8e-9ec0-fd4965490fb9",
                    "timingId": "def0bdef-7278-40f7-9b26-bce57b23acc7",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "6e920510-98b6-41e7-b60c-e7d7af81d3f4",
                    "activityIds": [
                      "84a27b69-f848-46a1-ad74-8cf5e56a689f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_14@enc_3",
                    "encounterId": "1e55cdb0-fc2d-478e-b392-937f2c457903",
                    "epochId": "ac31381d-c74c-4a5d-8dd9-ed49b147aa91"
                  },
                  {
                    "id": "8c1032e5-4172-4a45-8acc-31c6a7170813",
                    "activityIds": [
                      "84a27b69-f848-46a1-ad74-8cf5e56a689f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_14@enc_11",
                    "encounterId": "e9b883bf-5e58-40ab-a4e6-19e0cb3f1960",
                    "timingId": "30e2c586-d47b-42ac-91f1-c2cb492bcab3",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "27c9af0c-f123-42eb-9b8c-e31b8f1dca32",
                    "activityIds": [
                      "7fa32694-2a84-4e5d-9575-0a4639601156"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_15@enc_1",
                    "encounterId": "62174547-37ae-4535-a8f1-ce0609b7aeaa",
                    "epochId": "42a36ce7-2ce6-4ccc-afc0-0a7d9605190f"
                  },
                  {
                    "id": "c02ccbfb-cde9-427a-b5bc-aa12de13c5cd",
                    "activityIds": [
                      "703c6ab5-49d5-4ae2-821f-52ed6c547724"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_16@enc_2",
                    "encounterId": "f845acb2-6ccc-4c5d-9aab-67e4c632d59d",
                    "epochId": "268e1c4d-92e1-401e-afd6-63c53cde04ea"
                  },
                  {
                    "id": "3836b749-eb8f-44af-b693-64d15632ddc4",
                    "activityIds": [
                      "4c2c603a-712f-4011-838f-6b95e7dfa1cd"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_17@enc_10",
                    "encounterId": "fdeed36f-6c32-416d-8f3a-a88c03215771",
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "dd695dba-cd6e-44e0-9bc6-686ca06f459b",
                    "activityIds": [
                      "a75b6ae3-90fd-4c22-930c-182dd4ab86d2"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_18@enc_9",
                    "encounterId": "17568e63-7559-4d6c-910f-120a81c21324",
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "7d0a68a8-2d97-4920-8128-219eb4c74e5c",
                    "activityIds": [
                      "a75b6ae3-90fd-4c22-930c-182dd4ab86d2"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_18@enc_10",
                    "encounterId": "fdeed36f-6c32-416d-8f3a-a88c03215771",
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "119f9c07-d260-42b0-a7a7-127e61fdf926",
                    "activityIds": [
                      "25b08c4c-30e1-46a6-9be3-a91418608fdf"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_4",
                    "encounterId": "c4efbabd-737e-497e-a7bd-bc4870c824a2",
                    "epochId": "5e453d8c-b48d-465b-9a41-1907c6900c09"
                  },
                  {
                    "id": "6ce6332d-2cf7-4b93-8957-a79a379b0227",
                    "activityIds": [
                      "25b08c4c-30e1-46a6-9be3-a91418608fdf"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_10",
                    "encounterId": "fdeed36f-6c32-416d-8f3a-a88c03215771",
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "535144bc-292f-41af-ac7f-30cc3f7df345",
                    "activityIds": [
                      "25b08c4c-30e1-46a6-9be3-a91418608fdf"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_11",
                    "encounterId": "e9b883bf-5e58-40ab-a4e6-19e0cb3f1960",
                    "timingId": "30e2c586-d47b-42ac-91f1-c2cb492bcab3",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "67af876f-446d-4ca2-a6e3-808b0613be37",
                    "activityIds": [
                      "25b08c4c-30e1-46a6-9be3-a91418608fdf"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_12",
                    "encounterId": "79d35e9f-160c-48e8-873b-a9747a912cae",
                    "timingId": "9fc212da-53c6-4306-8208-384c69f4c1a3",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "cc04234b-d340-4f29-813f-3d52b37664e2",
                    "activityIds": [
                      "25b08c4c-30e1-46a6-9be3-a91418608fdf"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_13",
                    "encounterId": "88ddd4c1-25ec-4e8e-9ec0-fd4965490fb9",
                    "timingId": "def0bdef-7278-40f7-9b26-bce57b23acc7",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "845642ab-ee3a-48fc-a1dd-9d6ab4f6bc46",
                    "activityIds": [
                      "143296c6-3554-4020-904a-935de6170375"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_4",
                    "encounterId": "c4efbabd-737e-497e-a7bd-bc4870c824a2",
                    "epochId": "5e453d8c-b48d-465b-9a41-1907c6900c09"
                  },
                  {
                    "id": "8cb92882-d2f2-43eb-8712-2ddd95a35247",
                    "activityIds": [
                      "143296c6-3554-4020-904a-935de6170375"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_9",
                    "encounterId": "17568e63-7559-4d6c-910f-120a81c21324",
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "abe3396b-77c2-4427-a1ac-03e90855f420",
                    "activityIds": [
                      "143296c6-3554-4020-904a-935de6170375"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_10",
                    "encounterId": "fdeed36f-6c32-416d-8f3a-a88c03215771",
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "44ceacfc-06c6-4d41-b77f-558119d0d840",
                    "activityIds": [
                      "143296c6-3554-4020-904a-935de6170375"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_11",
                    "encounterId": "e9b883bf-5e58-40ab-a4e6-19e0cb3f1960",
                    "timingId": "30e2c586-d47b-42ac-91f1-c2cb492bcab3",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "d5e39cc6-2519-45da-afeb-e882b6d7a127",
                    "activityIds": [
                      "143296c6-3554-4020-904a-935de6170375"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_13",
                    "encounterId": "88ddd4c1-25ec-4e8e-9ec0-fd4965490fb9",
                    "timingId": "def0bdef-7278-40f7-9b26-bce57b23acc7",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "2e947167-dced-4d4c-ae01-7e149bb2cc4d",
                    "activityIds": [
                      "4b1d3b59-26f4-4525-bc52-091119323625"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_21@enc_1",
                    "encounterId": "62174547-37ae-4535-a8f1-ce0609b7aeaa",
                    "epochId": "42a36ce7-2ce6-4ccc-afc0-0a7d9605190f"
                  },
                  {
                    "id": "7c019419-a5cf-48cb-94fa-988b35c9b738",
                    "activityIds": [
                      "4b1d3b59-26f4-4525-bc52-091119323625"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_21@enc_3",
                    "encounterId": "1e55cdb0-fc2d-478e-b392-937f2c457903",
                    "epochId": "ac31381d-c74c-4a5d-8dd9-ed49b147aa91"
                  },
                  {
                    "id": "2cde8f55-76c8-4e21-9ba0-ff740c0c7872",
                    "activityIds": [
                      "f8362489-fc0a-42f3-835d-7a29d354c3eb"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_1",
                    "encounterId": "62174547-37ae-4535-a8f1-ce0609b7aeaa",
                    "epochId": "42a36ce7-2ce6-4ccc-afc0-0a7d9605190f"
                  },
                  {
                    "id": "298cf6b5-50f9-438f-af80-7eef876889d3",
                    "activityIds": [
                      "f8362489-fc0a-42f3-835d-7a29d354c3eb"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_3",
                    "encounterId": "1e55cdb0-fc2d-478e-b392-937f2c457903",
                    "epochId": "ac31381d-c74c-4a5d-8dd9-ed49b147aa91"
                  },
                  {
                    "id": "59323a77-03c0-46da-aa22-7d400e509e15",
                    "activityIds": [
                      "f8362489-fc0a-42f3-835d-7a29d354c3eb"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_9",
                    "encounterId": "17568e63-7559-4d6c-910f-120a81c21324",
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "02d1f9e7-dc70-4a74-8544-654de9456701",
                    "activityIds": [
                      "f8362489-fc0a-42f3-835d-7a29d354c3eb"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_11",
                    "encounterId": "e9b883bf-5e58-40ab-a4e6-19e0cb3f1960",
                    "timingId": "30e2c586-d47b-42ac-91f1-c2cb492bcab3",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "4607940a-05b5-4d18-a60a-21b4363c8302",
                    "activityIds": [
                      "f8362489-fc0a-42f3-835d-7a29d354c3eb"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_12",
                    "encounterId": "79d35e9f-160c-48e8-873b-a9747a912cae",
                    "timingId": "9fc212da-53c6-4306-8208-384c69f4c1a3",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "c11e1089-51a7-4f5e-8116-d8ef4ab1209d",
                    "activityIds": [
                      "f8362489-fc0a-42f3-835d-7a29d354c3eb"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_13",
                    "encounterId": "88ddd4c1-25ec-4e8e-9ec0-fd4965490fb9",
                    "timingId": "def0bdef-7278-40f7-9b26-bce57b23acc7",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "48e72369-2088-4344-8d4c-84a8a930f009",
                    "activityIds": [
                      "50f61d5f-6d5a-4b48-b016-6721a82dd9a2"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_23@enc_1",
                    "encounterId": "62174547-37ae-4535-a8f1-ce0609b7aeaa",
                    "epochId": "42a36ce7-2ce6-4ccc-afc0-0a7d9605190f"
                  },
                  {
                    "id": "ec0f520e-a491-45e8-b332-bff4d59cba5e",
                    "activityIds": [
                      "50f61d5f-6d5a-4b48-b016-6721a82dd9a2"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_23@enc_3",
                    "encounterId": "1e55cdb0-fc2d-478e-b392-937f2c457903",
                    "epochId": "ac31381d-c74c-4a5d-8dd9-ed49b147aa91"
                  },
                  {
                    "id": "7adb28a7-b5a4-4815-a299-92279c82da9f",
                    "activityIds": [
                      "50f61d5f-6d5a-4b48-b016-6721a82dd9a2"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_23@enc_9",
                    "encounterId": "17568e63-7559-4d6c-910f-120a81c21324",
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "a7c93d87-542b-4c7f-99fd-d0a8e19d835d",
                    "activityIds": [
                      "50f61d5f-6d5a-4b48-b016-6721a82dd9a2"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_23@enc_11",
                    "encounterId": "e9b883bf-5e58-40ab-a4e6-19e0cb3f1960",
                    "timingId": "30e2c586-d47b-42ac-91f1-c2cb492bcab3",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "a3d3da39-d8e6-440a-b186-e9da389b579f",
                    "activityIds": [
                      "50f61d5f-6d5a-4b48-b016-6721a82dd9a2"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_23@enc_12",
                    "encounterId": "79d35e9f-160c-48e8-873b-a9747a912cae",
                    "timingId": "9fc212da-53c6-4306-8208-384c69f4c1a3",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "9061bda4-9ead-41ca-96bf-4abf8f3fe23c",
                    "activityIds": [
                      "50f61d5f-6d5a-4b48-b016-6721a82dd9a2"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_23@enc_13",
                    "encounterId": "88ddd4c1-25ec-4e8e-9ec0-fd4965490fb9",
                    "timingId": "def0bdef-7278-40f7-9b26-bce57b23acc7",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "43beae02-e3e4-4a3d-83dc-4dcc1d4dab83",
                    "activityIds": [
                      "a632259b-05cd-4b58-ac30-24b2fadc4224"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_1",
                    "encounterId": "62174547-37ae-4535-a8f1-ce0609b7aeaa",
                    "epochId": "42a36ce7-2ce6-4ccc-afc0-0a7d9605190f"
                  },
                  {
                    "id": "e37c648a-461b-4b33-bd24-83ae1a14d4e3",
                    "activityIds": [
                      "a632259b-05cd-4b58-ac30-24b2fadc4224"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_3",
                    "encounterId": "1e55cdb0-fc2d-478e-b392-937f2c457903",
                    "epochId": "ac31381d-c74c-4a5d-8dd9-ed49b147aa91"
                  },
                  {
                    "id": "07781fd8-25c6-4507-a595-fa762f2ac536",
                    "activityIds": [
                      "a632259b-05cd-4b58-ac30-24b2fadc4224"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_9",
                    "encounterId": "17568e63-7559-4d6c-910f-120a81c21324",
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "db3a9c14-9b9c-4a5a-bc18-1f4a9cb97c32",
                    "activityIds": [
                      "a632259b-05cd-4b58-ac30-24b2fadc4224"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_11",
                    "encounterId": "e9b883bf-5e58-40ab-a4e6-19e0cb3f1960",
                    "timingId": "30e2c586-d47b-42ac-91f1-c2cb492bcab3",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "af74f6a4-597d-461c-b3ec-db1b581969f4",
                    "activityIds": [
                      "a632259b-05cd-4b58-ac30-24b2fadc4224"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_12",
                    "encounterId": "79d35e9f-160c-48e8-873b-a9747a912cae",
                    "timingId": "9fc212da-53c6-4306-8208-384c69f4c1a3",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "3eb6bddf-0382-4994-8bc0-da1581dccbd0",
                    "activityIds": [
                      "a632259b-05cd-4b58-ac30-24b2fadc4224"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_13",
                    "encounterId": "88ddd4c1-25ec-4e8e-9ec0-fd4965490fb9",
                    "timingId": "def0bdef-7278-40f7-9b26-bce57b23acc7",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "2c9104ef-425e-49bc-96c8-89c324437d75",
                    "activityIds": [
                      "ebfd763c-149d-43f9-b7c5-0d3b7c9532c2"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_25@enc_3",
                    "encounterId": "1e55cdb0-fc2d-478e-b392-937f2c457903",
                    "epochId": "ac31381d-c74c-4a5d-8dd9-ed49b147aa91"
                  },
                  {
                    "id": "0d0a167f-3934-4e4a-a3cd-45318f26a660",
                    "activityIds": [
                      "a4a27a10-b80b-4d97-8ddd-2f4c157c368e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_26@enc_4",
                    "encounterId": "c4efbabd-737e-497e-a7bd-bc4870c824a2",
                    "epochId": "5e453d8c-b48d-465b-9a41-1907c6900c09"
                  },
                  {
                    "id": "74467989-e91e-46e9-8c9e-ab08f8086684",
                    "activityIds": [
                      "a4a27a10-b80b-4d97-8ddd-2f4c157c368e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_26@enc_5",
                    "encounterId": "0ccea7b6-8f87-4bdb-b65c-0370eefca065",
                    "epochId": "5e453d8c-b48d-465b-9a41-1907c6900c09"
                  },
                  {
                    "id": "8afcddab-847c-4007-bc1e-5039a7f30948",
                    "activityIds": [
                      "a4a27a10-b80b-4d97-8ddd-2f4c157c368e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_26@enc_6",
                    "encounterId": "89ad4ea6-35a1-47a4-8fa2-b1c3c63690bf",
                    "epochId": "5e453d8c-b48d-465b-9a41-1907c6900c09"
                  },
                  {
                    "id": "0bc8fc40-c46c-4485-942b-e70a161746be",
                    "activityIds": [
                      "17ab9f60-7471-41c5-b7d0-b819af9b89d9"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_27@enc_9",
                    "encounterId": "17568e63-7559-4d6c-910f-120a81c21324",
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "8842699d-f55d-4b30-9d04-c37fe5137a04",
                    "activityIds": [
                      "ad7ce556-2f71-4b2a-a7a4-3129ad93e909"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_28@enc_2",
                    "encounterId": "f845acb2-6ccc-4c5d-9aab-67e4c632d59d",
                    "epochId": "268e1c4d-92e1-401e-afd6-63c53cde04ea"
                  },
                  {
                    "id": "18944ac9-54b9-4b7e-bc03-619744874aca",
                    "activityIds": [
                      "ad7ce556-2f71-4b2a-a7a4-3129ad93e909"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_28@enc_3",
                    "encounterId": "1e55cdb0-fc2d-478e-b392-937f2c457903",
                    "epochId": "ac31381d-c74c-4a5d-8dd9-ed49b147aa91"
                  },
                  {
                    "id": "1de98293-aed0-4a8a-825a-9fa8d27e6991",
                    "activityIds": [
                      "ad7ce556-2f71-4b2a-a7a4-3129ad93e909"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_28@enc_4",
                    "encounterId": "c4efbabd-737e-497e-a7bd-bc4870c824a2",
                    "epochId": "5e453d8c-b48d-465b-9a41-1907c6900c09"
                  },
                  {
                    "id": "1b484f4c-92e8-4987-9e14-edf743835dff",
                    "activityIds": [
                      "ad7ce556-2f71-4b2a-a7a4-3129ad93e909"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_28@enc_5",
                    "encounterId": "0ccea7b6-8f87-4bdb-b65c-0370eefca065",
                    "epochId": "5e453d8c-b48d-465b-9a41-1907c6900c09"
                  },
                  {
                    "id": "02b4d657-5056-452e-94cd-4b104caf3c29",
                    "activityIds": [
                      "ad7ce556-2f71-4b2a-a7a4-3129ad93e909"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_28@enc_6",
                    "encounterId": "89ad4ea6-35a1-47a4-8fa2-b1c3c63690bf",
                    "epochId": "5e453d8c-b48d-465b-9a41-1907c6900c09"
                  },
                  {
                    "id": "1cab0db4-e53b-477a-9c63-b41348513595",
                    "activityIds": [
                      "ad7ce556-2f71-4b2a-a7a4-3129ad93e909"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_28@enc_7",
                    "encounterId": "e8a799cf-d1b2-4032-8cdb-36728e5c0cda",
                    "epochId": "5e453d8c-b48d-465b-9a41-1907c6900c09"
                  },
                  {
                    "id": "ec069772-7a8d-4a5f-82f5-a49ad38ec28f",
                    "activityIds": [
                      "ad7ce556-2f71-4b2a-a7a4-3129ad93e909"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_28@enc_8",
                    "encounterId": "f27d97b8-e803-44dd-900a-e675a43f9367",
                    "epochId": "5e453d8c-b48d-465b-9a41-1907c6900c09"
                  },
                  {
                    "id": "d7369031-dccb-422e-a887-503ff7056f51",
                    "activityIds": [
                      "ad7ce556-2f71-4b2a-a7a4-3129ad93e909"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_28@enc_9",
                    "encounterId": "17568e63-7559-4d6c-910f-120a81c21324",
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "1036f086-4467-4fbf-9d68-a13782c453c9",
                    "activityIds": [
                      "ad7ce556-2f71-4b2a-a7a4-3129ad93e909"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_28@enc_10",
                    "encounterId": "fdeed36f-6c32-416d-8f3a-a88c03215771",
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "db37ed4e-db19-4dca-afcb-3b97e22ca1d7",
                    "activityIds": [
                      "ad7ce556-2f71-4b2a-a7a4-3129ad93e909"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_28@enc_11",
                    "encounterId": "e9b883bf-5e58-40ab-a4e6-19e0cb3f1960",
                    "timingId": "30e2c586-d47b-42ac-91f1-c2cb492bcab3",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "a29878d6-ca77-4e85-8b10-a9c89c80bb37",
                    "activityIds": [
                      "ad7ce556-2f71-4b2a-a7a4-3129ad93e909"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_28@enc_12",
                    "encounterId": "79d35e9f-160c-48e8-873b-a9747a912cae",
                    "timingId": "9fc212da-53c6-4306-8208-384c69f4c1a3",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "9c23e33e-2d95-4f9d-b680-ec01f31ed2c5",
                    "activityIds": [
                      "ad7ce556-2f71-4b2a-a7a4-3129ad93e909"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_28@enc_13",
                    "encounterId": "88ddd4c1-25ec-4e8e-9ec0-fd4965490fb9",
                    "timingId": "def0bdef-7278-40f7-9b26-bce57b23acc7",
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b"
                  },
                  {
                    "id": "9af31d20-6886-4680-a69f-ad4492e4d55b",
                    "name": "InformedConsent",
                    "description": "Event anchor: InformedConsent",
                    "activityIds": [],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "dd1cd127-3043-4009-ba89-cb48229a81b3",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Event"
                      },
                      {
                        "id": "3955ceb3-40e6-44ab-9ebb-8dc9307d75ce",
                        "url": "http://example.org/usdm/intraDayOrder",
                        "instanceType": "ExtensionAttribute",
                        "valueInteger": 10
                      }
                    ],
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b",
                    "scheduledDay": 1
                  },
                  {
                    "id": "7d610294-8764-4d60-a75d-2c0fc7635358",
                    "name": "Randomization",
                    "description": "Event anchor: Randomization",
                    "activityIds": [
                      "703c6ab5-49d5-4ae2-821f-52ed6c547724"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "dd1cd127-3043-4009-ba89-cb48229a81b3",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Event"
                      },
                      {
                        "id": "3955ceb3-40e6-44ab-9ebb-8dc9307d75ce",
                        "url": "http://example.org/usdm/intraDayOrder",
                        "instanceType": "ExtensionAttribute",
                        "valueInteger": 40
                      }
                    ],
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b",
                    "scheduledDay": 1
                  },
                  {
                    "id": "bd7d2c5f-028a-470b-87c2-0953f7d001e6",
                    "name": "FirstDose",
                    "description": "Event anchor: FirstDose",
                    "activityIds": [
                      "17ab9f60-7471-41c5-b7d0-b819af9b89d9"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "dd1cd127-3043-4009-ba89-cb48229a81b3",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Event"
                      },
                      {
                        "id": "3955ceb3-40e6-44ab-9ebb-8dc9307d75ce",
                        "url": "http://example.org/usdm/intraDayOrder",
                        "instanceType": "ExtensionAttribute",
                        "valueInteger": 60
                      }
                    ],
                    "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b",
                    "scheduledDay": 1
                  },
                  {
                    "id": "788e3dbd-2fde-4a8a-9eaa-4828dfa2ca4b",
                    "name": "Anchor: Screening Window",
                    "activityIds": [],
                    "encounterId": "fdeed36f-6c32-416d-8f3a-a88c03215771",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "3f6d3458-bcee-42c3-bc9e-99f4530566ed",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "123ffa8c-d229-4207-b1b4-bdef01a89309",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "e7c83ab6-591d-4c42-88cc-cdbfbee4ffa9",
                    "name": "Anchor: PET-CT Baseline Window",
                    "activityIds": [],
                    "encounterId": "fdeed36f-6c32-416d-8f3a-a88c03215771",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "7f5d3b63-466e-4583-8fd4-8de06021e9ab",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "c341377b-feba-40a3-b237-49360780e585",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  },
                  {
                    "id": "18713b10-de4d-4589-89f1-51bdcdde3f53",
                    "name": "Anchor: Day 100 Disease Assessment",
                    "activityIds": [],
                    "encounterId": "fdeed36f-6c32-416d-8f3a-a88c03215771",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "ec925a7a-a485-4682-9c8c-14cd7d4f4ffe",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "24989da6-5503-43c1-9cc3-f788c55cf091",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548"
                  }
                ],
                "timings": [
                  {
                    "id": "a29bdb0c-f387-4082-82f1-2a35ac0c02a6",
                    "name": "Screening Window",
                    "type": {
                      "id": "0a63a884-a718-40a8-8dbe-be9a515eca08",
                      "code": "C71151",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Within",
                      "instanceType": "Code"
                    },
                    "value": "P14D",
                    "valueLabel": "Day 14",
                    "relativeToFrom": {
                      "id": "cc8b3f49-44c2-42c2-995a-b17e3c7fc2d8",
                      "code": "C71154",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Randomization",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "788e3dbd-2fde-4a8a-9eaa-4828dfa2ca4b",
                    "instanceType": "Timing",
                    "windowLower": "-P14D",
                    "windowUpper": "P0D"
                  },
                  {
                    "id": "855b276d-589b-4c9e-9929-013b526ec7c0",
                    "name": "ECHO Eligibility Window",
                    "type": {
                      "id": "19ccaa40-7210-473a-a11b-02e4bc5aa626",
                      "code": "C71151",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Within",
                      "instanceType": "Code"
                    },
                    "value": "P28D",
                    "valueLabel": "Day 28",
                    "relativeToFrom": {
                      "id": "13c4931a-a66f-47cd-b515-f07e1a4c0354",
                      "code": "C71158",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Screening",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "d492513d-56fb-40f7-9b9f-9c203ea15d9c",
                    "instanceType": "Timing",
                    "windowLower": "-P28D",
                    "windowUpper": "P0D"
                  },
                  {
                    "id": "13a2ba86-8c93-4d33-b8f2-dfc6f0338462",
                    "name": "PET-CT Baseline Window",
                    "type": {
                      "id": "f89164f4-40a1-4a99-a8e5-faa3dcc698bc",
                      "code": "C71151",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Within",
                      "instanceType": "Code"
                    },
                    "value": "P28D",
                    "valueLabel": "Day 28",
                    "relativeToFrom": {
                      "id": "0dd16b56-5855-4a3b-8f92-d2527d657523",
                      "code": "C71154",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Randomization",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "e7c83ab6-591d-4c42-88cc-cdbfbee4ffa9",
                    "instanceType": "Timing",
                    "windowLower": "-P28D",
                    "windowUpper": "P0D"
                  },
                  {
                    "id": "904019a2-47bc-4692-a12b-f2dfec2717fc",
                    "name": "Leukapheresis Timing",
                    "type": {
                      "id": "17c2579e-de60-452e-a17c-ce3d42bb5efd",
                      "code": "C71151",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Within",
                      "instanceType": "Code"
                    },
                    "value": "P5D",
                    "valueLabel": "Day 5",
                    "relativeToFrom": {
                      "id": "d51dbfe1-c59c-4070-aa3c-613cdcd7a08d",
                      "code": "C71154",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Randomization",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "2c121eec-481a-4d48-b810-5d49f65813d8",
                    "instanceType": "Timing",
                    "windowLower": "P0D",
                    "windowUpper": "P5D"
                  },
                  {
                    "id": "f177e91b-31f6-4160-9149-8af2f899b139",
                    "name": "Conditioning Chemotherapy",
                    "type": {
                      "id": "34e243b6-c665-481f-9147-5cfd92bd2ac9",
                      "code": "C71149",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Before",
                      "instanceType": "Code"
                    },
                    "value": "P5D",
                    "valueLabel": "Day 5",
                    "relativeToFrom": {
                      "id": "1a3bd63d-9f81-4af4-8d76-b5a79698143a",
                      "code": "C71155",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "First Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "53495fcb-197e-4a34-b32f-a51116384b55",
                    "instanceType": "Timing",
                    "windowLower": "-P5D",
                    "windowUpper": "-P3D"
                  },
                  {
                    "id": "71b8611c-fc31-4185-80c8-f00c1d2af0d8",
                    "name": "CAR-T Rest Days",
                    "type": {
                      "id": "ccd8c063-95f5-44ad-b46b-96d92947d6da",
                      "code": "C71149",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Before",
                      "instanceType": "Code"
                    },
                    "value": "P2D",
                    "valueLabel": "Day 2",
                    "relativeToFrom": {
                      "id": "3e9ff90d-a60f-4dbf-aff6-afcbcb087bcf",
                      "code": "C71155",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "First Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "640a42fc-64ca-4126-846f-2993da4cd6e7",
                    "instanceType": "Timing",
                    "windowLower": "-P2D",
                    "windowUpper": "-P1D"
                  },
                  {
                    "id": "30e2c586-d47b-42ac-91f1-c2cb492bcab3",
                    "name": "Day 50 Disease Assessment",
                    "type": {
                      "id": "3fda4840-4470-45f9-9fc7-53b18c8b4257",
                      "code": "C71148",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Fixed Reference",
                      "instanceType": "Code"
                    },
                    "value": "P50D",
                    "valueLabel": "Day 50",
                    "relativeToFrom": {
                      "id": "327b284c-9524-45dd-b434-912175b0499f",
                      "code": "C71154",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Randomization",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "5c09aa99-fbaa-4cfe-8343-63dcd7ccce07",
                    "instanceType": "Timing",
                    "windowLower": "-P7D",
                    "windowUpper": "P21D"
                  },
                  {
                    "id": "9fc212da-53c6-4306-8208-384c69f4c1a3",
                    "name": "Day 100 Disease Assessment",
                    "type": {
                      "id": "1ea81edc-6cc7-49ee-9949-d98c99797335",
                      "code": "C71148",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Fixed Reference",
                      "instanceType": "Code"
                    },
                    "value": "P100D",
                    "valueLabel": "Day 100",
                    "relativeToFrom": {
                      "id": "5e446f69-5c4a-4a0a-9ce7-85151efac319",
                      "code": "C71154",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Randomization",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "18713b10-de4d-4589-89f1-51bdcdde3f53",
                    "instanceType": "Timing",
                    "windowLower": "-P14D",
                    "windowUpper": "P14D"
                  },
                  {
                    "id": "def0bdef-7278-40f7-9b26-bce57b23acc7",
                    "name": "Day 150 Disease Assessment",
                    "type": {
                      "id": "96f33fc7-b3d6-4b8f-8a00-5e0bf564a599",
                      "code": "C71148",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Fixed Reference",
                      "instanceType": "Code"
                    },
                    "value": "P150D",
                    "valueLabel": "Day 150",
                    "relativeToFrom": {
                      "id": "060d19ce-1e7e-4e05-91f4-367ccd89b180",
                      "code": "C71154",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Randomization",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "18713b10-de4d-4589-89f1-51bdcdde3f53",
                    "instanceType": "Timing",
                    "windowLower": "-P14D",
                    "windowUpper": "P14D"
                  },
                  {
                    "id": "4752cd41-2749-46c4-b558-79c9428f77b0",
                    "name": "SOC Cycle Interval",
                    "type": {
                      "id": "7f020bfb-540c-45ec-a4e5-73e3261f0451",
                      "code": "C71152",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Between",
                      "instanceType": "Code"
                    },
                    "value": "P3W",
                    "valueLabel": "3 weeks",
                    "relativeToFrom": {
                      "id": "505062bc-2fc1-4ce2-97c6-d03323697adc",
                      "code": "C71157",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Previous Visit",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "997fec6c-4458-4cfe-bc0a-02acb594a3c4",
                    "instanceType": "Timing",
                    "windowLower": "P2W",
                    "windowUpper": "P3W"
                  }
                ],
                "exits": [
                  {
                    "id": "cc799328-9d59-4f40-a869-3bc7ca17a55e",
                    "name": "SOC Study Completion",
                    "exitType": "Completion",
                    "instanceType": "ScheduleTimelineExit",
                    "description": "Approximately 5 years from informed consent"
                  },
                  {
                    "id": "5d680e8e-b513-4bc0-9ec9-07ab02d28dcc",
                    "name": "Axicabtagene Ciloleucel Study Completion",
                    "exitType": "Completion",
                    "instanceType": "ScheduleTimelineExit",
                    "description": "Approximately 15 years including transition to LTFU study"
                  },
                  {
                    "id": "5be6e926-98da-4598-b5a9-9b2c0fe102b8",
                    "name": "AE Reporting Exit",
                    "exitType": "Early Termination",
                    "instanceType": "ScheduleTimelineExit",
                    "description": "Reporting ends at Day 150 post-randomization or initiation of new lymphoma therapy, whichever occurs first"
                  }
                ]
              }
            ],
            "encounters": [
              {
                "id": "c4efbabd-737e-497e-a7bd-bc4870c824a2",
                "name": "Conditioning Day -5",
                "instanceType": "Encounter",
                "type": {
                  "id": "8c837bb7-2d6d-4541-865f-9e2829019742",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "5e453d8c-b48d-465b-9a41-1907c6900c09",
                "extensionAttributes": [
                  {
                    "id": "3976e21e-9aed-4cbb-85bf-7d90091412a7",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "6f926e4b-9c4e-4ca6-a9e4-e1280fd3f0af",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "c4c12789-d185-4c6d-8fc3-4f56557a8d96",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": -5
                  }
                ]
              },
              {
                "id": "0ccea7b6-8f87-4bdb-b65c-0370eefca065",
                "name": "Conditioning Day -4",
                "instanceType": "Encounter",
                "type": {
                  "id": "dcb89c1c-89ac-42a2-9ce5-682c5e5e9508",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "5e453d8c-b48d-465b-9a41-1907c6900c09",
                "extensionAttributes": [
                  {
                    "id": "792dceea-a816-4ad0-9409-087c682b6717",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "c6674ee1-c786-4da0-990e-fb4f713fb2d6",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "88254c7d-d68a-4e92-a241-39b9360dd5ff",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": -4
                  }
                ]
              },
              {
                "id": "89ad4ea6-35a1-47a4-8fa2-b1c3c63690bf",
                "name": "Conditioning Day -3",
                "instanceType": "Encounter",
                "type": {
                  "id": "b2294222-b21b-4623-8b90-506c9e89c956",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "5e453d8c-b48d-465b-9a41-1907c6900c09",
                "extensionAttributes": [
                  {
                    "id": "0989c1ca-59ef-4365-96b4-e2e6e42ffdb4",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "cf37faef-986c-4f53-84f0-af2d1726eda6",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "b4a4ac49-b75f-4498-85f9-b00de5dc0e0a",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": -3
                  }
                ]
              },
              {
                "id": "e8a799cf-d1b2-4032-8cdb-36728e5c0cda",
                "name": "Conditioning Day -2",
                "instanceType": "Encounter",
                "type": {
                  "id": "1b743d63-ad31-47d8-a096-263315ea22e7",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "5e453d8c-b48d-465b-9a41-1907c6900c09",
                "extensionAttributes": [
                  {
                    "id": "3241c550-dd4e-435c-a89d-bc1f302c7589",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "f7ffb04b-384a-4913-a450-c2d63f73cac5",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "4c24fb82-e7e7-4561-a936-7471d8b2562a",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": -2
                  }
                ]
              },
              {
                "id": "f27d97b8-e803-44dd-900a-e675a43f9367",
                "name": "Conditioning Day -1",
                "instanceType": "Encounter",
                "type": {
                  "id": "d4a9fae4-e2d1-4fa6-b477-fea44e47838c",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "5e453d8c-b48d-465b-9a41-1907c6900c09",
                "extensionAttributes": [
                  {
                    "id": "c03ba22b-8c46-426e-a314-7c4fdc831153",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "3a1057da-4fa9-4e2f-a9b2-d670f680d434",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "8fc7c5d9-2808-485f-919c-0eba17af41c2",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": -1
                  }
                ]
              },
              {
                "id": "17568e63-7559-4d6c-910f-120a81c21324",
                "name": "Treatment Day 0",
                "instanceType": "Encounter",
                "type": {
                  "id": "b2172882-7dab-4bf7-a584-df025e535df4",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Visit",
                  "instanceType": "Code"
                },
                "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548",
                "extensionAttributes": [
                  {
                    "id": "6c4713c1-996b-4935-9cba-8131828c4675",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "ae94557c-6ae0-494f-840f-3a0efc7327c2",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "c8cfbb33-311c-4f38-a80e-2b3db9876cd5",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 0
                  }
                ]
              },
              {
                "id": "fdeed36f-6c32-416d-8f3a-a88c03215771",
                "name": "Treatment Day 1-7",
                "instanceType": "Encounter",
                "type": {
                  "id": "0f272de3-bede-4bbe-bc77-090a6a20d20c",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Visit",
                  "instanceType": "Code"
                },
                "epochId": "42b3feb6-bbd6-4282-832c-3754f90cc548",
                "extensionAttributes": [
                  {
                    "id": "c8587cd2-a227-423a-9bdb-739889d24f59",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "d39f447c-2df1-4815-96e9-02c4ef5bb746",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "50a8c385-1c96-4b9a-bffe-257f00b80523",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 1
                  }
                ]
              },
              {
                "id": "e9b883bf-5e58-40ab-a4e6-19e0cb3f1960",
                "name": "Follow-up Day 50",
                "instanceType": "Encounter",
                "type": {
                  "id": "8bbdff32-8afd-4879-af5b-a3f0db85238e",
                  "code": "C98777",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Follow-up Visit",
                  "instanceType": "Code"
                },
                "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b",
                "extensionAttributes": [
                  {
                    "id": "e61314c6-3a70-4ffe-bd68-ef13e5593f45",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "d5f2978f-fe32-4a6d-b4ea-373534becab4",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "93a78489-9784-45e3-be58-0016bea4a938",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 50
                  }
                ]
              },
              {
                "id": "79d35e9f-160c-48e8-873b-a9747a912cae",
                "name": "Follow-up Day 100",
                "instanceType": "Encounter",
                "type": {
                  "id": "1cb38ade-6de2-4737-94f1-24566303f7be",
                  "code": "C98777",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Follow-up Visit",
                  "instanceType": "Code"
                },
                "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b",
                "extensionAttributes": [
                  {
                    "id": "0044015b-3c9c-4aa0-a61d-a339c2575ba6",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "efba796c-466e-4cda-8c64-b77764954bae",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "f3f77745-d63a-43a4-b498-aec7e9a193d1",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 100
                  }
                ]
              },
              {
                "id": "88ddd4c1-25ec-4e8e-9ec0-fd4965490fb9",
                "name": "Follow-up Day 150",
                "instanceType": "Encounter",
                "type": {
                  "id": "9a20eedd-fc28-4727-9128-e555ec33be96",
                  "code": "C98777",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Follow-up Visit",
                  "instanceType": "Code"
                },
                "epochId": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b",
                "extensionAttributes": [
                  {
                    "id": "f100f09d-7274-4d13-b46e-8d7b016ff2b8",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "24dd0141-daaf-4771-b7de-107797f906bb",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "acfbbdab-939b-43c7-9fb0-bd6748566157",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 150
                  }
                ]
              },
              {
                "id": "1e55cdb0-fc2d-478e-b392-937f2c457903",
                "name": "Leukapheresis (Within approx 5 days)",
                "instanceType": "Encounter",
                "type": {
                  "id": "55dc2488-8089-4c4d-b3f5-69e61cb0aa72",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "ac31381d-c74c-4a5d-8dd9-ed49b147aa91",
                "extensionAttributes": [
                  {
                    "id": "6f1b5a1e-4b62-4357-ab05-37e0607df650",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "9d057622-b4d9-4835-926f-273c31286ffe",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "f845acb2-6ccc-4c5d-9aab-67e4c632d59d",
                "name": "Randomization Call",
                "instanceType": "Encounter",
                "type": {
                  "id": "eb35bf71-0665-4fba-87b3-0f09d4eafdbd",
                  "code": "C71738",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Randomization Visit",
                  "instanceType": "Code"
                },
                "epochId": "268e1c4d-92e1-401e-afd6-63c53cde04ea",
                "extensionAttributes": [
                  {
                    "id": "26811051-65f8-4862-89d1-8b706cd2d600",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "91e55a41-b3f2-4619-8538-6b70ad5d5ba1",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "phone"
                  }
                ]
              },
              {
                "id": "62174547-37ae-4535-a8f1-ce0609b7aeaa",
                "name": "Screening (Within 14 days)",
                "instanceType": "Encounter",
                "type": {
                  "id": "7e2b6a79-2204-4c70-a164-a87ad2cbcae4",
                  "code": "C98779",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Screening Visit",
                  "instanceType": "Code"
                },
                "epochId": "42a36ce7-2ce6-4ccc-afc0-0a7d9605190f",
                "extensionAttributes": [
                  {
                    "id": "4a79cb3f-189e-49d8-9cb2-dfa0a8bc155c",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "8b88747f-4c1b-4bae-b39a-a6641dc5d085",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              }
            ],
            "activities": [
              {
                "id": "ad7ce556-2f71-4b2a-a7a4-3129ad93e909",
                "name": "Adverse events/ Concomitant medication",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "d39a6a05-e833-43f9-86f8-3b314e4f959f",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "10c8b12b-ced4-4382-83fc-dcce9d698a2b",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "120f9efa-c9fa-48c2-bdf5-e1240150d230",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "e1308d60-207a-4ab5-bff2-67c4f4e0bc7e",
                "name": "Archived tumor sample",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "858ac014-4fc3-4425-9b66-84a230f1dc3b",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "15b8e11e-a44f-4be1-bc52-fc35942b85f8",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "bfe32eac-5af1-48f5-bab9-c6d2b97d232b",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "a7035553-3d3b-41b8-9cbe-950ccbac5d49",
                "name": "Autologous Stem Cell Transplant",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "a7035553-3d3b-41b8-9cbe-950ccbac5d49",
                    "name": "Autologous Stem Cell Transplant",
                    "procedureType": "Therapeutic Procedure",
                    "code": {
                      "id": "acf294b5-a2d5-4f9f-8fcb-91268f9e548e",
                      "code": "C49236",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Therapeutic Procedure",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "ASCT",
                    "description": "Infusion of autologous stem cells following high-dose therapy"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "6a8c3558-eea5-455b-b026-0d315578e7fe",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "bd3d7d38-b150-4bf9-8619-cd8cbe1ef4b6",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "2d6f1843-2af6-4461-b74f-fd9dd4e25949",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "17ab9f60-7471-41c5-b7d0-b819af9b89d9",
                "name": "Axicabtagene ciloleucel infusion IV",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "e1d7ac85-59ef-45e1-858d-7c3b17192abc",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "c28014bf-031c-4b27-85b7-c0d565aee1de",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "administration"
                  },
                  {
                    "id": "9d0df3f2-1050-4608-8af2-7d20b0ec8149",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "a910067b-1677-4d65-bf2d-94f567392835",
                "name": "Blood Draw",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "7a780924-3963-44b4-aa78-4e58fabee5cc",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "142ac403-a65b-4d8d-b466-34a50fa0971f",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "2ac88ddb-122f-4afb-a3b3-54a6b6f60c05",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "371d27c8-8dbf-4d8e-8f6e-004bbf5ced41",
                "name": "Blood draw for CBC w/differential",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "f030824b-ced3-4781-9897-1297199649f8",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "0b299f95-6f83-4fc8-9711-1e5da64ad95e",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "0e76eb28-d2e0-47d1-9792-020f2b3c8c61",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "a75b6ae3-90fd-4c22-930c-182dd4ab86d2",
                "name": "Blood draw for CRP/Ferritin",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "c4620164-c7e3-46a5-9bc7-4173baa07cbd",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "e13df971-d646-468b-a017-a20e9de21fef",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "1d8bffaf-5fa3-45b3-9fbc-5d4ded0f9589",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "7fa32694-2a84-4e5d-9575-0a4639601156",
                "name": "Blood draw for LDH",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "ba57ab56-ca5e-4b04-987c-7596b2c40076",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "5eed3361-469f-472c-90cb-bf8e9f04edc4",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "732c42ae-b32e-4801-9720-6417d66a5e14",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "25b08c4c-30e1-46a6-9be3-a91418608fdf",
                "name": "Blood draw for PBMCs and additional analysis",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "d4771d60-d7e5-4f35-b074-d2ce1e76d902",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "3c5f81eb-ffbe-45c5-8388-fa2f8ca5e16f",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "8bf87065-3bc1-45a5-87ba-68352309d012",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "84a27b69-f848-46a1-ad74-8cf5e56a689f",
                "name": "Blood draw for anti-axicabtagene ciloleucel antibodies",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "e24cc34b-f760-4cb1-8a9b-327963db5fce",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "b09622ea-51f4-47fa-afcf-7502bc018fc8",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "5919eb1b-b6ec-4c79-970f-0fc44cba3102",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "4d7306fa-9334-491d-bcb4-68e10f61f0e0",
                "name": "Blood draw for chemistry panel",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "8c13c96e-8161-4eb8-9fe4-6007c73a6fa6",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "9e1d24fa-8904-4501-a29e-c69ac99f2af4",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "49440bf1-e6c3-448b-b963-6d3236b0a9a2",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "143296c6-3554-4020-904a-935de6170375",
                "name": "Blood draw for cytokines",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "b2ed26b1-070b-4cc0-960e-7c00f0e53985",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "d03c0e53-2ab4-4532-bb6e-115b56f4d4c3",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "587fd163-1e3e-409d-85bb-f7d41451df2c",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "4b1d3b59-26f4-4525-bc52-091119323625",
                "name": "Blood draw for serology (EU sites)",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "6cb1097a-ff53-4985-9ffb-0ab484aa49bc",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "ba3feb1f-7d44-47d8-bded-495fa524bc14",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "901f26cc-40f2-49ea-a700-1d0858f28619",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "420ec734-9723-4290-ac5e-f9106fb612bb",
                "name": "Bone Marrow Biopsy",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "420ec734-9723-4290-ac5e-f9106fb612bb",
                    "name": "Bone Marrow Biopsy",
                    "procedureType": "Biospecimen Collection",
                    "code": {
                      "id": "ab1bd7b7-7e8b-401a-9ed4-201b2d787b37",
                      "code": "C70793",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Biospecimen Collection",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Bone Marrow Biopsy and Aspirate",
                    "description": "Collection of bone marrow for disease staging and response assessment"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "423746f2-842c-4905-bdc3-6695731cc95c",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "1a065060-3fdf-461c-982c-e97450e6c63f",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "2f6d5f6f-62dc-4f83-8f75-1360e32e0e4a",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "1141bcac-6ed0-4cd7-9c4e-b9c41c47fe88",
                "name": "ECG",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "96436645-a017-46c9-97cd-7a0fc033f685",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "cdb1ce09-0165-440a-8e82-b6ea421c656b",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "585dda12-6f86-43f9-94f0-3d9cc3842bfc",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "ce497a62-35b6-41d1-9c3a-b4053097c57e",
                "name": "ECHO",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "cd2e6917-f604-4088-a81f-974a2f1e64ed",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "23944e75-5420-48a4-870d-7b4b219dbb75",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "a4876a0a-1148-4bbc-9354-d05dc471d224",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "53bf719f-7170-4a34-9003-8e1f466c50ad",
                "name": "ECOG performance status",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "5283b979-e1ef-465a-8373-a00a2ba57284",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "f713a0ab-007c-4b99-9333-081b21248d06",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "f9b764f0-cea7-4a9d-b10a-1d3d930d9701",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "f8362489-fc0a-42f3-835d-7a29d354c3eb",
                "name": "EORTC QLQ-C30",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "79756645-57fb-4590-8f17-bbe6e63083c8",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "6cc203d0-0b51-4752-8e91-4a0073ed5378",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "c5fe26e2-13a1-48dd-a323-15cdbd25ecf2",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "50f61d5f-6d5a-4b48-b016-6721a82dd9a2",
                "name": "EQ-5D-5L",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "143119ca-c9fd-40b3-a01b-0cce0aa068c0",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "2b4b7bdd-8eb9-4a67-be9b-d24ca585f6ee",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "f5f58456-4948-4b6f-be77-2dbf0586ddb0",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "62783d49-c6ac-4cee-8189-d541d437af65",
                "name": "Echocardiogram",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "eb28d125-1906-4418-9330-6eca8b5b2144",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "d54ff9dd-d55e-4f17-9089-9f66937ebcc9",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "351a16f3-f963-4dfd-9667-dbc189a5760c",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "c0ff9654-4230-4b2e-b2f7-f08e3edeb3d7",
                "name": "Electrocardiogram",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "c0ff9654-4230-4b2e-b2f7-f08e3edeb3d7",
                    "name": "Electrocardiogram",
                    "procedureType": "Diagnostic Procedure",
                    "code": {
                      "id": "4e309083-594c-407c-aa2f-af315eea1228",
                      "code": "C25391",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Diagnostic Procedure",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "ECG",
                    "description": "Assessment of cardiac electrical activity"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "cf4d98b8-6f44-410e-a341-5cf0f6b04c5d",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "8d894723-d318-4f5e-9d47-0ca9095e20a3",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "536e0a17-88bc-41d0-9ca2-f0d2bcb643cb",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "a4a27a10-b80b-4d97-8ddd-2f4c157c368e",
                "name": "Fludarabine/Cyclophosphamide",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "e65fa6f0-03d5-4086-96ce-5baacbebfd2d",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "89610e9b-b57b-4a9e-bbec-798fcd29bf37",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "059bd646-343f-4b8b-bc07-1e4ec8bedc1f",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "703c6ab5-49d5-4ae2-821f-52ed6c547724",
                "name": "IXRS/Randomization call",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "d5cb25e5-56d9-4dfc-83c4-db1b6bc060a2",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "cf076836-7440-49b2-9c80-2b147c2bd876",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "documentation"
                  },
                  {
                    "id": "5bc7bdd3-2830-45a6-baae-d079eed4403c",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "2e34875c-212d-414f-b2a5-8887e5f197e9",
                "name": "Informed Consent",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "2e34875c-212d-414f-b2a5-8887e5f197e9",
                    "name": "Informed Consent",
                    "procedureType": "Assessment",
                    "code": {
                      "id": "328ed0c9-50f1-4e54-af61-02cfde43ada9",
                      "code": "C25218",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Assessment",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Informed Consent Collection",
                    "description": "Collection of signed and dated institutional review board approved consent form"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "1ca39e2f-fb2e-4e59-8adb-08c31a7ba6ed",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "947af9f2-de07-4224-8ac1-ced76ab50396",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "be2a3c67-4200-4784-9add-c70ff587824b",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "088b4b8d-bdf3-456f-8996-40117e8d87ac",
                "name": "Intravenous Infusion",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "088b4b8d-bdf3-456f-8996-40117e8d87ac",
                    "name": "Intravenous Infusion",
                    "procedureType": "Therapeutic Procedure",
                    "code": {
                      "id": "a8609176-2824-4f71-87d7-9b3e98b084ea",
                      "code": "C49236",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Therapeutic Procedure",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "IV Infusion",
                    "description": "Administration of conditioning chemotherapy or axicabtagene ciloleucel"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "540474b9-5408-4138-ba2a-44e35dbbafbb",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "5cad3eed-d4b9-4284-89ec-a562e48e4832",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "694b7610-00ce-42ce-98c3-9031e8c264d4",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "ebfd763c-149d-43f9-b7c5-0d3b7c9532c2",
                "name": "Leukapheresis",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "d6b6d9a6-a6a3-474b-9fa2-947541e9eaf6",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa,procedures"
                  },
                  {
                    "id": "d2381876-04c2-4727-8190-101eb20e5b29",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "0ede15cd-bf12-4d49-b175-c633297f06b5",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "4c2c603a-712f-4011-838f-6b95e7dfa1cd",
                "name": "Lumbar Puncture",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "9814f555-ec43-4602-a9c2-5707b8840f5e",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "d584b689-7d43-4f46-8f6f-ad3c73bcc0b8",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "a8f8e3d0-a6d4-4332-be25-4d01935f59ea",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "657877e2-0bad-4121-aef7-e857b90be47d",
                "name": "Medical history",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "b413d650-106f-4cfb-a88b-8d02edcb917c",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "6fb134ba-f873-422a-aa02-ad166aedd3a2",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "6993c769-3766-4fe2-a8c8-132546d4af8d",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "e313ee9b-fb54-4d88-b4e5-dda944d8aa59",
                "name": "Neurological Examination",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "e313ee9b-fb54-4d88-b4e5-dda944d8aa59",
                    "name": "Neurological Examination",
                    "procedureType": "Assessment",
                    "code": {
                      "id": "ca78d915-6eac-4544-ae38-a1d9832a27d2",
                      "code": "C25218",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Assessment",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Neurological Exam",
                    "description": "Assessment of neurological function and toxicity"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "7962e300-8206-4bde-8dbe-ddb0d491cf81",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "8f055ad8-92a5-41f3-8cbc-75406c6d7d71",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "5e1eeea5-42df-4241-bc82-5e520bd7d382",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "ae842214-6b86-4c56-bf7d-fbef019181f2",
                "name": "Neurological assessment",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "6987e646-7d49-45a8-abcc-4fbf2d0e6b1e",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "9c85dc41-fbc0-453c-9301-c8add3a0c09c",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "68536946-9a1c-4838-9966-ad726f92821b",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "07749233-0006-4d96-ac61-36c87d85ae20",
                "name": "PET-CT Scan",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "07749233-0006-4d96-ac61-36c87d85ae20",
                    "name": "PET-CT Scan",
                    "procedureType": "Imaging Technique",
                    "code": {
                      "id": "d2dd421d-c6b4-4b16-ac29-5372e2f79e5c",
                      "code": "C17369",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Imaging Technique",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Positron Emission Tomography-Computed Tomography",
                    "description": "Baseline imaging for disease staging"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "ed0c36b8-a35f-4e8f-9890-adca1d32f17e",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "ffe6d440-9a1b-4317-8cef-1b29433d732d",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "f1d589a4-053e-40f8-9f18-a0fb83c2d5d6",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "cddfd22b-a39a-45eb-b16b-f59b1dc38d69",
                "name": "PET-CT disease assessment",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "6da70b82-e4af-43b9-93d2-8ae4ff48fd33",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "988d3762-0a2a-464e-a0e1-ae39ab223628",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "6f5b7164-a534-4e6a-83f2-bd545178f506",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "07dbae1d-67c6-4ec2-a8a3-ec3f4b73fa60",
                "name": "Physical exam",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "2481863d-da36-4534-b146-1493673934b0",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa,procedures"
                  },
                  {
                    "id": "1573c890-cc1f-4298-8c35-a6ece54ba94b",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "1a61fc91-4aa8-43ca-9469-d2150d91ee77",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "f13c1734-097d-455b-b575-42958bdc4939",
                "name": "Pregnancy Test",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "d94bcebd-610d-437e-bc8a-79f3714ac0ac",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "90fc6a62-deaf-40f6-8890-cba40be9fcee",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "82c2848d-8900-48e8-8220-6e3dd0b1644c",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "a8df3d05-22e5-4d67-b8de-314796038b7d",
                "name": "Pregnancy test (serum or urine)",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "941e8726-22fd-4a70-89ea-390983a9227a",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "570d33b5-359e-44d2-b1f6-d13d6278be51",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "83d65fc6-be77-4910-a35b-a4e20c8708be",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "04a9dd06-fe29-447e-9e81-ca942f646d2a",
                "name": "Vital Signs",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "3d600b8c-1735-4679-86e1-8135cef53b18",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "6b9aff54-50c2-4e0b-ac52-cfa57251835f",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "5f5892aa-c227-45f3-a28b-e1c2a144826e",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "8275f0dc-2f1e-4c07-8c2f-9f033d6eb3fa",
                "name": "Vital signs (BP, HR, RR, O2 sat, temp)",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "a40a2db0-871e-4846-9102-4a5d7044e900",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "962015d2-f802-4ef8-b0d3-786a4d5bfcd2",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "deb8abe5-986a-40d0-abfe-a7a8e408cccf",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "a632259b-05cd-4b58-ac30-24b2fadc4224",
                "name": "WPAI",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "3183bf4f-dfd5-4769-ba32-4ff02d874508",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "36ff8571-58fc-44de-9f2c-b3c2efca7db7",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "1a20b3c9-4ec6-477d-9618-8f6d8059ee86",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "7fc4d956-5f86-4c50-955c-b6bb132f1620",
                "name": "Weight (plus height at screening)",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "868298eb-53f8-4c01-972b-c0f7c272bfe2",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "cf6a1dc8-2f33-4ca5-8173-537b2654352e",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "d5f65dcc-e322-416f-854b-d840afd0e003",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              }
            ],
            "epochs": [
              {
                "id": "42a36ce7-2ce6-4ccc-afc0-0a7d9605190f",
                "name": "Screening",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "9ffd2f85-4cca-46ce-8ab5-1f25b975fb38",
                  "code": "C98779",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Screening Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "ccd62720-a411-41e4-a528-a8e6dd09b65e",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "traversal,soa"
                  },
                  {
                    "id": "83f82011-8da7-4ee7-8f75-e3d88455e23d",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "aab5c381-7b1e-4bb4-90af-825aa0ffcdb7",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "1"
                  }
                ]
              },
              {
                "id": "268e1c4d-92e1-401e-afd6-63c53cde04ea",
                "name": "Randomization",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "f43d5a01-b735-4c62-890c-acae777a372c",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "91473ccf-635b-4e6a-a23d-de645b8d908d",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "traversal,soa"
                  },
                  {
                    "id": "7e8bed22-7acb-480e-8838-42f0832322db",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "ac8975ec-f41f-4ec3-af02-2b03e76deb80",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "2"
                  }
                ]
              },
              {
                "id": "9cd79c3a-d690-48be-a6ba-caa9c7027c0b",
                "name": "Post Treatment Follow-up",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "5346938e-4528-4de0-be59-50e3bd7631b7",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "87f226a5-dd76-4cc4-b045-6f06fafec79b",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "traversal,soa"
                  },
                  {
                    "id": "cacf7595-1562-4977-8371-45e7e42b3a84",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "760dab34-e746-419f-969f-3aa372f59578",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "3"
                  }
                ]
              },
              {
                "id": "ac31381d-c74c-4a5d-8dd9-ed49b147aa91",
                "name": "Leukapheresis",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "96784773-b36d-489c-93af-506f055aeec7",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "e8a8205e-2103-487f-b024-6eaea2db80aa",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "a469f697-f4f9-45c7-8a4f-d59df7c9e2ff",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "sub"
                  }
                ]
              },
              {
                "id": "5e453d8c-b48d-465b-9a41-1907c6900c09",
                "name": "Conditioning Chemotherapy",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "346faa1a-1e63-4825-a6c6-ba81eb2e6148",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "175eba4a-fc8c-4c32-851f-18adda7ed621",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "c28bb945-f2d4-4409-ac38-1624d3c25223",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "sub"
                  }
                ]
              },
              {
                "id": "42b3feb6-bbd6-4282-832c-3754f90cc548",
                "name": "IP Administration",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "05ee6162-e0e3-4f2a-904c-5358ef171781",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "63e881d6-2b53-402f-a191-b5da0e5ddc31",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "ece0b969-7b7c-4070-a80d-479babb738a7",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "sub"
                  }
                ]
              }
            ],
            "activityGroups": [
              {
                "id": "775585ac-c4ce-4464-b878-1ac3ff01f23b",
                "name": "Procedures",
                "description": null,
                "childIds": [
                  "657877e2-0bad-4121-aef7-e857b90be47d",
                  "07dbae1d-67c6-4ec2-a8a3-ec3f4b73fa60",
                  "ae842214-6b86-4c56-bf7d-fbef019181f2",
                  "7fc4d956-5f86-4c50-955c-b6bb132f1620",
                  "8275f0dc-2f1e-4c07-8c2f-9f033d6eb3fa",
                  "53bf719f-7170-4a34-9003-8e1f466c50ad",
                  "1141bcac-6ed0-4cd7-9c4e-b9c41c47fe88",
                  "ce497a62-35b6-41d1-9c3a-b4053097c57e",
                  "cddfd22b-a39a-45eb-b16b-f59b1dc38d69",
                  "e1308d60-207a-4ab5-bff2-67c4f4e0bc7e",
                  "a8df3d05-22e5-4d67-b8de-314796038b7d",
                  "4d7306fa-9334-491d-bcb4-68e10f61f0e0",
                  "371d27c8-8dbf-4d8e-8f6e-004bbf5ced41",
                  "84a27b69-f848-46a1-ad74-8cf5e56a689f",
                  "7fa32694-2a84-4e5d-9575-0a4639601156",
                  "703c6ab5-49d5-4ae2-821f-52ed6c547724",
                  "4c2c603a-712f-4011-838f-6b95e7dfa1cd",
                  "a75b6ae3-90fd-4c22-930c-182dd4ab86d2",
                  "25b08c4c-30e1-46a6-9be3-a91418608fdf",
                  "143296c6-3554-4020-904a-935de6170375",
                  "4b1d3b59-26f4-4525-bc52-091119323625",
                  "f8362489-fc0a-42f3-835d-7a29d354c3eb",
                  "50f61d5f-6d5a-4b48-b016-6721a82dd9a2",
                  "a632259b-05cd-4b58-ac30-24b2fadc4224",
                  "ebfd763c-149d-43f9-b7c5-0d3b7c9532c2",
                  "a4a27a10-b80b-4d97-8ddd-2f4c157c368e",
                  "17ab9f60-7471-41c5-b7d0-b819af9b89d9",
                  "ad7ce556-2f71-4b2a-a7a4-3129ad93e909"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Medical history",
                  "Physical exam",
                  "Neurological assessment",
                  "Weight (plus height at screening)",
                  "Vital signs (BP, HR, RR, O2 sat, temp)",
                  "ECOG performance status",
                  "ECG",
                  "ECHO",
                  "PET-CT disease assessment",
                  "Archived tumor sample",
                  "Pregnancy test (serum or urine)",
                  "Blood draw for chemistry panel",
                  "Blood draw for CBC w/differential",
                  "Blood draw for anti-axicabtagene ciloleucel antibodies",
                  "Blood draw for LDH",
                  "IXRS/Randomization call",
                  "Lumbar Puncture",
                  "Blood draw for CRP/Ferritin",
                  "Blood draw for PBMCs and additional analysis",
                  "Blood draw for cytokines",
                  "Blood draw for serology (EU sites)",
                  "EORTC QLQ-C30",
                  "EQ-5D-5L",
                  "WPAI",
                  "Leukapheresis",
                  "Fludarabine/Cyclophosphamide",
                  "Axicabtagene ciloleucel infusion IV",
                  "Adverse events/ Concomitant medication"
                ]
              }
            ],
            "notes": [
              {
                "id": "09a935db-c37c-47f7-86a8-878f56d9bf6a",
                "text": "a. Physical Exam: Subjects with new-onset symptoms related to CRS should undergo physical examination at least daily until symptoms resolve to baseline.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "d842d5a2-6863-4d0f-99a9-126adeb6867b",
                "text": "b. Neurologic assessment: A neurological assessment should be done prior to axicabtagene ciloleucel infusion on treatment day 0, then on treatment day 1 and every other day during the minimum 7-day observation period.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "8be5631c-08d4-4189-8a0d-b4d23543a24d",
                "text": "c. Echo: Performed following the subjects last chemotherapy treatment and within 28 days prior to signing the consent may be used for confirmation of eligibility",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "0c999829-40c4-4830-b3a4-0743e7f756b9",
                "text": "d. PET-CT disease assessment: PET-CT should be performed as close to randomization as possible and within 28 days prior to randomization.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "841db5dd-552d-41a1-be50-7c7c68cd0892",
                "text": "e. Archived tumor sample: Archived tumor samples will be submitted to central laboratory for evaluation of CD19 expression and prognostic variables.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "8fcc4eb2-81b1-46e4-b580-b01619235885",
                "text": "f. Blood draw for anti-axicabtagene ciloleucel antibodies: Baseline antibody samples to be collected prior to start of leukapheresis.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "7af92172-c9ac-4410-8ae8-6df50550fb5b",
                "text": "g. Lumbar Puncture: Subjects with new onset Grade >= 2 neurologic symptoms post axicabtagene ciloleucel infusion will have lumbar puncture performed.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "9ac389c0-3ae1-4746-8271-8b15e8ca5bb6",
                "text": "h. Blood draws for PBMCs, cytokines, and additional analysis per Section 7.11.2: PBMC blood will be used for the analysis of tests that include anti-CD19 CAR T cells, lymphocytes, and RCR.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "edaa0c2b-21b3-4f16-b1a8-00b3d7629f90",
                "text": "i. EORTC QLQ-C30/EQ-5D-5L/WPAI: To be completed by the subject before any procedures are performed-excluding blood draws.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "d8b4b2c4-9365-475d-b36c-e05f78fd9d0f",
                "text": "j. Adverse Events: The investigator is responsible for reporting all adverse events observed by the investigator or reported by the subject that occur after randomization through the Day 150 post-randomization visit.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "d3d7461b-fe0d-4ccf-82fe-c474cbb3d1a8",
                "text": "k. Concomitant medications should be recorded from the date of the informed consent through the Day 150 post-randomization visit.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "dad9aca5-47a6-4993-9f5c-b94f8c18a37f",
                "text": "l. For European Union (EU) sites, viral serologic tests (eg, HIV, Hep B, Hep C) will be carried out per institution guidelines and EU regulations.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "1318cf28-ff65-4da8-842d-4b579b69577f",
                "text": "m. Subjects will be monitored daily through day 7 after treatment with axicabtagene ciloleucel unless otherwise required by country regulatory agencies.",
                "instanceType": "CommentAnnotation"
              }
            ],
            "model": {
              "id": "4d69ab4b-9642-4f61-afcb-5d895e3d3b75",
              "code": "C82639",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Parallel Study",
              "instanceType": "Code"
            },
            "indications": [
              {
                "id": "b02e38fd-9bd5-4ddf-93b4-f4db25c9d6f4",
                "name": "Relapsed/Refractory Diffuse Large B Cell Lymphoma",
                "isRareDisease": false,
                "instanceType": "Indication",
                "description": "Adult subjects with relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL) after first-line rituximab and anthracycline-based chemotherapy."
              }
            ],
            "procedures": [
              {
                "id": "2e34875c-212d-414f-b2a5-8887e5f197e9",
                "name": "Informed Consent",
                "procedureType": "Assessment",
                "code": {
                  "id": "328ed0c9-50f1-4e54-af61-02cfde43ada9",
                  "code": "C25218",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Assessment",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Informed Consent Collection",
                "description": "Collection of signed and dated institutional review board approved consent form"
              },
              {
                "id": "420ec734-9723-4290-ac5e-f9106fb612bb",
                "name": "Bone Marrow Biopsy",
                "procedureType": "Biospecimen Collection",
                "code": {
                  "id": "ab1bd7b7-7e8b-401a-9ed4-201b2d787b37",
                  "code": "C70793",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Biospecimen Collection",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Bone Marrow Biopsy and Aspirate",
                "description": "Collection of bone marrow for disease staging and response assessment"
              },
              {
                "id": "07749233-0006-4d96-ac61-36c87d85ae20",
                "name": "PET-CT Scan",
                "procedureType": "Imaging Technique",
                "code": {
                  "id": "d2dd421d-c6b4-4b16-ac29-5372e2f79e5c",
                  "code": "C17369",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Imaging Technique",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Positron Emission Tomography-Computed Tomography",
                "description": "Baseline imaging for disease staging"
              },
              {
                "id": "c0ff9654-4230-4b2e-b2f7-f08e3edeb3d7",
                "name": "Electrocardiogram",
                "procedureType": "Diagnostic Procedure",
                "code": {
                  "id": "4e309083-594c-407c-aa2f-af315eea1228",
                  "code": "C25391",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Diagnostic Procedure",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "ECG",
                "description": "Assessment of cardiac electrical activity"
              },
              {
                "id": "088b4b8d-bdf3-456f-8996-40117e8d87ac",
                "name": "Intravenous Infusion",
                "procedureType": "Therapeutic Procedure",
                "code": {
                  "id": "a8609176-2824-4f71-87d7-9b3e98b084ea",
                  "code": "C49236",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Therapeutic Procedure",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "IV Infusion",
                "description": "Administration of conditioning chemotherapy or axicabtagene ciloleucel"
              },
              {
                "id": "a7035553-3d3b-41b8-9cbe-950ccbac5d49",
                "name": "Autologous Stem Cell Transplant",
                "procedureType": "Therapeutic Procedure",
                "code": {
                  "id": "acf294b5-a2d5-4f9f-8fcb-91268f9e548e",
                  "code": "C49236",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Therapeutic Procedure",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "ASCT",
                "description": "Infusion of autologous stem cells following high-dose therapy"
              },
              {
                "id": "e313ee9b-fb54-4d88-b4e5-dda944d8aa59",
                "name": "Neurological Examination",
                "procedureType": "Assessment",
                "code": {
                  "id": "ca78d915-6eac-4544-ae38-a1d9832a27d2",
                  "code": "C25218",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Assessment",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Neurological Exam",
                "description": "Assessment of neurological function and toxicity"
              }
            ],
            "analysisPopulations": [
              {
                "id": "99144497-1600-4a13-ae07-b3af9ffb735e",
                "name": "Full Analysis Set",
                "text": "The Full Analysis Set (FAS) includes all subjects randomized to the study. Subjects will be analyzed according to the treatment group to which they were randomized.",
                "populationType": "Efficacy",
                "instanceType": "AnalysisPopulation",
                "label": "FAS",
                "populationDescription": "The Full Analysis Set (FAS) includes all subjects randomized to the study. Subjects will be analyzed according to the treatment group to which they were randomized.",
                "criteria": "All randomized subjects"
              },
              {
                "id": "5191afb1-257f-4995-a517-66075f0a1d98",
                "name": "Safety Analysis Set",
                "text": "The Safety Analysis Set includes all subjects who received any dose of axicabtagene ciloleucel (test arm) or any dose of protocol-defined salvage chemotherapy (control arm). Subjects will be analyzed according to the treatment they actually received.",
                "populationType": "Safety",
                "instanceType": "AnalysisPopulation",
                "label": "SAF",
                "populationDescription": "The Safety Analysis Set includes all subjects who received any dose of axicabtagene ciloleucel (test arm) or any dose of protocol-defined salvage chemotherapy (control arm). Subjects will be analyzed according to the treatment they actually received.",
                "criteria": "Received at least one dose of study treatment (axicabtagene ciloleucel or salvage chemotherapy)"
              },
              {
                "id": "0a9644d5-0893-48f4-bc34-b82cbdb2d5d5",
                "name": "Safety Analysis Set - ASCT",
                "text": "The Safety Analysis Set - ASCT includes all subjects in the control arm who received high-dose therapy (HDT) and autologous stem cell transplant (ASCT).",
                "populationType": "Safety",
                "instanceType": "AnalysisPopulation",
                "label": "SAF-ASCT",
                "populationDescription": "The Safety Analysis Set - ASCT includes all subjects in the control arm who received high-dose therapy (HDT) and autologous stem cell transplant (ASCT).",
                "criteria": "Control arm subjects who received HDT and ASCT"
              },
              {
                "id": "7774ca8f-4fbe-4077-a9bb-1f91783f36a1",
                "name": "QoL Analysis Set",
                "text": "The QoL Analysis Set includes all subjects in the FAS who have a baseline and at least one post-baseline QoL assessment.",
                "populationType": "Efficacy",
                "instanceType": "AnalysisPopulation",
                "label": "QoL Set",
                "populationDescription": "The QoL Analysis Set includes all subjects in the FAS who have a baseline and at least one post-baseline QoL assessment.",
                "criteria": "Randomized AND baseline QoL assessment AND >=1 post-baseline QoL assessment"
              },
              {
                "id": "adbacedd-0ed4-4f54-bd7b-f43a89c485dc",
                "name": "Retreatment Analysis Sets",
                "text": "The Retreatment Analysis Sets include subjects who meet protocol-defined criteria for retreatment and receive a second course of study treatment.",
                "populationType": "Efficacy",
                "instanceType": "AnalysisPopulation",
                "label": "Retreatment Set",
                "populationDescription": "The Retreatment Analysis Sets include subjects who meet protocol-defined criteria for retreatment and receive a second course of study treatment.",
                "criteria": "Met retreatment criteria AND received second course of treatment"
              },
              {
                "id": "d8703202-e09b-4ee3-9c04-eb802420624c",
                "name": "Subgroup Analysis Sets",
                "text": "Subgroup analysis sets are defined based on baseline characteristics and stratification factors, including response to first-line therapy and second-line age-adjusted International Prognostic Index (IPI).",
                "populationType": "Efficacy",
                "instanceType": "AnalysisPopulation",
                "label": "Subgroups",
                "populationDescription": "Subgroup analysis sets are defined based on baseline characteristics and stratification factors, including response to first-line therapy and second-line age-adjusted International Prognostic Index (IPI).",
                "criteria": "Defined by baseline covariates or stratification factors"
              }
            ],
            "characteristics": [
              {
                "id": "62847c8c-8cdd-49ea-ae05-ecbe7127c879",
                "code": "AGE_AT_RANDOMIZATION",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Age at randomization",
                "instanceType": "Code"
              },
              {
                "id": "37a61579-bb00-44da-b67d-af397e83ddd7",
                "code": "RESPONSE_TO_FIRST-LI",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Response to first-line therapy",
                "instanceType": "Code"
              },
              {
                "id": "c22dc675-36da-493b-ad34-954c2297c98a",
                "code": "SECOND-LINE_AGE-ADJU",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Second-line age-adjusted IPI",
                "instanceType": "Code"
              },
              {
                "id": "b452a422-480b-423b-a213-2c420dac5b2e",
                "code": "ECOG_PERFORMANCE_STA",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "ECOG performance status",
                "instanceType": "Code"
              }
            ],
            "extensionAttributes": [
              {
                "id": "ext_conceptual_2bc15f35-7754-49a7-a5f6-a06f6970cea0",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-conceptualAnchors",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"d492513d-56fb-40f7-9b9f-9c203ea15d9c\", \"name\": \"ECHO Eligibility Window\", \"classification\": \"Conceptual\", \"note\": \"Pure timing reference - no visit or activity instance\"}, {\"id\": \"2c121eec-481a-4d48-b810-5d49f65813d8\", \"name\": \"Leukapheresis Timing\", \"classification\": \"Conceptual\", \"note\": \"Pure timing reference - no visit or activity instance\"}, {\"id\": \"53495fcb-197e-4a34-b32f-a51116384b55\", \"name\": \"Conditioning Chemotherapy\", \"classification\": \"Conceptual\", \"note\": \"Pure timing reference - no visit or activity instance\"}, {\"id\": \"640a42fc-64ca-4126-846f-2993da4cd6e7\", \"name\": \"CAR-T Rest Days\", \"classification\": \"Conceptual\", \"note\": \"Pure timing reference - no visit or activity instance\"}, {\"id\": \"5c09aa99-fbaa-4cfe-8343-63dcd7ccce07\", \"name\": \"Day 50 Disease Assessment\", \"classification\": \"Conceptual\", \"note\": \"Pure timing reference - no visit or activity instance\"}, {\"id\": \"997fec6c-4458-4cfe-bc0a-02acb594a3c4\", \"name\": \"SOC Cycle Interval\", \"classification\": \"Conceptual\", \"note\": \"Pure timing reference - no visit or activity instance\"}]"
              },
              {
                "id": "334511b0-6bf4-4b8f-9102-2b29e9c33737",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-promotionIssues",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: 788e3dbd-2fde-4a8a-9eaa-4828dfa2ca4b (encounter: enc_10)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"conceptual_anchor_stored\", \"message\": \"CONCEPTUAL anchor 'ECHO Eligibility Window' stored as timing reference (no visit)\", \"affectedPath\": \"$.extensionAttributes[?(@.url contains 'conceptualAnchors')]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: e7c83ab6-591d-4c42-88cc-cdbfbee4ffa9 (encounter: enc_10)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"conceptual_anchor_stored\", \"message\": \"CONCEPTUAL anchor 'Leukapheresis Timing' stored as timing reference (no visit)\", \"affectedPath\": \"$.extensionAttributes[?(@.url contains 'conceptualAnchors')]\"}, {\"severity\": \"info\", \"category\": \"conceptual_anchor_stored\", \"message\": \"CONCEPTUAL anchor 'Conditioning Chemotherapy' stored as timing reference (no visit)\", \"affectedPath\": \"$.extensionAttributes[?(@.url contains 'conceptualAnchors')]\"}, {\"severity\": \"info\", \"category\": \"conceptual_anchor_stored\", \"message\": \"CONCEPTUAL anchor 'CAR-T Rest Days' stored as timing reference (no visit)\", \"affectedPath\": \"$.extensionAttributes[?(@.url contains 'conceptualAnchors')]\"}, {\"severity\": \"info\", \"category\": \"conceptual_anchor_stored\", \"message\": \"CONCEPTUAL anchor 'Day 50 Disease Assessment' stored as timing reference (no visit)\", \"affectedPath\": \"$.extensionAttributes[?(@.url contains 'conceptualAnchors')]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: 18713b10-de4d-4589-89f1-51bdcdde3f53 (encounter: enc_10)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"warning\", \"category\": \"timing_reference_remapped\", \"message\": \"Timing 'Day 150 Disease Assessment' reference remapped: cc52bd80-e789-4fb5-a0b0-b4c1093046ac \\u2192 18713b10-de4d-4589-89f1-51bdcdde3f53\", \"affectedPath\": \"$.timings[?(@.id=='timing_9')]\"}, {\"severity\": \"info\", \"category\": \"conceptual_anchor_stored\", \"message\": \"CONCEPTUAL anchor 'SOC Cycle Interval' stored as timing reference (no visit)\", \"affectedPath\": \"$.extensionAttributes[?(@.url contains 'conceptualAnchors')]\"}]"
              },
              {
                "id": "e0332c3e-d634-4e4d-988a-ec1acf553ac3",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-timeAnchors",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"98898ff1-5104-48aa-b420-8f5dd98577a9\", \"definition\": \"First administration of investigational product\", \"anchorType\": \"FirstDose\", \"classification\": \"Event\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 60, \"sourceText\": \"first dose\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"01180888-2fe8-46e9-a599-7eda0d32b1ed\", \"definition\": \"Date of subject randomization\", \"anchorType\": \"Randomization\", \"classification\": \"Event\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 40, \"sourceText\": \"day of randomization\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"e7f49fb0-3574-4a7a-9167-08e61f02fb7d\", \"definition\": \"Informed consent obtained\", \"anchorType\": \"InformedConsent\", \"classification\": \"Event\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 10, \"sourceText\": \"informed consent\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"cd589b19-5c49-4ed7-9522-91bb08ccdc26\", \"definition\": \"transplant\", \"anchorType\": \"Custom\", \"classification\": \"Conceptual\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 100, \"sourceText\": \"transplant\", \"encounterId\": null, \"activityId\": null}]"
              },
              {
                "id": "ce1132b7-c20f-427a-8e96-8ee81710bb36",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-repetitions",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"831b94d9-e407-4e36-98d3-130924cfc964\", \"type\": \"Daily\", \"interval\": \"P1D\", \"sourceText\": \"od\"}, {\"id\": \"bb234e83-99dc-4d91-b09e-6560f6d8030c\", \"type\": \"Interval\", \"interval\": \"PT6H\", \"sourceText\": \"every 6 hours\"}, {\"id\": \"4784d31f-5f6a-42d8-8336-ab36a4ee9996\", \"type\": \"Interval\", \"sourceText\": \"bid\"}, {\"id\": \"de1faceb-ef95-4d87-83be-3ce078badd39\", \"type\": \"Cycle\", \"cycleLength\": \"P3D\", \"sourceText\": \"Up to 3 cycles\"}, {\"id\": \"65a08de6-5410-4131-b38e-89e3632c843b\", \"type\": \"Continuous\", \"startOffset\": \"-P5D\", \"endOffset\": \"-P3D\", \"sourceText\": \"day -5 to day -3\"}, {\"id\": \"cf61157d-645d-4ba8-8c49-028d6a39df72\", \"type\": \"Continuous\", \"startOffset\": \"-P5D\", \"endOffset\": \"-P3D\", \"sourceText\": \"day -5 through day -3\"}, {\"id\": \"e54c33a9-9db0-49fe-abcd-08ef99740e70\", \"type\": \"Continuous\", \"startOffset\": \"P1D\", \"endOffset\": \"P4D\", \"sourceText\": \"days 1-4\"}, {\"id\": \"76a33550-272b-4897-9f24-6c7b6ff795b6\", \"type\": \"Continuous\", \"sourceText\": \"screening period\"}, {\"id\": \"fffbd0eb-8ed7-423d-8c64-c37c3b41ebd6\", \"type\": \"Continuous\", \"sourceText\": \"Treatment Period\"}, {\"id\": \"3aea87e5-2466-44fa-8586-4dd7ca370824\", \"type\": \"Continuous\", \"sourceText\": \"treatment period\"}, {\"id\": \"3474a161-c430-4ae1-b983-30450f796694\", \"type\": \"Continuous\", \"sourceText\": \"observation period\"}, {\"id\": \"c3fec135-52f5-4f6d-8e34-f2f5a7ac7e84\", \"type\": \"Continuous\", \"sourceText\": \"Follow-up Period\"}, {\"id\": \"fe38e0d0-7f74-4d23-8404-184d84acda59\", \"type\": \"Continuous\", \"sourceText\": \"7 days after\"}, {\"id\": \"100d8a95-f7c8-470f-bb5c-43011e3a20ad\", \"type\": \"Continuous\", \"sourceText\": \"5 days after\"}, {\"id\": \"1268a451-2001-48d8-b484-a16643253a56\", \"type\": \"Continuous\", \"sourceText\": \"48 hours before\"}, {\"id\": \"d0030de3-a838-4068-bc5e-11132122476b\", \"type\": \"Continuous\", \"sourceText\": \"30 days after\"}, {\"id\": \"acff8267-1a63-4e84-aedd-b4d39bbb2d4a\", \"type\": \"Cycle\", \"startOffset\": \"P0D\", \"endOffset\": \"P63D\", \"interval\": \"P21D\", \"minObservations\": 2, \"exitCondition\": \"Subjects responding to second-line combination chemotherapy after 2 or 3 cycles (PR or CR) should proceed to high-dose therapy (HDT) and autologous stem cell transplant (ASCT).\", \"sourceText\": \"Up to 3 cycles (6 to 9 weeks) of combination chemotherapy will be administered every 2 to 3 weeks.\"}, {\"id\": \"76b03c4b-05f0-4518-bf14-26af42aee4a9\", \"type\": \"Continuous\", \"startOffset\": \"-P5D\", \"endOffset\": \"-P3D\", \"interval\": \"P1D\", \"minObservations\": 3, \"exitCondition\": \"Completion of 3-day regimen\", \"sourceText\": \"receive a 3 day conditioning chemotherapy regimen consisting of fludarabine 30 mg/m2/day and cyclophosphamide 500 mg/m2/day (day -5 to day -3)\"}, {\"id\": \"1fc48159-a85d-42c4-8594-ec74316e1a89\", \"type\": \"Continuous\", \"startOffset\": \"P0D\", \"endOffset\": \"P7D\", \"interval\": \"P1D\", \"minObservations\": 7, \"exitCondition\": \"Minimum 7 days unless otherwise required by country regulatory agencies\", \"sourceText\": \"Subjects will be under an observation period for at least 7 days after axicabtagene ciloleucel infusion to monitor for and manage any adverse events\"}, {\"id\": \"cb218b87-9bb8-40dc-a272-ff9f76280b5b\", \"type\": \"Continuous\", \"startOffset\": \"P0D\", \"endOffset\": \"P15Y\", \"interval\": \"null\", \"minObservations\": 1, \"exitCondition\": \"15-year follow-up completion\", \"sourceText\": \"subjects who received at least one dose of axicabtagene ciloleucel as protocol therapy will complete the remainder of the 15-year follow-up assessments\"}]"
              },
              {
                "id": "28bda849-6ce9-45bd-9ca1-4246ec677bd4",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-traversalConstraints",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"d9d7dc7a-cd3b-4570-8436-071a4304a02d\", \"requiredSequence\": [\"epoch_1\", \"epoch_2\", \"epoch_6\", \"epoch_6\", \"epoch_6\"], \"allowEarlyExit\": true, \"exitEpochIds\": [], \"mandatoryVisits\": [\"enc_2\", \"enc_10\", \"enc_1\", \"enc_11\", \"enc_2\"], \"sourceText\": \"[{'condition': 'Randomized to Axicabtagene Ciloleucel Arm', 'path': ['CONDITIONING_CHEMOTHERAPY', 'AXI_CEL_INFUSION_DAY_0', 'POST_INFUSION_MONITORING']}, {'condition': 'Randomized to Standard of Care (SOC) Arm', 'path': ['SALVAGE_COMBINATION_CHEMOTHERAPY', 'RESPONSE_ASSESSMENT']}, {'condition': 'SOC Arm: Subject achieves PR or CR after 2-3 cycles', 'path': ['HIGH_DOSE_THERAPY', 'AUTOLOGOUS_STEM_CELL_TRANSPLANT']}, {'condition': 'SOC Arm: Subject does not respond to chemotherapy', 'path': ['OFF_PROTOCOL_TREATMENT']}]\"}]"
              },
              {
                "id": "dc1e28b6-c343-4157-a43b-bf206511b2d1",
                "url": "https://protocol2usdm.io/extensions/x-footnoteConditions",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"1e15e56e-42ea-4ecb-b856-30ae45c3eb8b\", \"conditionType\": \"frequency_daily\", \"text\": \"a. Physical Exam: Subjects with new-onset symptoms related to CRS should undergo physical examination at least daily until symptoms resolve to baseline.\", \"footnoteId\": \"e2733b20-39c6-4b21-8e3a-bf57b5379403\", \"structuredCondition\": \"if(symptoms == 'CRS') { frequency = 'P1D' } until(symptoms == 'baseline')\", \"appliesToActivityIds\": [\"07dbae1d-67c6-4ec2-a8a3-ec3f4b73fa60\"], \"sourceText\": \"a. Physical Exam: Subjects with new-onset symptoms related to CRS should undergo physical examinatio\"}, {\"id\": \"22fb5292-cd3b-471e-aa9a-9955d8a993b8\", \"conditionType\": \"timing_before\", \"text\": \"b. Neurologic assessment: A neurological assessment should be done prior to axicabtagene ciloleucel infusion on treatment day 0, then on treatment day 1 and every other day during the minimum 7-day observation period.\", \"footnoteId\": \"0024e894-5a10-4ee3-be0c-4a74dab62ee0\", \"structuredCondition\": \"timing.before(infusion, Day0); timing.at(Day1); timing.every(P2D) until(Day7)\", \"appliesToActivityIds\": [\"84a27b69-f848-46a1-ad74-8cf5e56a689f\", \"17ab9f60-7471-41c5-b7d0-b819af9b89d9\", \"ae842214-6b86-4c56-bf7d-fbef019181f2\"], \"sourceText\": \"b. Neurologic assessment: A neurological assessment should be done prior to axicabtagene ciloleucel \"}, {\"id\": \"8fdde07a-5dfa-4292-9527-452df37e1d69\", \"conditionType\": \"timing_before\", \"text\": \"c. Echo: Performed following the subjects last chemotherapy treatment and within 28 days prior to signing the consent may be used for confirmation of eligibility\", \"footnoteId\": \"dbf4b232-3e39-4140-9986-302db34eac7c\", \"structuredCondition\": \"timing.after(last_chemo) && timing.before(consent, P28D)\", \"appliesToActivityIds\": [\"ce497a62-35b6-41d1-9c3a-b4053097c57e\"], \"sourceText\": \"c. Echo: Performed following the subjects last chemotherapy treatment and within 28 days prior to si\"}, {\"id\": \"1c39897e-cafc-4a5f-bd74-85ff75d157b9\", \"conditionType\": \"timing_before\", \"text\": \"d. PET-CT disease assessment: PET-CT should be performed as close to randomization as possible and within 28 days prior to randomization.\", \"footnoteId\": \"e3e60d89-8353-4426-99ad-c159952e8ca6\", \"structuredCondition\": \"timing.before(randomization, P28D)\", \"appliesToActivityIds\": [\"cddfd22b-a39a-45eb-b16b-f59b1dc38d69\"], \"sourceText\": \"d. PET-CT disease assessment: PET-CT should be performed as close to randomization as possible and w\"}, {\"id\": \"7e392c09-281f-451b-945f-2bce223bb07b\", \"conditionType\": \"general\", \"text\": \"e. Archived tumor sample: Archived tumor samples will be submitted to central laboratory for evaluation of CD19 expression and prognostic variables.\", \"footnoteId\": \"761443c9-620d-4b4c-a71a-ba526b0bc528\", \"structuredCondition\": \"submit_to(central_lab)\", \"appliesToActivityIds\": [\"e1308d60-207a-4ab5-bff2-67c4f4e0bc7e\"], \"sourceText\": \"e. Archived tumor sample: Archived tumor samples will be submitted to central laboratory for evaluat\"}, {\"id\": \"d63a60c9-eb2c-4f67-9dce-1daa951ec3c6\", \"conditionType\": \"timing_before\", \"text\": \"f. Blood draw for anti-axicabtagene ciloleucel antibodies: Baseline antibody samples to be collected prior to start of leukapheresis.\", \"footnoteId\": \"526c5307-97b3-4071-a923-ee94a4c8070a\", \"structuredCondition\": \"timing.before(leukapheresis)\", \"appliesToActivityIds\": [\"84a27b69-f848-46a1-ad74-8cf5e56a689f\"], \"sourceText\": \"f. Blood draw for anti-axicabtagene ciloleucel antibodies: Baseline antibody samples to be collected\"}, {\"id\": \"57175a71-a433-42e7-9ce6-ddab0bd448fd\", \"conditionType\": \"general\", \"text\": \"g. Lumbar Puncture: Subjects with new onset Grade >= 2 neurologic symptoms post axicabtagene ciloleucel infusion will have lumbar puncture performed.\", \"footnoteId\": \"b004c4c9-4ce6-46ba-814f-e951535eea35\", \"structuredCondition\": \"if(neurologic_symptoms >= Grade2 && timing.after(infusion))\", \"appliesToActivityIds\": [\"4c2c603a-712f-4011-838f-6b95e7dfa1cd\"], \"sourceText\": \"g. Lumbar Puncture: Subjects with new onset Grade >= 2 neurologic symptoms post axicabtagene ciloleu\"}, {\"id\": \"2c327258-cc0c-49fa-8e53-7d89887e68e4\", \"conditionType\": \"general\", \"text\": \"h. Blood draws for PBMCs, cytokines, and additional analysis per Section 7.11.2: PBMC blood will be used for the analysis of tests that include anti-CD19 CAR T cells, lymphocytes, and RCR.\", \"footnoteId\": \"50d25535-1fb4-4390-b8f2-2adfa6e00910\", \"structuredCondition\": \"analysis_includes(anti-CD19 CAR T cells, lymphocytes, RCR)\", \"appliesToActivityIds\": [\"a8df3d05-22e5-4d67-b8de-314796038b7d\", \"143296c6-3554-4020-904a-935de6170375\", \"4d7306fa-9334-491d-bcb4-68e10f61f0e0\", \"25b08c4c-30e1-46a6-9be3-a91418608fdf\"], \"sourceText\": \"h. Blood draws for PBMCs, cytokines, and additional analysis per Section 7.11.2: PBMC blood will be \"}, {\"id\": \"7c8d4a83-81f8-46cd-b16d-e4ff76ebd89f\", \"conditionType\": \"timing_before\", \"text\": \"i. EORTC QLQ-C30/EQ-5D-5L/WPAI: To be completed by the subject before any procedures are performed-excluding blood draws.\", \"footnoteId\": \"ff2548a1-fb8e-4c25-8499-f28732ecfa0a\", \"structuredCondition\": \"timing.before(all_procedures) excluding(blood_draws)\", \"appliesToActivityIds\": [\"a632259b-05cd-4b58-ac30-24b2fadc4224\", \"50f61d5f-6d5a-4b48-b016-6721a82dd9a2\", \"f8362489-fc0a-42f3-835d-7a29d354c3eb\"], \"sourceText\": \"i. EORTC QLQ-C30/EQ-5D-5L/WPAI: To be completed by the subject before any procedures are performed-e\"}, {\"id\": \"adbbf12e-dd74-47d0-a0c5-bc3efa4d7dd6\", \"conditionType\": \"timing_after\", \"text\": \"j. Adverse Events: The investigator is responsible for reporting all adverse events observed by the investigator or reported by the subject that occur after randomization through the Day 150 post-randomization visit.\", \"footnoteId\": \"a8679a81-c2c2-4a90-9340-0d74aef3d671\", \"structuredCondition\": \"timing.range(randomization, Day150_post_randomization)\", \"appliesToActivityIds\": [\"ad7ce556-2f71-4b2a-a7a4-3129ad93e909\"], \"sourceText\": \"j. Adverse Events: The investigator is responsible for reporting all adverse events observed by the \"}, {\"id\": \"03816278-4fdc-425d-87ea-d7afba132cc6\", \"conditionType\": \"general\", \"text\": \"k. Concomitant medications should be recorded from the date of the informed consent through the Day 150 post-randomization visit.\", \"footnoteId\": \"474d0c53-0630-4e42-9cc0-4da97b77f082\", \"structuredCondition\": \"timing.range(informed_consent, Day150_post_randomization)\", \"appliesToActivityIds\": [\"ad7ce556-2f71-4b2a-a7a4-3129ad93e909\"], \"sourceText\": \"k. Concomitant medications should be recorded from the date of the informed consent through the Day \"}, {\"id\": \"f42d3b96-c919-4e31-a7ce-b1a5c6731cb2\", \"conditionType\": \"general\", \"text\": \"l. For European Union (EU) sites, viral serologic tests (eg, HIV, Hep B, Hep C) will be carried out per institution guidelines and EU regulations.\", \"footnoteId\": \"4630931f-3fe5-496e-a11c-d52b9aa9a8ab\", \"structuredCondition\": \"if(site == 'EU') { protocol = 'institution_guidelines' }\", \"appliesToActivityIds\": [\"a8df3d05-22e5-4d67-b8de-314796038b7d\"], \"sourceText\": \"l. For European Union (EU) sites, viral serologic tests (eg, HIV, Hep B, Hep C) will be carried out \"}, {\"id\": \"c2d16945-59d4-49c6-b643-84df3f3d0820\", \"conditionType\": \"timing_after\", \"text\": \"m. Subjects will be monitored daily through day 7 after treatment with axicabtagene ciloleucel unless otherwise required by country regulatory agencies.\", \"footnoteId\": \"d9cbd514-e2b9-442b-89f6-f71b42d3a6e3\", \"structuredCondition\": \"frequency.daily until(Day7_after_treatment)\", \"appliesToActivityIds\": [\"84a27b69-f848-46a1-ad74-8cf5e56a689f\", \"17ab9f60-7471-41c5-b7d0-b819af9b89d9\"], \"sourceText\": \"m. Subjects will be monitored daily through day 7 after treatment with axicabtagene ciloleucel unles\"}]"
              },
              {
                "id": "a9add028-8eae-4cc3-9911-87f39720321d",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-endpointAlgorithms",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"46687959-9d71-46e4-abfd-3617c248fb64\", \"name\": \"Primary: Event-free Survival (EFS)\", \"endpointType\": \"Primary\", \"inputs\": [\"randomization_date\", \"disease_progression_date\", \"new_lymphoma_therapy_start_date\", \"death_date\", \"data_cutoff_date\"], \"timeWindow\": {\"reference\": \"randomization\", \"duration\": \"Until earliest event or data cutoff\"}, \"algorithm\": \"min(disease_progression_date, new_lymphoma_therapy_start_date, death_date) - randomization_date\", \"successCriteria\": \"Statistically significant improvement (50% hypothesized) compared to SOC; 1-sided alpha 2.5%\", \"sourceText\": \"EFS is defined as the time from randomization to the earliest date of disease progression per the Lugano Classification {Cheson 2014}, commencement of new lymphoma therapy, or death from any cause.\"}, {\"id\": \"ce2ffea6-a359-4ac5-8b5a-65520cc47746\", \"name\": \"Objective Response Rate (ORR)\", \"endpointType\": \"Secondary\", \"inputs\": [\"subjects_with_response\", \"total_randomized_subjects\"], \"timeWindow\": {\"reference\": \"randomization\", \"duration\": \"Assessed at time of primary EFS analysis\"}, \"algorithm\": \"subjects_with_response / total_randomized_subjects\", \"successCriteria\": \"Statistically significant improvement compared to SOC tested hierarchically after EFS\", \"sourceText\": \"To evaluate the effect of axicabtagene ciloleucel compared to SOC on objective response rate (ORR), as detennined by blinded centrnl review\"}, {\"id\": \"8bd8bd7f-93ab-4dda-9e83-63b614b1ed1c\", \"name\": \"Overall Survival (OS)\", \"endpointType\": \"Secondary\", \"inputs\": [\"randomization_date\", \"death_date\", \"analysis_cutoff_date\"], \"timeWindow\": {\"reference\": \"randomization\", \"duration\": \"Up to 5 years after first subject randomized\"}, \"algorithm\": \"death_date - randomization_date\", \"successCriteria\": \"Statistically significant improvement compared to SOC tested hierarchically after ORR\", \"sourceText\": \"To evaluate the effect of axicabtagene ciloleucel compared to SOC on overall survival (OS)\"}, {\"id\": \"3bbb4b3a-057e-448a-aa7f-3021f7c327f0\", \"name\": \"Progression-free Survival (PFS)\", \"endpointType\": \"Secondary\", \"inputs\": [\"randomization_date\", \"disease_progression_date\", \"death_date\"], \"timeWindow\": {\"reference\": \"randomization\", \"duration\": \"Until progression or death\"}, \"algorithm\": \"min(disease_progression_date, death_date) - randomization_date\", \"successCriteria\": \"Comparison between treatment arms\", \"sourceText\": \"To evaluate the effect of axicabtagene ciloleucel compared to SOC on progression-free smvival (PFS)\"}, {\"id\": \"bf923ba9-8b0a-4b1b-884c-b82fa834fcb4\", \"name\": \"Quality of Life Change (EORTC QLQ-C30)\", \"endpointType\": \"Secondary\", \"inputs\": [\"screening_score\", \"post_baseline_score\"], \"timeWindow\": {\"reference\": \"screening\", \"duration\": \"Post-baseline assessment points\"}, \"algorithm\": \"post_baseline_score - screening_score\", \"successCriteria\": \"Evaluation of global health status and physical functioning domains\", \"sourceText\": \"Changes from screening to post baseline in the global health status QoL scale and the physical functioning domain of the European Organisation for Research and Treatment of Cancer Quality of Life Ques\"}]"
              },
              {
                "id": "c960a7a6-1c8b-4aac-b099-d5880e583e57",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-derivedVariables",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"94ae96f2-65f9-487a-8909-0000cde70a83\", \"name\": \"Event-free Survival\", \"variableType\": \"TimeToEvent\", \"sourceVariables\": [\"Date of Randomization\", \"Date of Progression\", \"Date of Death\", \"Date of New Anti-lymphoma Therapy\"], \"derivationRule\": \"Time from randomization to the date of first documentation of progression, death from any cause, or commencement of new anti-lymphoma therapy.\", \"baselineDefinition\": \"Date of Randomization\", \"baselineVisit\": \"Day 0\", \"analysisWindow\": \"Study duration until event or censoring\", \"imputationRule\": \"Censoring rules per protocol for subjects without events\", \"unit\": \"Months\"}, {\"id\": \"983791a8-7c73-49a0-bd5e-b1dbe6204032\", \"name\": \"ORR\", \"variableType\": \"Categorical\", \"sourceVariables\": [\"Best Objective Response\"], \"derivationRule\": \"Proportion of subjects who achieve a best objective response of Complete Response (CR) or Partial Response (PR).\", \"baselineDefinition\": \"Pre-treatment disease assessment\", \"baselineVisit\": \"Screening\", \"analysisWindow\": \"Post-baseline assessments\", \"imputationRule\": \"Subjects with no post-baseline assessment are considered non-responders\", \"unit\": \"Percentage\"}, {\"id\": \"265bca49-0174-4d9b-86d3-3d8d3c220eb8\", \"name\": \"OS\", \"variableType\": \"TimeToEvent\", \"sourceVariables\": [\"Date of Randomization\", \"Date of Death\"], \"derivationRule\": \"Time from randomization to the date of death from any cause.\", \"baselineDefinition\": \"Date of Randomization\", \"baselineVisit\": \"Day 0\", \"analysisWindow\": \"Long-term follow-up\", \"imputationRule\": \"Censored at date last known alive\", \"unit\": \"Months\"}, {\"id\": \"87075d35-4ede-414a-a528-200eb43caac0\", \"name\": \"Progression-free Survival\", \"variableType\": \"TimeToEvent\", \"sourceVariables\": [\"Date of Randomization\", \"Date of Progression\", \"Date of Death\"], \"derivationRule\": \"Time from randomization to the date of first documentation of progression or death from any cause.\", \"baselineDefinition\": \"Date of Randomization\", \"baselineVisit\": \"Day 0\", \"analysisWindow\": \"Study duration until event or censoring\", \"imputationRule\": \"Censoring rules per protocol\", \"unit\": \"Months\"}, {\"id\": \"940887d1-30b4-4a9c-bf44-98b748a0b223\", \"name\": \"Duration of Response\", \"variableType\": \"TimeToEvent\", \"sourceVariables\": [\"Date of First Response\", \"Date of Progression\", \"Date of Death\"], \"derivationRule\": \"Time from the first objective response (CR or PR) to the date of progression or death.\", \"baselineDefinition\": \"Date of first documented CR or PR\", \"baselineVisit\": \"Post-baseline\", \"analysisWindow\": \"From response onset until event\", \"imputationRule\": \"Censored at last evaluable disease assessment\", \"unit\": \"Months\"}, {\"id\": \"612d2d9d-09a0-4be6-ba02-2746da4e4402\", \"name\": \"Time to Next Therapy\", \"variableType\": \"TimeToEvent\", \"sourceVariables\": [\"Date of Randomization\", \"Date of New Anti-lymphoma Therapy\"], \"derivationRule\": \"Time from randomization to the start date of the first new anti-lymphoma therapy.\", \"baselineDefinition\": \"Date of Randomization\", \"baselineVisit\": \"Day 0\", \"analysisWindow\": \"Study duration\", \"imputationRule\": \"Censored at last contact or death if no therapy started\", \"unit\": \"Months\"}]"
              },
              {
                "id": "11773a03-3f46-4048-97d0-53bdae568ed0",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-stateMachine",
                "instanceType": "ExtensionAttribute",
                "valueString": "{\"id\": \"576a96eb-f824-4195-a20b-6b646cb6b85b\", \"initialState\": \"Screening\", \"terminalStates\": [\"Early Termination\", \"Completed\"], \"states\": [\"Screening\", \"Randomization\", \"Treatment\", \"Disease Assessment\", \"Follow Up\", \"Long Term Follow Up\", \"Early Termination\"], \"transitions\": [{\"fromState\": \"Screening\", \"toState\": \"Randomization\", \"trigger\": \"Progress to Randomization\"}, {\"fromState\": \"Randomization\", \"toState\": \"Treatment\", \"trigger\": \"Progress to Treatment\"}, {\"fromState\": \"Treatment\", \"toState\": \"Disease Assessment\", \"trigger\": \"Progress to Disease Assessment\"}, {\"fromState\": \"Disease Assessment\", \"toState\": \"Follow Up\", \"trigger\": \"Progress to Follow Up\"}, {\"fromState\": \"Follow Up\", \"toState\": \"Long Term Follow Up\", \"trigger\": \"Progress to Long Term Follow Up\"}, {\"fromState\": \"Treatment\", \"toState\": \"Early Termination\", \"trigger\": \"Subject exits to Early Termination\"}], \"epochIds\": {\"Screening\": \"SCREENING\", \"Randomization\": \"RANDOMIZATION\", \"Treatment\": \"TREATMENT\", \"Disease Assessment\": \"DISEASE_ASSESSMENT\", \"Follow Up\": \"FOLLOW_UP\", \"Long Term Follow Up\": \"LONG_TERM_FOLLOW_UP\", \"Early Termination\": \"EARLY_TERMINATION\"}}"
              },
              {
                "id": "77aa1430-0fbd-458a-bc22-8a28cc958410",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-dosingRegimens",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"ea59bd7d-8d58-43e8-a15f-a5dcd626b00c\", \"treatmentName\": \"Axicabtagene ciloleucel\", \"frequency\": \"Single\", \"route\": \"IV\", \"startDay\": 1, \"doseLevels\": [{\"amount\": 2000000.0, \"unit\": \"anti-CD19 CAR T cells/kg\", \"description\": \"Target dose\"}], \"durationDescription\": \"One-time dose\"}, {\"id\": \"d07ef536-33f9-4cc6-b78e-2b6f285a99db\", \"treatmentName\": \"Fludarabine\", \"frequency\": \"QD\", \"route\": \"IV\", \"startDay\": 1, \"doseLevels\": [{\"amount\": 30.0, \"unit\": \"mg/m2/day\", \"description\": \"Conditioning chemotherapy\"}], \"durationDescription\": \"3 days\"}, {\"id\": \"c059a2b0-e913-49ee-885c-2336311ed26e\", \"treatmentName\": \"Cyclophosphamide\", \"frequency\": \"QD\", \"route\": \"IV\", \"startDay\": 1, \"doseLevels\": [{\"amount\": 500.0, \"unit\": \"mg/m2/day\", \"description\": \"Conditioning chemotherapy\"}], \"durationDescription\": \"3 days\"}, {\"id\": \"228408f1-edfd-4aff-bed6-a530ca927fd7\", \"treatmentName\": \"Standard of Care (SOC) - Platinum-based salvage combination chemotherapy (R-ICE, R-DHAP, R-ESHAP, or R-GDP)\", \"frequency\": \"Q3W\", \"route\": \"IV\", \"startDay\": 1, \"durationDescription\": \"2 to 3 cycles (6 to 9 weeks)\", \"doseModifications\": [\"Subjects responding to second-line combination chemotherapy after 2 or 3 cycles (PR or CR) should proceed to high-dose therapy (HDT) and autologous stem cell transplant (ASCT).\"]}]"
              },
              {
                "id": "d9f769ed-a5bb-4e7e-866c-f67d8cc7912a",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-visitWindows",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"c0b1699a-40c5-4df1-8f93-6cc424573465\", \"visitName\": \"screening\", \"targetDay\": -14, \"windowBefore\": 7, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 1, \"epoch\": \"Screening\", \"sourceText\": \"(0 to 1 vs 2 to 3) as assessed at the time of screening. For subjects randomized to the control arm of the study, SOC will consist of a protocol-defined, platinum-based salvage combination chemotherap\"}, {\"id\": \"48b0d444-5386-430e-a3ae-7c680b0eb05c\", \"visitName\": \"Conditioning Chemotherapy Day -5\", \"targetDay\": -5, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 3, \"epoch\": \"Conditioning\"}, {\"id\": \"b8cbbfed-cf1f-48e2-8d10-5b128d979fba\", \"visitName\": \"Conditioning Chemotherapy Day -4\", \"targetDay\": -4, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 4, \"epoch\": \"Conditioning\"}, {\"id\": \"5c13de67-9a92-47bc-b164-ff86ddc0557c\", \"visitName\": \"Conditioning Chemotherapy Day -3\", \"targetDay\": -3, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 5, \"epoch\": \"Conditioning\"}, {\"id\": \"0e637104-b387-485d-8a5f-9e259f347572\", \"visitName\": \"Rest Day -2\", \"targetDay\": -2, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 6, \"epoch\": \"Pre-Infusion\"}, {\"id\": \"b6bdab4d-3a92-4267-96f0-cc8e804e5d1e\", \"visitName\": \"Rest Day -1\", \"targetDay\": -1, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 7, \"epoch\": \"Pre-Infusion\"}, {\"id\": \"f2c603c3-4281-4549-937d-84df695602d2\", \"visitName\": \"Early Termination\", \"targetDay\": null, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 7, \"sourceText\": \"response [PR] or complete response [CR]) should proceed to high-dose therapy (HDT) and autologous stem cell transplant (ASCT). An independent Data Safety Monitoring Board (DSMB) will meet every\"}, {\"id\": \"7c4185bd-f3f3-423d-8916-ea8cf5709c25\", \"visitName\": \"baseline\", \"targetDay\": 0, \"windowBefore\": 1, \"windowAfter\": 1, \"isRequired\": true, \"visitNumber\": 8, \"sourceText\": \"marrow biopsy; disease staging, including a baseline PET-CT scan; and blood draws for lactate dehydrogenase levels, complete blood count (CBC), and blood chemistries. Subjects will also undergo baseli\"}, {\"id\": \"e46cab11-bcd1-433c-a9ae-d169fd2d37ce\", \"visitName\": \"Visit 1\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 9, \"sourceText\": \"MSGV1 Murine stem cell virus-based vector NCI\"}, {\"id\": \"9e11f63c-f8df-4775-a636-7eaabb73ed06\", \"visitName\": \"end of study\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 7, \"isRequired\": true, \"visitNumber\": 10, \"sourceText\": \"The end of study is defined as when the last remaining subject completes their last visit on this study and transitions to a separate LTFU study (Section 3.5.3), or, when the last remaining subject, w\"}, {\"id\": \"f0f0a365-fc09-4427-8331-b62f48dd3129\", \"visitName\": \"Month 12\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 11, \"sourceText\": \"Month 12, or until a change in lymphoma therapy, or disease progression, whichever occurs first. Targeted concomitant therapies include gammaglobulin, immunosuppressive drugs, anti-infective drugs, an\"}, {\"id\": \"e1c23412-2361-49d3-bb2d-f213609a3d9f\", \"visitName\": \"Month 9\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 12, \"sourceText\": \"through Month 9 or until change in lymphoma therapy or disease progression, whichever comes first. If subject\\u2019s disease has not progressed by Month 9, disease assessments can be evaluated per CT scans\"}, {\"id\": \"02fdfed8-c9ef-4d0f-b4a6-bf7718599a95\", \"visitName\": \"Leukapheresis\", \"targetDay\": null, \"windowBefore\": null, \"windowAfter\": null, \"isRequired\": true, \"visitNumber\": 2, \"epoch\": \"Pre-Treatment\"}, {\"id\": \"bf552e5d-b30a-43a8-8dfd-b944e8652337\", \"visitName\": \"SOC Cycle 1\", \"targetDay\": null, \"windowBefore\": null, \"windowAfter\": null, \"isRequired\": true, \"visitNumber\": 10, \"targetWeek\": 1, \"epoch\": \"SOC Treatment\"}, {\"id\": \"b7fdde8c-77f0-43d9-9047-fad280af3a23\", \"visitName\": \"SOC Cycle 2\", \"targetDay\": null, \"windowBefore\": null, \"windowAfter\": null, \"isRequired\": true, \"visitNumber\": 11, \"targetWeek\": 3, \"epoch\": \"SOC Treatment\"}, {\"id\": \"9413e4f2-d7b1-453f-8c45-3bf04536a0b8\", \"visitName\": \"SOC Cycle 3\", \"targetDay\": null, \"windowBefore\": null, \"windowAfter\": null, \"isRequired\": false, \"visitNumber\": 12, \"targetWeek\": 6, \"epoch\": \"SOC Treatment\"}, {\"id\": \"6b9a0226-a2eb-4edb-8d56-867840bede41\", \"visitName\": \"Long-term Follow-up\", \"targetDay\": null, \"windowBefore\": null, \"windowAfter\": null, \"isRequired\": true, \"visitNumber\": 13, \"epoch\": \"Follow-up\"}, {\"id\": \"266a18c8-d13e-498a-810b-39c678e3877a\", \"visitName\": \"Randomization\", \"targetDay\": 1, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 18, \"sourceText\": \"1:1 ratio to receive axicabtagene ciloleucel or SOC. Randomization will be stratified by response to first-line therapy (primary refractory, vs relapse \\u2264 6 months of first-line therapy vs relapse > 6 \"}, {\"id\": \"88599ed2-5b19-42ea-8f4e-bc63d3ecd8b9\", \"visitName\": \"Day 2\", \"targetDay\": 2, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 19, \"sourceText\": \"Ifosfamide 5 g/m2 24h-CI on day 2 with mesna \\u2022 Carboplatin area under the curve (AUC) 5 on day 2, maximum dose 800 mg\"}, {\"id\": \"4ce4c9ea-4367-4210-8fba-78350d061162\", \"visitName\": \"Day 5\", \"targetDay\": 5, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 20, \"sourceText\": \"Cytarabine 2 g/m2 on day 5\"}, {\"id\": \"4dee2c7b-188d-42e4-9ba0-d86753224b8e\", \"visitName\": \"Observation Period (Post-Infusion)\", \"targetDay\": 7, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 9, \"targetWeek\": 1, \"epoch\": \"Post-Treatment\"}, {\"id\": \"19d62ad6-343f-4409-b229-fd459e5fe8ac\", \"visitName\": \"Day 50\", \"targetDay\": 50, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 22, \"sourceText\": \"Day 50 (from randomization) Disease Assessmentb Day 150 (from randomization) Disease Assessmentb Treatment Period: Standard of Care Therapy Treatment Arm\"}, {\"id\": \"e36170e3-e348-47da-9a87-efd5d8b9275a\", \"visitName\": \"Day 100\", \"targetDay\": 100, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 23, \"sourceText\": \"Day 100 (from randomization) Disease Assessmentb a Bridging therapy: At the discretion of the investigator, corticosteroid bridging therapy may be considered for subjects with high disease\"}, {\"id\": \"95ea8c43-a3c5-4c4a-ba12-1ab267cd0516\", \"visitName\": \"Day 150\", \"targetDay\": 150, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 24, \"sourceText\": \"Day 150 (from randomization) Disease Assessmentb Treatment Period: Standard of Care Therapy Treatment Arm Subjects randomized to the SOC arm will receive a second-line\"}, {\"id\": \"4c56563d-5a09-43f6-8c10-ff0e04840aa4\", \"visitName\": \"Follow-up\", \"targetDay\": 365, \"windowBefore\": 7, \"windowAfter\": 7, \"isRequired\": true, \"visitNumber\": 25, \"sourceText\": \"Long-term Follow-up (LTFU) study. For a subject who completes the entire protocol from the date of informed consent through the completion of the long-term follow-up period, the\"}]"
              },
              {
                "id": "cec086d4-0294-438e-bb68-00d73474c428",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-randomizationScheme",
                "instanceType": "ExtensionAttribute",
                "valueString": "{\"id\": \"400e628b-b48f-46d5-8419-0872369b1f6b\", \"ratio\": \"1:1\", \"method\": \"Stratified randomization\", \"centralRandomization\": true, \"stratificationFactors\": [{\"id\": \"cccedf2a-9e01-4f03-b20f-0d2ae544db27\", \"name\": \"Age\", \"categories\": [\"<5 years\", \"\\u22655 years\"], \"isBlocking\": false, \"sourceText\": \"response to first-line therapy (primary refractory, vs relapse \\n\\u2264 6 months of first-line therapy vs relapse > 6 and \\u2264 12 months of  first-line \\ntherapy) and second-line age-adjusted international prog\"}, {\"id\": \"2d33b991-f810-4058-8042-744844487f0a\", \"name\": \"Response to first-line therapy\", \"categories\": [\"primary refractory\", \"relapse \\u2264 6 months of first-line therapy\", \"relapse > 6 and \\u2264 12 months of first-line therapy\"], \"isBlocking\": false}, {\"id\": \"9c512ec3-54bd-4d00-a451-a491d7a3fe26\", \"name\": \"Second-line age-adjusted International Prognostic Index (IPI)\", \"categories\": [\"0 to 1\", \"2 to 3\"], \"isBlocking\": false}], \"sourceText\": \"Axicabtagene ciloleucel; KTE-C19\\nKite Pharma, Inc.\\nClinical Protocol: KTE-C19-107 (ZUMA-7)\\nAmendment 6\\nCONFIDENTIAL\\nPage 2\\n14 April 2023\\nPROTOCOL SYNOPSIS\\nTitle:\\nA Phase 3, Randomized, Open-Label Stud\"}"
              },
              {
                "id": "ext_execution_model_1b97e4b5-2058-4aba-9e53-0f9c6d2c89d5",
                "url": "https://protocol2usdm.io/extensions/x-executionModel",
                "instanceType": "ExtensionAttribute",
                "valueObject": {
                  "schemaVersion": "1.0.0",
                  "extractionTimestamp": "2026-01-23T03:37:17.537298",
                  "executionModel": {
                    "timeAnchors": [
                      {
                        "id": "98898ff1-5104-48aa-b420-8f5dd98577a9",
                        "definition": "First administration of investigational product",
                        "anchorType": "FirstDose",
                        "classification": "Event",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 60,
                        "sourceText": "first dose",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "01180888-2fe8-46e9-a599-7eda0d32b1ed",
                        "definition": "Date of subject randomization",
                        "anchorType": "Randomization",
                        "classification": "Event",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 40,
                        "sourceText": "day of randomization",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "e7f49fb0-3574-4a7a-9167-08e61f02fb7d",
                        "definition": "Informed consent obtained",
                        "anchorType": "InformedConsent",
                        "classification": "Event",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 10,
                        "sourceText": "informed consent",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "cd589b19-5c49-4ed7-9522-91bb08ccdc26",
                        "definition": "transplant",
                        "anchorType": "Custom",
                        "classification": "Conceptual",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 100,
                        "sourceText": "transplant",
                        "encounterId": null,
                        "activityId": null
                      }
                    ],
                    "repetitions": [
                      {
                        "id": "831b94d9-e407-4e36-98d3-130924cfc964",
                        "type": "Daily",
                        "interval": "P1D",
                        "sourceText": "od"
                      },
                      {
                        "id": "bb234e83-99dc-4d91-b09e-6560f6d8030c",
                        "type": "Interval",
                        "interval": "PT6H",
                        "sourceText": "every 6 hours"
                      },
                      {
                        "id": "4784d31f-5f6a-42d8-8336-ab36a4ee9996",
                        "type": "Interval",
                        "sourceText": "bid"
                      },
                      {
                        "id": "de1faceb-ef95-4d87-83be-3ce078badd39",
                        "type": "Cycle",
                        "cycleLength": "P3D",
                        "sourceText": "Up to 3 cycles"
                      },
                      {
                        "id": "65a08de6-5410-4131-b38e-89e3632c843b",
                        "type": "Continuous",
                        "startOffset": "-P5D",
                        "endOffset": "-P3D",
                        "sourceText": "day -5 to day -3"
                      },
                      {
                        "id": "cf61157d-645d-4ba8-8c49-028d6a39df72",
                        "type": "Continuous",
                        "startOffset": "-P5D",
                        "endOffset": "-P3D",
                        "sourceText": "day -5 through day -3"
                      },
                      {
                        "id": "e54c33a9-9db0-49fe-abcd-08ef99740e70",
                        "type": "Continuous",
                        "startOffset": "P1D",
                        "endOffset": "P4D",
                        "sourceText": "days 1-4"
                      },
                      {
                        "id": "76a33550-272b-4897-9f24-6c7b6ff795b6",
                        "type": "Continuous",
                        "sourceText": "screening period"
                      },
                      {
                        "id": "fffbd0eb-8ed7-423d-8c64-c37c3b41ebd6",
                        "type": "Continuous",
                        "sourceText": "Treatment Period"
                      },
                      {
                        "id": "3aea87e5-2466-44fa-8586-4dd7ca370824",
                        "type": "Continuous",
                        "sourceText": "treatment period"
                      },
                      {
                        "id": "3474a161-c430-4ae1-b983-30450f796694",
                        "type": "Continuous",
                        "sourceText": "observation period"
                      },
                      {
                        "id": "c3fec135-52f5-4f6d-8e34-f2f5a7ac7e84",
                        "type": "Continuous",
                        "sourceText": "Follow-up Period"
                      },
                      {
                        "id": "fe38e0d0-7f74-4d23-8404-184d84acda59",
                        "type": "Continuous",
                        "sourceText": "7 days after"
                      },
                      {
                        "id": "100d8a95-f7c8-470f-bb5c-43011e3a20ad",
                        "type": "Continuous",
                        "sourceText": "5 days after"
                      },
                      {
                        "id": "1268a451-2001-48d8-b484-a16643253a56",
                        "type": "Continuous",
                        "sourceText": "48 hours before"
                      },
                      {
                        "id": "d0030de3-a838-4068-bc5e-11132122476b",
                        "type": "Continuous",
                        "sourceText": "30 days after"
                      },
                      {
                        "id": "acff8267-1a63-4e84-aedd-b4d39bbb2d4a",
                        "type": "Cycle",
                        "startOffset": "P0D",
                        "endOffset": "P63D",
                        "interval": "P21D",
                        "minObservations": 2,
                        "exitCondition": "Subjects responding to second-line combination chemotherapy after 2 or 3 cycles (PR or CR) should proceed to high-dose therapy (HDT) and autologous stem cell transplant (ASCT).",
                        "sourceText": "Up to 3 cycles (6 to 9 weeks) of combination chemotherapy will be administered every 2 to 3 weeks."
                      },
                      {
                        "id": "76b03c4b-05f0-4518-bf14-26af42aee4a9",
                        "type": "Continuous",
                        "startOffset": "-P5D",
                        "endOffset": "-P3D",
                        "interval": "P1D",
                        "minObservations": 3,
                        "exitCondition": "Completion of 3-day regimen",
                        "sourceText": "receive a 3 day conditioning chemotherapy regimen consisting of fludarabine 30 mg/m2/day and cyclophosphamide 500 mg/m2/day (day -5 to day -3)"
                      },
                      {
                        "id": "1fc48159-a85d-42c4-8594-ec74316e1a89",
                        "type": "Continuous",
                        "startOffset": "P0D",
                        "endOffset": "P7D",
                        "interval": "P1D",
                        "minObservations": 7,
                        "exitCondition": "Minimum 7 days unless otherwise required by country regulatory agencies",
                        "sourceText": "Subjects will be under an observation period for at least 7 days after axicabtagene ciloleucel infusion to monitor for and manage any adverse events"
                      },
                      {
                        "id": "cb218b87-9bb8-40dc-a272-ff9f76280b5b",
                        "type": "Continuous",
                        "startOffset": "P0D",
                        "endOffset": "P15Y",
                        "interval": "null",
                        "minObservations": 1,
                        "exitCondition": "15-year follow-up completion",
                        "sourceText": "subjects who received at least one dose of axicabtagene ciloleucel as protocol therapy will complete the remainder of the 15-year follow-up assessments"
                      }
                    ],
                    "samplingConstraints": [],
                    "traversalConstraints": [
                      {
                        "id": "d9d7dc7a-cd3b-4570-8436-071a4304a02d",
                        "requiredSequence": [
                          "epoch_1",
                          "epoch_2",
                          "epoch_6",
                          "epoch_6",
                          "epoch_6"
                        ],
                        "allowEarlyExit": true,
                        "exitEpochIds": [
                          "55b81f3d-2c13-48ee-9f06-6a77ff27afad"
                        ],
                        "mandatoryVisits": [
                          "End of Study",
                          "Randomization",
                          "Day 1",
                          "Screening",
                          "Day 50 Disease Assessment",
                          "Day 150 Disease Assessment"
                        ],
                        "sourceText": "[{'condition': 'Randomized to Axicabtagene Ciloleucel Arm', 'path': ['CONDITIONING_CHEMOTHERAPY', 'AXI_CEL_INFUSION_DAY_0', 'POST_INFUSION_MONITORING']}, {'condition': 'Randomized to Standard of Care (SOC) Arm', 'path': ['SALVAGE_COMBINATION_CHEMOTHERAPY', 'RESPONSE_ASSESSMENT']}, {'condition': 'SOC Arm: Subject achieves PR or CR after 2-3 cycles', 'path': ['HIGH_DOSE_THERAPY', 'AUTOLOGOUS_STEM_CELL_TRANSPLANT']}, {'condition': 'SOC Arm: Subject does not respond to chemotherapy', 'path': ['OFF_PROTOCOL_TREATMENT']}]"
                      }
                    ],
                    "executionTypes": [
                      {
                        "activityId": "Blood Draw",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 4"
                      },
                      {
                        "activityId": "Vital Signs",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 2"
                      },
                      {
                        "activityId": "Electrocardiogram",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 4"
                      },
                      {
                        "activityId": "Pe",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Adverse Events",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 1"
                      },
                      {
                        "activityId": "Concomitant Medications",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 1"
                      },
                      {
                        "activityId": "Pharmacokinetic",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Dosing",
                        "executionType": "Single",
                        "rationale": "WINDOW signals: 1; SINGLE signals: 4"
                      },
                      {
                        "activityId": "Ct Scan",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 4"
                      },
                      {
                        "activityId": "Biopsy",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 8"
                      },
                      {
                        "activityId": "Diary",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Screening Assessment",
                        "executionType": "Single",
                        "rationale": "Assessment of age-adjusted International Prognostic Index (IPI) and stratification factors occurs once at the time of screening."
                      },
                      {
                        "activityId": "Randomization",
                        "executionType": "Single",
                        "rationale": "Subjects are randomized in a 1:1 ratio once to either axicabtagene ciloleucel or SOC."
                      },
                      {
                        "activityId": "High-Dose Therapy (HDT) and Autologous Stem Cell Transplant (ASCT)",
                        "executionType": "Single",
                        "rationale": "Conditional workflow where subjects only proceed to HDT and ASCT if they achieve a partial response (PR) or complete response (CR) to second-line chemotherapy."
                      },
                      {
                        "activityId": "Data Safety Monitoring Board (DSMB) Review",
                        "executionType": "Single",
                        "rationale": "The board meets on a scheduled basis every 6 months after the first subject is randomized."
                      },
                      {
                        "activityId": "aed62812-2b28-4ec0-aadd-c2d46017831f",
                        "executionType": "Single",
                        "rationale": "Continuous monitoring from the time of randomization until the earliest date of disease progression, new therapy, or death."
                      },
                      {
                        "activityId": "Patient Reported Outcomes (PROs) and Quality of Life (QoL)",
                        "executionType": "Single",
                        "rationale": "Evaluations of PROs and QoL are typically scheduled repeats at specific study visits to compare treatment arms over time."
                      }
                    ],
                    "footnoteConditions": [
                      {
                        "id": "1e15e56e-42ea-4ecb-b856-30ae45c3eb8b",
                        "conditionType": "frequency_daily",
                        "text": "a. Physical Exam: Subjects with new-onset symptoms related to CRS should undergo physical examination at least daily until symptoms resolve to baseline.",
                        "footnoteId": "e2733b20-39c6-4b21-8e3a-bf57b5379403",
                        "structuredCondition": "if(symptoms == 'CRS') { frequency = 'P1D' } until(symptoms == 'baseline')",
                        "appliesToActivityIds": [
                          "Physical Exam"
                        ],
                        "sourceText": "a. Physical Exam: Subjects with new-onset symptoms related to CRS should undergo physical examinatio"
                      },
                      {
                        "id": "22fb5292-cd3b-471e-aa9a-9955d8a993b8",
                        "conditionType": "timing_before",
                        "text": "b. Neurologic assessment: A neurological assessment should be done prior to axicabtagene ciloleucel infusion on treatment day 0, then on treatment day 1 and every other day during the minimum 7-day observation period.",
                        "footnoteId": "0024e894-5a10-4ee3-be0c-4a74dab62ee0",
                        "structuredCondition": "timing.before(infusion, Day0); timing.at(Day1); timing.every(P2D) until(Day7)",
                        "appliesToActivityIds": [
                          "Neurologic assessment"
                        ],
                        "sourceText": "b. Neurologic assessment: A neurological assessment should be done prior to axicabtagene ciloleucel "
                      },
                      {
                        "id": "8fdde07a-5dfa-4292-9527-452df37e1d69",
                        "conditionType": "timing_before",
                        "text": "c. Echo: Performed following the subjects last chemotherapy treatment and within 28 days prior to signing the consent may be used for confirmation of eligibility",
                        "footnoteId": "dbf4b232-3e39-4140-9986-302db34eac7c",
                        "structuredCondition": "timing.after(last_chemo) && timing.before(consent, P28D)",
                        "appliesToActivityIds": [
                          "Echo"
                        ],
                        "sourceText": "c. Echo: Performed following the subjects last chemotherapy treatment and within 28 days prior to si"
                      },
                      {
                        "id": "1c39897e-cafc-4a5f-bd74-85ff75d157b9",
                        "conditionType": "timing_before",
                        "text": "d. PET-CT disease assessment: PET-CT should be performed as close to randomization as possible and within 28 days prior to randomization.",
                        "footnoteId": "e3e60d89-8353-4426-99ad-c159952e8ca6",
                        "structuredCondition": "timing.before(randomization, P28D)",
                        "appliesToActivityIds": [
                          "e6862361-6bf2-4cb2-a6a9-19ad6bad6968"
                        ],
                        "sourceText": "d. PET-CT disease assessment: PET-CT should be performed as close to randomization as possible and w"
                      },
                      {
                        "id": "7e392c09-281f-451b-945f-2bce223bb07b",
                        "conditionType": "general",
                        "text": "e. Archived tumor sample: Archived tumor samples will be submitted to central laboratory for evaluation of CD19 expression and prognostic variables.",
                        "footnoteId": "761443c9-620d-4b4c-a71a-ba526b0bc528",
                        "structuredCondition": "submit_to(central_lab)",
                        "appliesToActivityIds": [
                          "Archived tumor sample"
                        ],
                        "sourceText": "e. Archived tumor sample: Archived tumor samples will be submitted to central laboratory for evaluat"
                      },
                      {
                        "id": "d63a60c9-eb2c-4f67-9dce-1daa951ec3c6",
                        "conditionType": "timing_before",
                        "text": "f. Blood draw for anti-axicabtagene ciloleucel antibodies: Baseline antibody samples to be collected prior to start of leukapheresis.",
                        "footnoteId": "526c5307-97b3-4071-a923-ee94a4c8070a",
                        "structuredCondition": "timing.before(leukapheresis)",
                        "appliesToActivityIds": [
                          "Blood draw for anti-axicabtagene ciloleucel antibodies"
                        ],
                        "sourceText": "f. Blood draw for anti-axicabtagene ciloleucel antibodies: Baseline antibody samples to be collected"
                      },
                      {
                        "id": "57175a71-a433-42e7-9ce6-ddab0bd448fd",
                        "conditionType": "general",
                        "text": "g. Lumbar Puncture: Subjects with new onset Grade >= 2 neurologic symptoms post axicabtagene ciloleucel infusion will have lumbar puncture performed.",
                        "footnoteId": "b004c4c9-4ce6-46ba-814f-e951535eea35",
                        "structuredCondition": "if(neurologic_symptoms >= Grade2 && timing.after(infusion))",
                        "appliesToActivityIds": [
                          "Lumbar Puncture"
                        ],
                        "sourceText": "g. Lumbar Puncture: Subjects with new onset Grade >= 2 neurologic symptoms post axicabtagene ciloleu"
                      },
                      {
                        "id": "2c327258-cc0c-49fa-8e53-7d89887e68e4",
                        "conditionType": "general",
                        "text": "h. Blood draws for PBMCs, cytokines, and additional analysis per Section 7.11.2: PBMC blood will be used for the analysis of tests that include anti-CD19 CAR T cells, lymphocytes, and RCR.",
                        "footnoteId": "50d25535-1fb4-4390-b8f2-2adfa6e00910",
                        "structuredCondition": "analysis_includes(anti-CD19 CAR T cells, lymphocytes, RCR)",
                        "appliesToActivityIds": [
                          "Blood draws for PBMCs, cytokines, and additional analysis"
                        ],
                        "sourceText": "h. Blood draws for PBMCs, cytokines, and additional analysis per Section 7.11.2: PBMC blood will be "
                      },
                      {
                        "id": "7c8d4a83-81f8-46cd-b16d-e4ff76ebd89f",
                        "conditionType": "timing_before",
                        "text": "i. EORTC QLQ-C30/EQ-5D-5L/WPAI: To be completed by the subject before any procedures are performed-excluding blood draws.",
                        "footnoteId": "ff2548a1-fb8e-4c25-8499-f28732ecfa0a",
                        "structuredCondition": "timing.before(all_procedures) excluding(blood_draws)",
                        "appliesToActivityIds": [
                          "f188f400-1435-4151-8316-15b479689858",
                          "c0e5e48e-bb50-41ae-bdd4-1ca4068c5cc4",
                          "WPAI"
                        ],
                        "sourceText": "i. EORTC QLQ-C30/EQ-5D-5L/WPAI: To be completed by the subject before any procedures are performed-e"
                      },
                      {
                        "id": "adbbf12e-dd74-47d0-a0c5-bc3efa4d7dd6",
                        "conditionType": "timing_after",
                        "text": "j. Adverse Events: The investigator is responsible for reporting all adverse events observed by the investigator or reported by the subject that occur after randomization through the Day 150 post-randomization visit.",
                        "footnoteId": "a8679a81-c2c2-4a90-9340-0d74aef3d671",
                        "structuredCondition": "timing.range(randomization, Day150_post_randomization)",
                        "appliesToActivityIds": [
                          "Adverse Events"
                        ],
                        "sourceText": "j. Adverse Events: The investigator is responsible for reporting all adverse events observed by the "
                      },
                      {
                        "id": "03816278-4fdc-425d-87ea-d7afba132cc6",
                        "conditionType": "general",
                        "text": "k. Concomitant medications should be recorded from the date of the informed consent through the Day 150 post-randomization visit.",
                        "footnoteId": "474d0c53-0630-4e42-9cc0-4da97b77f082",
                        "structuredCondition": "timing.range(informed_consent, Day150_post_randomization)",
                        "appliesToActivityIds": [
                          "Concomitant medications"
                        ],
                        "sourceText": "k. Concomitant medications should be recorded from the date of the informed consent through the Day "
                      },
                      {
                        "id": "f42d3b96-c919-4e31-a7ce-b1a5c6731cb2",
                        "conditionType": "general",
                        "text": "l. For European Union (EU) sites, viral serologic tests (eg, HIV, Hep B, Hep C) will be carried out per institution guidelines and EU regulations.",
                        "footnoteId": "4630931f-3fe5-496e-a11c-d52b9aa9a8ab",
                        "structuredCondition": "if(site == 'EU') { protocol = 'institution_guidelines' }",
                        "appliesToActivityIds": [
                          "viral serologic tests"
                        ],
                        "sourceText": "l. For European Union (EU) sites, viral serologic tests (eg, HIV, Hep B, Hep C) will be carried out "
                      },
                      {
                        "id": "c2d16945-59d4-49c6-b643-84df3f3d0820",
                        "conditionType": "timing_after",
                        "text": "m. Subjects will be monitored daily through day 7 after treatment with axicabtagene ciloleucel unless otherwise required by country regulatory agencies.",
                        "footnoteId": "d9cbd514-e2b9-442b-89f6-f71b42d3a6e3",
                        "structuredCondition": "frequency.daily until(Day7_after_treatment)",
                        "appliesToActivityIds": [
                          "Monitoring"
                        ],
                        "sourceText": "m. Subjects will be monitored daily through day 7 after treatment with axicabtagene ciloleucel unles"
                      }
                    ],
                    "endpointAlgorithms": [
                      {
                        "id": "46687959-9d71-46e4-abfd-3617c248fb64",
                        "name": "Primary: Event-free Survival (EFS)",
                        "endpointType": "Primary",
                        "inputs": [
                          "randomization_date",
                          "disease_progression_date",
                          "new_lymphoma_therapy_start_date",
                          "death_date",
                          "data_cutoff_date"
                        ],
                        "timeWindow": {
                          "reference": "randomization",
                          "duration": "Until earliest event or data cutoff"
                        },
                        "algorithm": "min(disease_progression_date, new_lymphoma_therapy_start_date, death_date) - randomization_date",
                        "successCriteria": "Statistically significant improvement (50% hypothesized) compared to SOC; 1-sided alpha 2.5%",
                        "sourceText": "EFS is defined as the time from randomization to the earliest date of disease progression per the Lugano Classification {Cheson 2014}, commencement of new lymphoma therapy, or death from any cause."
                      },
                      {
                        "id": "ce2ffea6-a359-4ac5-8b5a-65520cc47746",
                        "name": "Objective Response Rate (ORR)",
                        "endpointType": "Secondary",
                        "inputs": [
                          "subjects_with_response",
                          "total_randomized_subjects"
                        ],
                        "timeWindow": {
                          "reference": "randomization",
                          "duration": "Assessed at time of primary EFS analysis"
                        },
                        "algorithm": "subjects_with_response / total_randomized_subjects",
                        "successCriteria": "Statistically significant improvement compared to SOC tested hierarchically after EFS",
                        "sourceText": "To evaluate the effect of axicabtagene ciloleucel compared to SOC on objective response rate (ORR), as detennined by blinded centrnl review"
                      },
                      {
                        "id": "8bd8bd7f-93ab-4dda-9e83-63b614b1ed1c",
                        "name": "Overall Survival (OS)",
                        "endpointType": "Secondary",
                        "inputs": [
                          "randomization_date",
                          "death_date",
                          "analysis_cutoff_date"
                        ],
                        "timeWindow": {
                          "reference": "randomization",
                          "duration": "Up to 5 years after first subject randomized"
                        },
                        "algorithm": "death_date - randomization_date",
                        "successCriteria": "Statistically significant improvement compared to SOC tested hierarchically after ORR",
                        "sourceText": "To evaluate the effect of axicabtagene ciloleucel compared to SOC on overall survival (OS)"
                      },
                      {
                        "id": "3bbb4b3a-057e-448a-aa7f-3021f7c327f0",
                        "name": "Progression-free Survival (PFS)",
                        "endpointType": "Secondary",
                        "inputs": [
                          "randomization_date",
                          "disease_progression_date",
                          "death_date"
                        ],
                        "timeWindow": {
                          "reference": "randomization",
                          "duration": "Until progression or death"
                        },
                        "algorithm": "min(disease_progression_date, death_date) - randomization_date",
                        "successCriteria": "Comparison between treatment arms",
                        "sourceText": "To evaluate the effect of axicabtagene ciloleucel compared to SOC on progression-free smvival (PFS)"
                      },
                      {
                        "id": "bf923ba9-8b0a-4b1b-884c-b82fa834fcb4",
                        "name": "Quality of Life Change (EORTC QLQ-C30)",
                        "endpointType": "Secondary",
                        "inputs": [
                          "screening_score",
                          "post_baseline_score"
                        ],
                        "timeWindow": {
                          "reference": "screening",
                          "duration": "Post-baseline assessment points"
                        },
                        "algorithm": "post_baseline_score - screening_score",
                        "successCriteria": "Evaluation of global health status and physical functioning domains",
                        "sourceText": "Changes from screening to post baseline in the global health status QoL scale and the physical functioning domain of the European Organisation for Research and Treatment of Cancer Quality of Life Ques"
                      }
                    ],
                    "derivedVariables": [
                      {
                        "id": "94ae96f2-65f9-487a-8909-0000cde70a83",
                        "name": "Event-free Survival",
                        "variableType": "TimeToEvent",
                        "sourceVariables": [
                          "Date of Randomization",
                          "Date of Progression",
                          "Date of Death",
                          "Date of New Anti-lymphoma Therapy"
                        ],
                        "derivationRule": "Time from randomization to the date of first documentation of progression, death from any cause, or commencement of new anti-lymphoma therapy.",
                        "baselineDefinition": "Date of Randomization",
                        "baselineVisit": "Day 0",
                        "analysisWindow": "Study duration until event or censoring",
                        "imputationRule": "Censoring rules per protocol for subjects without events",
                        "unit": "Months"
                      },
                      {
                        "id": "983791a8-7c73-49a0-bd5e-b1dbe6204032",
                        "name": "ORR",
                        "variableType": "Categorical",
                        "sourceVariables": [
                          "Best Objective Response"
                        ],
                        "derivationRule": "Proportion of subjects who achieve a best objective response of Complete Response (CR) or Partial Response (PR).",
                        "baselineDefinition": "Pre-treatment disease assessment",
                        "baselineVisit": "Screening",
                        "analysisWindow": "Post-baseline assessments",
                        "imputationRule": "Subjects with no post-baseline assessment are considered non-responders",
                        "unit": "Percentage"
                      },
                      {
                        "id": "265bca49-0174-4d9b-86d3-3d8d3c220eb8",
                        "name": "OS",
                        "variableType": "TimeToEvent",
                        "sourceVariables": [
                          "Date of Randomization",
                          "Date of Death"
                        ],
                        "derivationRule": "Time from randomization to the date of death from any cause.",
                        "baselineDefinition": "Date of Randomization",
                        "baselineVisit": "Day 0",
                        "analysisWindow": "Long-term follow-up",
                        "imputationRule": "Censored at date last known alive",
                        "unit": "Months"
                      },
                      {
                        "id": "87075d35-4ede-414a-a528-200eb43caac0",
                        "name": "Progression-free Survival",
                        "variableType": "TimeToEvent",
                        "sourceVariables": [
                          "Date of Randomization",
                          "Date of Progression",
                          "Date of Death"
                        ],
                        "derivationRule": "Time from randomization to the date of first documentation of progression or death from any cause.",
                        "baselineDefinition": "Date of Randomization",
                        "baselineVisit": "Day 0",
                        "analysisWindow": "Study duration until event or censoring",
                        "imputationRule": "Censoring rules per protocol",
                        "unit": "Months"
                      },
                      {
                        "id": "940887d1-30b4-4a9c-bf44-98b748a0b223",
                        "name": "Duration of Response",
                        "variableType": "TimeToEvent",
                        "sourceVariables": [
                          "Date of First Response",
                          "Date of Progression",
                          "Date of Death"
                        ],
                        "derivationRule": "Time from the first objective response (CR or PR) to the date of progression or death.",
                        "baselineDefinition": "Date of first documented CR or PR",
                        "baselineVisit": "Post-baseline",
                        "analysisWindow": "From response onset until event",
                        "imputationRule": "Censored at last evaluable disease assessment",
                        "unit": "Months"
                      },
                      {
                        "id": "612d2d9d-09a0-4be6-ba02-2746da4e4402",
                        "name": "Time to Next Therapy",
                        "variableType": "TimeToEvent",
                        "sourceVariables": [
                          "Date of Randomization",
                          "Date of New Anti-lymphoma Therapy"
                        ],
                        "derivationRule": "Time from randomization to the start date of the first new anti-lymphoma therapy.",
                        "baselineDefinition": "Date of Randomization",
                        "baselineVisit": "Day 0",
                        "analysisWindow": "Study duration",
                        "imputationRule": "Censored at last contact or death if no therapy started",
                        "unit": "Months"
                      }
                    ],
                    "stateMachine": {
                      "id": "576a96eb-f824-4195-a20b-6b646cb6b85b",
                      "initialState": "Screening",
                      "terminalStates": [
                        "Early Termination",
                        "Completed"
                      ],
                      "states": [
                        "Screening",
                        "Randomization",
                        "Treatment",
                        "Disease Assessment",
                        "Follow Up",
                        "Long Term Follow Up",
                        "Early Termination"
                      ],
                      "transitions": [
                        {
                          "fromState": "Screening",
                          "toState": "Randomization",
                          "trigger": "Progress to Randomization"
                        },
                        {
                          "fromState": "Randomization",
                          "toState": "Treatment",
                          "trigger": "Progress to Treatment"
                        },
                        {
                          "fromState": "Treatment",
                          "toState": "Disease Assessment",
                          "trigger": "Progress to Disease Assessment"
                        },
                        {
                          "fromState": "Disease Assessment",
                          "toState": "Follow Up",
                          "trigger": "Progress to Follow Up"
                        },
                        {
                          "fromState": "Follow Up",
                          "toState": "Long Term Follow Up",
                          "trigger": "Progress to Long Term Follow Up"
                        },
                        {
                          "fromState": "Treatment",
                          "toState": "Early Termination",
                          "trigger": "Subject exits to Early Termination"
                        }
                      ],
                      "epochIds": {
                        "Screening": "SCREENING",
                        "Randomization": "RANDOMIZATION",
                        "Treatment": "TREATMENT",
                        "Disease Assessment": "DISEASE_ASSESSMENT",
                        "Follow Up": "FOLLOW_UP",
                        "Long Term Follow Up": "LONG_TERM_FOLLOW_UP",
                        "Early Termination": "EARLY_TERMINATION"
                      }
                    },
                    "dosingRegimens": [
                      {
                        "id": "ea59bd7d-8d58-43e8-a15f-a5dcd626b00c",
                        "treatmentName": "Axicabtagene ciloleucel",
                        "frequency": "Single",
                        "route": "IV",
                        "startDay": 1,
                        "doseLevels": [
                          {
                            "amount": 2000000.0,
                            "unit": "anti-CD19 CAR T cells/kg",
                            "description": "Target dose"
                          }
                        ],
                        "durationDescription": "One-time dose"
                      },
                      {
                        "id": "d07ef536-33f9-4cc6-b78e-2b6f285a99db",
                        "treatmentName": "Fludarabine",
                        "frequency": "QD",
                        "route": "IV",
                        "startDay": 1,
                        "doseLevels": [
                          {
                            "amount": 30.0,
                            "unit": "mg/m2/day",
                            "description": "Conditioning chemotherapy"
                          }
                        ],
                        "durationDescription": "3 days"
                      },
                      {
                        "id": "c059a2b0-e913-49ee-885c-2336311ed26e",
                        "treatmentName": "Cyclophosphamide",
                        "frequency": "QD",
                        "route": "IV",
                        "startDay": 1,
                        "doseLevels": [
                          {
                            "amount": 500.0,
                            "unit": "mg/m2/day",
                            "description": "Conditioning chemotherapy"
                          }
                        ],
                        "durationDescription": "3 days"
                      },
                      {
                        "id": "228408f1-edfd-4aff-bed6-a530ca927fd7",
                        "treatmentName": "Standard of Care (SOC) - Platinum-based salvage combination chemotherapy (R-ICE, R-DHAP, R-ESHAP, or R-GDP)",
                        "frequency": "Q3W",
                        "route": "IV",
                        "startDay": 1,
                        "durationDescription": "2 to 3 cycles (6 to 9 weeks)",
                        "doseModifications": [
                          "Subjects responding to second-line combination chemotherapy after 2 or 3 cycles (PR or CR) should proceed to high-dose therapy (HDT) and autologous stem cell transplant (ASCT)."
                        ]
                      }
                    ],
                    "visitWindows": [
                      {
                        "id": "c0b1699a-40c5-4df1-8f93-6cc424573465",
                        "visitName": "screening",
                        "targetDay": -14,
                        "windowBefore": 7,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 1,
                        "epoch": "Screening",
                        "sourceText": "(0 to 1 vs 2 to 3) as assessed at the time of screening. For subjects randomized to the control arm of the study, SOC will consist of a protocol-defined, platinum-based salvage combination chemotherap"
                      },
                      {
                        "id": "48b0d444-5386-430e-a3ae-7c680b0eb05c",
                        "visitName": "Conditioning Chemotherapy Day -5",
                        "targetDay": -5,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 3,
                        "epoch": "Conditioning"
                      },
                      {
                        "id": "b8cbbfed-cf1f-48e2-8d10-5b128d979fba",
                        "visitName": "Conditioning Chemotherapy Day -4",
                        "targetDay": -4,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 4,
                        "epoch": "Conditioning"
                      },
                      {
                        "id": "5c13de67-9a92-47bc-b164-ff86ddc0557c",
                        "visitName": "Conditioning Chemotherapy Day -3",
                        "targetDay": -3,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 5,
                        "epoch": "Conditioning"
                      },
                      {
                        "id": "0e637104-b387-485d-8a5f-9e259f347572",
                        "visitName": "Rest Day -2",
                        "targetDay": -2,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 6,
                        "epoch": "Pre-Infusion"
                      },
                      {
                        "id": "b6bdab4d-3a92-4267-96f0-cc8e804e5d1e",
                        "visitName": "Rest Day -1",
                        "targetDay": -1,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 7,
                        "epoch": "Pre-Infusion"
                      },
                      {
                        "id": "f2c603c3-4281-4549-937d-84df695602d2",
                        "visitName": "Early Termination",
                        "targetDay": null,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 7,
                        "sourceText": "response [PR] or complete response [CR]) should proceed to high-dose therapy (HDT) and autologous stem cell transplant (ASCT). An independent Data Safety Monitoring Board (DSMB) will meet every"
                      },
                      {
                        "id": "7c4185bd-f3f3-423d-8916-ea8cf5709c25",
                        "visitName": "baseline",
                        "targetDay": 0,
                        "windowBefore": 1,
                        "windowAfter": 1,
                        "isRequired": true,
                        "visitNumber": 8,
                        "sourceText": "marrow biopsy; disease staging, including a baseline PET-CT scan; and blood draws for lactate dehydrogenase levels, complete blood count (CBC), and blood chemistries. Subjects will also undergo baseli"
                      },
                      {
                        "id": "e46cab11-bcd1-433c-a9ae-d169fd2d37ce",
                        "visitName": "Visit 1",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 9,
                        "sourceText": "MSGV1 Murine stem cell virus-based vector NCI"
                      },
                      {
                        "id": "9e11f63c-f8df-4775-a636-7eaabb73ed06",
                        "visitName": "end of study",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 7,
                        "isRequired": true,
                        "visitNumber": 10,
                        "sourceText": "The end of study is defined as when the last remaining subject completes their last visit on this study and transitions to a separate LTFU study (Section 3.5.3), or, when the last remaining subject, w"
                      },
                      {
                        "id": "f0f0a365-fc09-4427-8331-b62f48dd3129",
                        "visitName": "Month 12",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 11,
                        "sourceText": "Month 12, or until a change in lymphoma therapy, or disease progression, whichever occurs first. Targeted concomitant therapies include gammaglobulin, immunosuppressive drugs, anti-infective drugs, an"
                      },
                      {
                        "id": "e1c23412-2361-49d3-bb2d-f213609a3d9f",
                        "visitName": "Month 9",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 12,
                        "sourceText": "through Month 9 or until change in lymphoma therapy or disease progression, whichever comes first. If subjectâ€™s disease has not progressed by Month 9, disease assessments can be evaluated per CT scans"
                      },
                      {
                        "id": "02fdfed8-c9ef-4d0f-b4a6-bf7718599a95",
                        "visitName": "Leukapheresis",
                        "targetDay": null,
                        "windowBefore": null,
                        "windowAfter": null,
                        "isRequired": true,
                        "visitNumber": 2,
                        "epoch": "Pre-Treatment"
                      },
                      {
                        "id": "bf552e5d-b30a-43a8-8dfd-b944e8652337",
                        "visitName": "SOC Cycle 1",
                        "targetDay": null,
                        "windowBefore": null,
                        "windowAfter": null,
                        "isRequired": true,
                        "visitNumber": 10,
                        "targetWeek": 1,
                        "epoch": "SOC Treatment"
                      },
                      {
                        "id": "b7fdde8c-77f0-43d9-9047-fad280af3a23",
                        "visitName": "SOC Cycle 2",
                        "targetDay": null,
                        "windowBefore": null,
                        "windowAfter": null,
                        "isRequired": true,
                        "visitNumber": 11,
                        "targetWeek": 3,
                        "epoch": "SOC Treatment"
                      },
                      {
                        "id": "9413e4f2-d7b1-453f-8c45-3bf04536a0b8",
                        "visitName": "SOC Cycle 3",
                        "targetDay": null,
                        "windowBefore": null,
                        "windowAfter": null,
                        "isRequired": false,
                        "visitNumber": 12,
                        "targetWeek": 6,
                        "epoch": "SOC Treatment"
                      },
                      {
                        "id": "6b9a0226-a2eb-4edb-8d56-867840bede41",
                        "visitName": "Long-term Follow-up",
                        "targetDay": null,
                        "windowBefore": null,
                        "windowAfter": null,
                        "isRequired": true,
                        "visitNumber": 13,
                        "epoch": "Follow-up"
                      },
                      {
                        "id": "266a18c8-d13e-498a-810b-39c678e3877a",
                        "visitName": "Randomization",
                        "targetDay": 1,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 18,
                        "sourceText": "1:1 ratio to receive axicabtagene ciloleucel or SOC. Randomization will be stratified by response to first-line therapy (primary refractory, vs relapse â‰¤ 6 months of first-line therapy vs relapse > 6 "
                      },
                      {
                        "id": "88599ed2-5b19-42ea-8f4e-bc63d3ecd8b9",
                        "visitName": "Day 2",
                        "targetDay": 2,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 19,
                        "sourceText": "Ifosfamide 5 g/m2 24h-CI on day 2 with mesna â€¢ Carboplatin area under the curve (AUC) 5 on day 2, maximum dose 800 mg"
                      },
                      {
                        "id": "4ce4c9ea-4367-4210-8fba-78350d061162",
                        "visitName": "Day 5",
                        "targetDay": 5,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 20,
                        "sourceText": "Cytarabine 2 g/m2 on day 5"
                      },
                      {
                        "id": "4dee2c7b-188d-42e4-9ba0-d86753224b8e",
                        "visitName": "Observation Period (Post-Infusion)",
                        "targetDay": 7,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 9,
                        "targetWeek": 1,
                        "epoch": "Post-Treatment"
                      },
                      {
                        "id": "19d62ad6-343f-4409-b229-fd459e5fe8ac",
                        "visitName": "Day 50",
                        "targetDay": 50,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 22,
                        "sourceText": "Day 50 (from randomization) Disease Assessmentb Day 150 (from randomization) Disease Assessmentb Treatment Period: Standard of Care Therapy Treatment Arm"
                      },
                      {
                        "id": "e36170e3-e348-47da-9a87-efd5d8b9275a",
                        "visitName": "Day 100",
                        "targetDay": 100,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 23,
                        "sourceText": "Day 100 (from randomization) Disease Assessmentb a Bridging therapy: At the discretion of the investigator, corticosteroid bridging therapy may be considered for subjects with high disease"
                      },
                      {
                        "id": "95ea8c43-a3c5-4c4a-ba12-1ab267cd0516",
                        "visitName": "Day 150",
                        "targetDay": 150,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 24,
                        "sourceText": "Day 150 (from randomization) Disease Assessmentb Treatment Period: Standard of Care Therapy Treatment Arm Subjects randomized to the SOC arm will receive a second-line"
                      },
                      {
                        "id": "4c56563d-5a09-43f6-8c10-ff0e04840aa4",
                        "visitName": "Follow-up",
                        "targetDay": 365,
                        "windowBefore": 7,
                        "windowAfter": 7,
                        "isRequired": true,
                        "visitNumber": 25,
                        "sourceText": "Long-term Follow-up (LTFU) study. For a subject who completes the entire protocol from the date of informed consent through the completion of the long-term follow-up period, the"
                      }
                    ],
                    "randomizationScheme": {
                      "id": "400e628b-b48f-46d5-8419-0872369b1f6b",
                      "ratio": "1:1",
                      "method": "Stratified randomization",
                      "centralRandomization": true,
                      "stratificationFactors": [
                        {
                          "id": "cccedf2a-9e01-4f03-b20f-0d2ae544db27",
                          "name": "Age",
                          "categories": [
                            "<5 years",
                            "â‰¥5 years"
                          ],
                          "isBlocking": false,
                          "sourceText": "response to first-line therapy (primary refractory, vs relapse \nâ‰¤ 6 months of first-line therapy vs relapse > 6 and â‰¤ 12 months of  first-line \ntherapy) and second-line age-adjusted international prog"
                        },
                        {
                          "id": "2d33b991-f810-4058-8042-744844487f0a",
                          "name": "Response to first-line therapy",
                          "categories": [
                            "primary refractory",
                            "relapse â‰¤ 6 months of first-line therapy",
                            "relapse > 6 and â‰¤ 12 months of first-line therapy"
                          ],
                          "isBlocking": false
                        },
                        {
                          "id": "9c512ec3-54bd-4d00-a451-a491d7a3fe26",
                          "name": "Second-line age-adjusted International Prognostic Index (IPI)",
                          "categories": [
                            "0 to 1",
                            "2 to 3"
                          ],
                          "isBlocking": false
                        }
                      ],
                      "sourceText": "Axicabtagene ciloleucel; KTE-C19\nKite Pharma, Inc.\nClinical Protocol: KTE-C19-107 (ZUMA-7)\nAmendment 6\nCONFIDENTIAL\nPage 2\n14 April 2023\nPROTOCOL SYNOPSIS\nTitle:\nA Phase 3, Randomized, Open-Label Stud"
                    }
                  }
                }
              },
              {
                "id": "67d5b83d-40e4-4655-b95e-d990b5ec1d00",
                "url": "https://protocol2usdm.io/extensions/x-soaFootnotes",
                "valueString": "[\"a. Physical Exam: Subjects with new-onset symptoms related to CRS should undergo physical examination at least daily until symptoms resolve to baseline.\", \"b. Neurologic assessment: A neurological assessment should be done prior to axicabtagene ciloleucel infusion on treatment day 0, then on treatment day 1 and every other day during the minimum 7-day observation period.\", \"c. Echo: Performed following the subjects last chemotherapy treatment and within 28 days prior to signing the consent may be used for confirmation of eligibility\", \"d. PET-CT disease assessment: PET-CT should be performed as close to randomization as possible and within 28 days prior to randomization.\", \"e. Archived tumor sample: Archived tumor samples will be submitted to central laboratory for evaluation of CD19 expression and prognostic variables.\", \"f. Blood draw for anti-axicabtagene ciloleucel antibodies: Baseline antibody samples to be collected prior to start of leukapheresis.\", \"g. Lumbar Puncture: Subjects with new onset Grade >= 2 neurologic symptoms post axicabtagene ciloleucel infusion will have lumbar puncture performed.\", \"h. Blood draws for PBMCs, cytokines, and additional analysis per Section 7.11.2: PBMC blood will be used for the analysis of tests that include anti-CD19 CAR T cells, lymphocytes, and RCR.\", \"i. EORTC QLQ-C30/EQ-5D-5L/WPAI: To be completed by the subject before any procedures are performed-excluding blood draws.\", \"j. Adverse Events: The investigator is responsible for reporting all adverse events observed by the investigator or reported by the subject that occur after randomization through the Day 150 post-randomization visit.\", \"k. Concomitant medications should be recorded from the date of the informed consent through the Day 150 post-randomization visit.\", \"l. For European Union (EU) sites, viral serologic tests (eg, HIV, Hep B, Hep C) will be carried out per institution guidelines and EU regulations.\", \"m. Subjects will be monitored daily through day 7 after treatment with axicabtagene ciloleucel unless otherwise required by country regulatory agencies.\", \"9. SAFETY REPORTING\"]",
                "instanceType": "ExtensionAttribute"
              }
            ],
            "administrations": [
              {
                "id": "b449f92b-34a1-478b-a950-06464ca14598",
                "name": "Axicabtagene ciloleucel Administration",
                "instanceType": "Administration",
                "dose": "2000000.0 anti-CD19 CAR T cells/kg",
                "doseFrequency": "Single",
                "route": {
                  "id": "7a2b34ac-2113-4f62-b9f0-4b5f2cb6ad95",
                  "code": "IV",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "IV",
                  "instanceType": "Code"
                },
                "duration": "One-time dose"
              },
              {
                "id": "edef9e23-25be-4747-b799-7562eec2763c",
                "name": "Fludarabine Administration",
                "instanceType": "Administration",
                "dose": "30.0 mg/m2/day",
                "doseFrequency": "QD",
                "route": {
                  "id": "d8871c7a-28de-4481-8694-0b82a4113305",
                  "code": "IV",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "IV",
                  "instanceType": "Code"
                },
                "duration": "3 days"
              },
              {
                "id": "0bf66b3c-05c5-4cd3-afd8-1b6a13ea6e27",
                "name": "Cyclophosphamide Administration",
                "instanceType": "Administration",
                "dose": "500.0 mg/m2/day",
                "doseFrequency": "QD",
                "route": {
                  "id": "ee8eeadc-ac27-4bfe-be05-11d8302faa25",
                  "code": "IV",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "IV",
                  "instanceType": "Code"
                },
                "duration": "3 days"
              },
              {
                "id": "dfc42842-0dbb-4794-af83-e44e3515b372",
                "name": "Standard of Care (SOC) - Platinum-based salvage combination chemotherapy (R-ICE, R-DHAP, R-ESHAP, or R-GDP) Administration",
                "instanceType": "Administration",
                "doseFrequency": "Q3W",
                "route": {
                  "id": "34ceb503-2d4a-4477-a95d-1e42886f0a0c",
                  "code": "IV",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "IV",
                  "instanceType": "Code"
                },
                "duration": "2 to 3 cycles (6 to 9 weeks)"
              }
            ]
          }
        ],
        "titles": [
          {
            "id": "789121dd-1e01-47fc-86b2-59916a93bf5c",
            "text": "A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy of Axicabtagene Ciloleucel versus Standard of Care Therapy in Subjects with Relapsed/Refractory Diffuse Large B Cell Lymphoma (ZUMA-7)",
            "type": {
              "id": "6a5f4fb6-37a6-430c-98a5-ae5a0c8f2cda",
              "code": "Official Study Title",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Official Study Title",
              "instanceType": "Code"
            },
            "instanceType": "StudyTitle"
          },
          {
            "id": "84560724-767a-469a-ad04-05230bb67266",
            "text": "ZUMA-7",
            "type": {
              "id": "0b287dfd-f212-43a1-8fbd-8a7a490119a0",
              "code": "Study Acronym",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Study Acronym",
              "instanceType": "Code"
            },
            "instanceType": "StudyTitle"
          }
        ],
        "studyIdentifiers": [
          {
            "id": "a5e54c18-44c1-4eee-8907-d5af2ddc76f0",
            "text": "KTE-C19-107",
            "instanceType": "StudyIdentifier",
            "scopeId": "c049dba7-5199-450f-a84f-af9b541cd40a",
            "type": {
              "code": "C132351",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Sponsor Protocol Identifier",
              "instanceType": "Code"
            }
          },
          {
            "id": "b45badc0-c185-4f76-b544-1a5f264bf8f5",
            "text": "016278",
            "instanceType": "StudyIdentifier",
            "scopeId": "fc5aa47f-9a99-439c-a23a-32ac1bdf74df",
            "type": {
              "code": "C218685",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "US FDA Investigational New Drug Application Number",
              "instanceType": "Code"
            }
          },
          {
            "id": "4b3f71fc-8800-416c-a4b6-df9489e49814",
            "text": "2017-002261-22",
            "instanceType": "StudyIdentifier",
            "scopeId": "02268204-400b-49e9-a530-4885c6740199",
            "type": {
              "code": "C98714",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Clinical Trial Registry Identifier",
              "instanceType": "Code"
            }
          },
          {
            "id": "b368ffb8-1413-4bca-a3d5-ed7479c61def",
            "text": "KTE-C19",
            "instanceType": "StudyIdentifier",
            "scopeId": "c049dba7-5199-450f-a84f-af9b541cd40a",
            "type": {
              "code": "C132351",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Sponsor Protocol Identifier",
              "instanceType": "Code"
            }
          }
        ],
        "organizations": [
          {
            "id": "c049dba7-5199-450f-a84f-af9b541cd40a",
            "name": "Kite Pharma, Inc.",
            "type": {
              "id": "338f08ae-5b4d-4025-b088-513758753c9c",
              "code": "C54086",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Pharmaceutical Company",
              "instanceType": "Code"
            },
            "identifier": "Kite Pharma, Inc.",
            "identifierScheme": "DUNS",
            "instanceType": "Organization"
          },
          {
            "id": "2b42dd59-c961-416c-9b81-cd14b1a5cc2d",
            "name": "Gilead Sciences Inc.",
            "type": {
              "id": "c4c2f34d-04a3-4d7c-827a-64f5cc995fe9",
              "code": "C54086",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Pharmaceutical Company",
              "instanceType": "Code"
            },
            "identifier": "Gilead Sciences Inc.",
            "identifierScheme": "DUNS",
            "instanceType": "Organization"
          },
          {
            "id": "6488cec4-372b-4224-9202-b405c2b801ad",
            "name": "Data Safety Monitoring Board",
            "type": {
              "id": "349ed5e4-f546-4a96-a111-311ae881d91c",
              "code": "C25461",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Regulatory Agency",
              "instanceType": "Code"
            },
            "identifier": "Data Safety Monitoring Board",
            "identifierScheme": "DUNS",
            "instanceType": "Organization"
          },
          {
            "id": "c049dba7-5199-450f-a84f-af9b541cd40a",
            "name": "Banner MD Anderson Cancer Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "1",
            "type": {
              "id": "bc29cfc4-babf-4758-984c-10903dede232",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2b42dd59-c961-416c-9b81-cd14b1a5cc2d",
            "name": "Mayo Clinic Hospital",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "2",
            "type": {
              "id": "f3d7e73d-5972-4356-ac00-2d4fc567a60f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "6488cec4-372b-4224-9202-b405c2b801ad",
            "name": "UC San Diego Moores Cancer Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "3",
            "type": {
              "id": "73617646-d441-4e10-96dc-00307cc14d53",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b0691558-5f6f-4994-84f5-3e8ba2f30f65",
            "name": "UCLA",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "4",
            "type": {
              "id": "ae4dd4a0-9ee7-4713-9f96-cac2bef1e211",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c6289dd2-fbbe-4099-9886-ff703f114e51",
            "name": "Stanford Cancer Institute",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "5",
            "type": {
              "id": "5a0bcbf6-f1ac-47c5-8b73-46225b14c159",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b5961fc1-2edc-426a-b504-06913a892f5e",
            "name": "University of Miami Hospital/Sylvester Cancer Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "6",
            "type": {
              "id": "4128ab1a-c3b9-4a64-a506-83868856a4c7",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "86818914-a17c-4b05-8d3c-999357e42850",
            "name": "Moffitt Cancer Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "7",
            "type": {
              "id": "fbbb3926-9a51-4d3c-8f2a-1921b3267374",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3ac42d6c-f278-41ec-8d58-578046209165",
            "name": "Northwestern University",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "8",
            "type": {
              "id": "e15324b1-fa0f-4a28-9b7b-ced7abc9b31f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b3715214-7f5d-4db2-97df-900e2a248226",
            "name": "University of Chicago Medical Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "9",
            "type": {
              "id": "344dd1e0-3421-417e-a253-aa935dacef40",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e5011022-3887-4d4c-a4ea-076b048105d8",
            "name": "University of Iowa Hospitals and Clinics",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "10",
            "type": {
              "id": "94390a7b-dd26-4aad-88e4-07866b7b02d7",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "975e1cc8-9b92-4cb5-a067-7929c3798479",
            "name": "The University of Kansas Cancer Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "11",
            "type": {
              "id": "9c66bafd-af7f-4c17-b329-11e0080621f9",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3159e59d-7d15-4180-96c7-752fe6bb9fc0",
            "name": "University of Maryland Greenbaum Cancer Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "12",
            "type": {
              "id": "e37a72c3-8955-46fa-8453-43c42ec9cf31",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9b7bc7e5-3830-4725-8aca-247da549fb45",
            "name": "Dana-Farber Cancer Institute",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "13",
            "type": {
              "id": "19c0df8e-2e75-4b66-9e1b-cd994a6ed906",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b2492be0-e176-4744-8fe7-ef1765cadc8d",
            "name": "Barbara Ann Karmanos Cancer Institute",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "14",
            "type": {
              "id": "8497d8b8-4a5b-4d6f-a5a4-6f32e970fa9b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "aa83dc21-fce1-460e-bcf7-89cf1e0f357a",
            "name": "Mayo Clinic Patient Location",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "15",
            "type": {
              "id": "4bce119d-c721-45d1-a40f-46ad6d0e9c39",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "38a3007d-d41d-4436-8851-1fcdd3695651",
            "name": "Washington University School of Medicine",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "16",
            "type": {
              "id": "9e48ba08-7d1c-454f-b2c2-e70d6b0c5693",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e7b289b2-600b-4275-a58b-a73700a9f261",
            "name": "John Theurer Cancer Center at Hackensack",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "17",
            "type": {
              "id": "12ce1735-a898-4cd9-bf62-0b2a425088b0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f0c6210e-58f8-4a83-b7b7-3bb77b4e8800",
            "name": "Memorial Sloan Kettering Cancer Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "18",
            "type": {
              "id": "9552c929-5a90-4144-b431-388bfc8f948e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2edceaeb-2393-40ff-ab20-0866ab2613c1",
            "name": "Icahn School of Medicine at Mount Sinai",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "19",
            "type": {
              "id": "70d6f3a7-aeda-4a06-ba92-d96322562a70",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e13433f5-ef32-4696-9249-5848e70e9e8d",
            "name": "University of Rochester Medical Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "20",
            "type": {
              "id": "99693541-ba6f-4f7d-a599-aea1c362e6f0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5e975f18-4bce-4456-bd05-58f61dd522dc",
            "name": "Cleveland Clinic",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "21",
            "type": {
              "id": "e80da702-4c44-419b-8f0a-ac2d34cc66dd",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "30c29320-3a64-42b3-bdeb-b54609e50b45",
            "name": "James Cancer Hospital at Ohio State",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "22",
            "type": {
              "id": "0d444523-8b77-4398-8b55-7b133831b817",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ad3fb662-c508-4bac-8d13-c1b37d7a8181",
            "name": "Thomas Jefferson University",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "23",
            "type": {
              "id": "b49ee96d-d277-4dcc-a529-5e8074ba1229",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "871b6b4f-9f53-43d0-9c94-0c446bd61330",
            "name": "UPMC Hillman Cancer Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "24",
            "type": {
              "id": "f662465f-a1ec-4547-94b0-280e49e8deba",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "cda21e4d-0d87-4c1f-9af0-fd6c8e44723a",
            "name": "Sarah Cannon Research Institute",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "25",
            "type": {
              "id": "825f970d-21f1-402b-93fc-9b1c968faef1",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5f999fd0-d52f-4e8d-910e-c83ef1a79056",
            "name": "Henry-Joyce Cancer Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "26",
            "type": {
              "id": "8e22c1b7-c7c2-4902-b4f2-9a255f914e75",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "84de371b-5ded-4ea4-b30a-c40c2c501e52",
            "name": "MD Anderson Cancer Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "27",
            "type": {
              "id": "3724cdef-be7c-49a1-bd2d-18b5755cae63",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9729b906-67e8-404f-8d95-927df61ec774",
            "name": "University of Utah Huntsman Cancer Institute",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "28",
            "type": {
              "id": "e38a17b8-bf0f-4b74-add9-a58be1ec2ac0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b789099e-cc6c-46d6-a13f-827daedc661d",
            "name": "University of Virginia Health System",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "29",
            "type": {
              "id": "c017830b-5a3e-4945-b30c-0f26d6e5df61",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "36f802c7-413f-4050-8c9c-bedd199a15fa",
            "name": "Swedish Cancer Institute",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "30",
            "type": {
              "id": "57e725cf-a748-4ff1-9dbe-15e9d98b0488",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "903e31dd-abd6-4d65-9611-1299fdcf52a8",
            "name": "Peter MacCallum Cancer Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "31",
            "type": {
              "id": "5f483402-fbd2-4199-93bb-b2efe382b1b3",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5701a2c3-614a-4025-b59c-394e22d2b0fa",
            "name": "Universitatsklinikum Graz",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "32",
            "type": {
              "id": "0649dad9-9ab9-4343-a65a-c833ed641283",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0d8535e9-2831-4378-b38d-0009596dd621",
            "name": "Medizinische Universitat Innsbruck",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "33",
            "type": {
              "id": "d07d7518-cb17-4bf6-9dba-f6052ca47694",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "6cb09ef6-ea45-495a-bcbb-f28c8ad51a1d",
            "name": "Cliniques Universiaires Saint-Luc",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "34",
            "type": {
              "id": "d1f48ebd-e4af-4985-bb8b-fb348ef8dfe9",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "caba5ced-c510-4d04-82a6-551eec8001d6",
            "name": "UZ Gasthuisberg",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "35",
            "type": {
              "id": "308e2437-ebea-4f18-b1e3-372b495d3010",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a79aef80-d9b3-4d53-8f0c-b9760ed2b504",
            "name": "Vancouver General Hospital",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "36",
            "type": {
              "id": "3f48ca14-83d3-4194-9e72-a5a690c80f9d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "dcc86ea9-5783-4918-a90b-1ca7a61f501a",
            "name": "CancerCare Manitoba",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "37",
            "type": {
              "id": "747a574e-4eb9-4086-a440-f2ca2d85ddc0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e6b7516b-e04d-4fa2-883b-51bf36b5c7f7",
            "name": "Princess Margaret Cancer Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "38",
            "type": {
              "id": "2e5b5eea-f25c-41a2-b16c-9ad15a96564e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "cbe7dae0-0378-4a5d-ac9e-ba38c6d3aad1",
            "name": "McGill University Health Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "39",
            "type": {
              "id": "13b7f817-b6cc-4ca5-a921-5108daa258ab",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9faf2bd6-01d1-42b3-941f-29b0e6271dba",
            "name": "QEII Health Sciences Centre",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "40",
            "type": {
              "id": "d3f1f6d3-1050-4ce5-aa3a-bd0070bdb8b4",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          }
        ],
        "studyPhase": {
          "id": "81241d3f-8feb-4034-907c-65fa243881ae",
          "code": "Phase3",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Phase3",
          "instanceType": "Code"
        },
        "eligibilityCriterionItems": [
          {
            "id": "e6a2d0eb-82dd-4d1b-9b7c-7286844e03c4",
            "name": "Histologically proven large B-cell lymphoma",
            "text": "Histologically proven large B-cell lymphoma including the following types defined by WHO 2016: DLBCL not otherwise specified (including ABC/GCB); HGBL with or without MYC and BCL2 and/or BCL6 rearrangement; DLBCL arising from FL; T-cell/histiocyte rich large B-cell lymphoma; DLBCL associated with chronic inflammation; Primary cutaneous DLBCL, leg type; Epstein-Barr virus (EBV) + DLBCL",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "8e96dc49-493b-4073-b1bd-bed4bedf18a6",
            "name": "Relapsed or refractory disease",
            "text": "Relapsed or refractory disease after first-line chemoimmunotherapy. Refractory disease defined as no complete remission to first-line therapy; subjects who are intolerant to first-line therapy are excluded (Progressive disease (PD) as best response; Stable disease (SD) as best response after at least 4 cycles; PR as best response after at least 6 cycles and biopsy-proven residual disease or disease progression â‰¤ 12 months of therapy). Relapsed disease defined as complete remission to first-line therapy followed by biopsy-proven disease relapse â‰¤ 12 months of first-line therapy",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "2cdb34f3-b1ed-4df8-90ea-5117326a01c6",
            "name": "Adequate first-line therapy",
            "text": "Subjects must have received adequate first-line therapy including at a minimum: Anti-CD20 monoclonal antibody unless investigator determines that tumor is CD20 negative, and An anthracycline containing chemotherapy regimen",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "79cc0570-a367-4a08-924f-ce53498ff05a",
            "name": "Intent to proceed to HDT and ASCT",
            "text": "Intent to proceed to HDT and ASCT if response to second-line therapy",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "cdf10c44-ad57-4563-9621-de53e16a9f9a",
            "name": "Radiographically documented disease",
            "text": "Subjects must have radiographically documented disease",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "31d2f33c-02c6-499a-9114-42c955d58a56",
            "name": "No CNS involvement",
            "text": "No known history or suspicion of central nervous system (CNS) involvement by lymphoma",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "85446d2a-54d7-430a-839a-f2dbc7df9f06",
            "name": "Prior systemic cancer therapy washout",
            "text": "At least 2 weeks or 5 half-lives, whichever is shorter, must have elapsed since any prior systemic cancer therapy at the time the subject provides consent",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "6fe487b1-dbd4-49a3-83cd-e2f5a3e5c94a",
            "name": "Age requirement",
            "text": "Age 18 years or older at the time of informed consent",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "37383cd2-bded-4f3f-b851-fd083c80bb38",
            "name": "ECOG performance status",
            "text": "ECOG performance status of 0 or 1",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "099617a7-b6ae-459d-afc3-d31f7b9345b6",
            "name": "Adequate organ function",
            "text": "Adequate bone marrow, renal, hepatic, pulmonary and cardiac function defined as: ANC â‰¥1000/ÂµL; Platelet count â‰¥ 75,000/ÂµL; Absolute lymphocyte count â‰¥ 100/ÂµL; Creatinine clearance â‰¥ 60 mL/min; ALT/AST â‰¤ 2.5 ULN; Total bilirubin â‰¤ 1.5 mg/dl (except Gilbertâ€™s); Cardiac ejection fraction â‰¥ 50%, no evidence of pericardial effusion, and no clinically significant ECG findings; No clinically significant pleural effusion; Baseline oxygen saturation > 92% on room air",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "2a87ad75-199f-481c-bd88-e213ccfe8ecb",
            "name": "Pregnancy test requirement",
            "text": "Females of childbearing potential must have a negative serum or urine pregnancy test (females who have undergone surgical sterilization or who have been postmenopausal for at least 2 years are not considered to be of childbearing potential)",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "11fbd449-f208-4963-bff9-7e5f96589543",
            "name": "History of other malignancy",
            "text": "History of malignancy other than nonmelanoma skin cancer or carcinoma in situ (eg, cervix, bladder, breast) unless disease free for at least 3 years",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "c9bfff35-16bb-4958-a41c-a6f72ba25675",
            "name": "Richterâ€™s transformation or PMBCL",
            "text": "History of Richterâ€™s transformation of CLL or PMBCL",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "b34f946e-3160-45b6-8e28-911dcb68d899",
            "name": "Prior stem cell transplant",
            "text": "History of autologous or allogeneic stem cell transplant",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "40247583-d4c9-407b-a2f5-34d54bfbd828",
            "name": "Lines of therapy for DLBCL",
            "text": "Received more than one line of therapy for DLBCL",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "47268ba5-b88e-46e7-805d-50b35c390f63",
            "name": "Prior CD19 targeted therapy",
            "text": "Prior CD19 targeted therapy",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "d027a56c-a92c-4ccf-98a8-ff525754af9e",
            "name": "Systemic immunostimulatory agents",
            "text": "Treatment with systemic immunostimulatory agents (including, but not limited to, interferon and IL-2) within 6 weeks or 5 half-lives of the drug, whichever is shorter, prior to the first dose of axicabtagene ciloleucel or SOC",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "b94dd332-9e78-4795-b0c7-c7025cd4026f",
            "name": "Prior CAR T or ZUMA-7 randomization",
            "text": "Prior chimeric antigen receptor therapy or other genetically modified T-cell therapy or prior randomization into ZUMA-7",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "75955aed-1c6e-4b5e-9bbc-5558db1dce23",
            "name": "Aminoglycoside hypersensitivity",
            "text": "History of severe, immediate hypersensitivity reaction attributed to aminoglycosides",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "e133a3b5-d747-4f3a-b6fd-1f96b2a0d918",
            "name": "Uncontrolled infection",
            "text": "Presence of fungal, bacterial, viral, or other infection that is uncontrolled or requiring intravenous (IV) antimicrobials for management. Simple urinary tract infection (UTI) and uncomplicated bacterial pharyngitis are permitted if responding to active treatment.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "d806c997-d6a3-4c7e-88bd-23e229a91bbb",
            "name": "HIV, Hepatitis B or C",
            "text": "Known history of infection with human immunodeficiency virus (HIV) or hepatitis B (HBsAg positive) or hepatitis C virus (anti-HCV positive). If there is a positive history of treated hepatitis B or hepatitis C, the viral load must be undetectable per quantitative polymerase chain reaction (PCR) and/or nucleic acid testing.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "9aa6a407-853f-47aa-b875-1b8fe8781e3b",
            "name": "Active tuberculosis",
            "text": "Active tuberculosis",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "00a91695-0760-4ac8-9425-d5f4996c1f59",
            "name": "Indwelling line or drain",
            "text": "Presence of any indwelling line or drain (eg, percutaneous nephrostomy tube, indwelling Foley catheter, biliary drain, or pleural/peritoneal/pericardial catheter). Dedicated central venous access catheters, such as a Port-a-Cath or Hickman catheter, are permitted.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "c6a2b12b-8fc9-49ed-913d-4c2cff127869",
            "name": "CSF malignant cells or brain metastases",
            "text": "Subjects with detectable cerebrospinal fluid malignant cells or known brain metastases or with a history of cerebrospinal fluid malignant cells or brain metastases",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "802b9c11-3b62-49d8-ac1c-0781ea548956",
            "name": "Non-malignant CNS disorder",
            "text": "History or presence of non-malignant CNS disorder, such as seizure disorder, cerebrovascular ischemia/hemorrhage, dementia, cerebellar disease, or any autoimmune disease with CNS involvement",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "4e52b1c9-c518-4276-bfc9-27e370daad89",
            "name": "Cardiac lymphoma involvement",
            "text": "Subjects with cardiac atrial or cardiac ventricular lymphoma involvement",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "c801b52a-485e-4ec9-9543-7c811d175302",
            "name": "Clinically significant cardiac disease",
            "text": "History of myocardial infarction, cardiac angioplasty or stenting, unstable angina, New York Heart Association Class II or greater congestive heart failure, or other clinically significant cardiac disease within 12 months of enrollment",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "0ddc6d84-c3bf-4283-adc0-f20313c4f3c9",
            "name": "Urgent therapy requirement",
            "text": "Requirement for urgent therapy due to tumor mass effects, such as bowel obstruction or blood vessel compression",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "e0514917-9592-4f92-b95c-5bcde5cef306",
            "name": "Autoimmune disease history",
            "text": "History of autoimmune disease requiring systemic immunosuppression and/or systemic disease modifying agents within the last 2 years",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "44576847-1af8-4804-bd6a-822c7894b345",
            "name": "Pulmonary fibrosis or pneumonitis",
            "text": "History of idiopathic pulmonary fibrosis, organizing pneumonia (eg, bronchiolitis obliterans), drug-induced pneumonitis, idiopathic pneumonitis, or evidence of active pneumonitis per chest computed tomography (CT) scan at screening. History of radiation pneumonitis in the radiation field (fibrosis) is allowed.",
            "instanceType": "EligibilityCriterionItem"
          }
        ],
        "studyInterventions": [
          {
            "id": "4a00452b-1c8f-453a-a5fe-0ad65488b78b",
            "name": "Axicabtagene ciloleucel",
            "type": {
              "id": "dfadba6d-a367-46fe-a92a-f66c5a744861",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "role": {
              "id": "8eb04880-7108-4804-98ce-9964eed23e76",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Autologous T cells transduced with retroviral vector containing anti-CD19 CD28/CD3Î¶ chimeric antigen receptor (KTE-C19)",
            "productIds": [
              "bdc36b27-75b3-411f-a3fe-d78a9a065eb3"
            ],
            "administrationIds": [
              "9444cc30-69a1-4e6b-90d2-247dac92af02",
              "ab679200-56c9-4d0d-b03b-c96ef4f83bd7"
            ]
          },
          {
            "id": "e7047767-c848-4cff-ad8e-bfdd3cdfde66",
            "name": "Standard of Care (SOC) Therapy",
            "type": {
              "id": "89b26046-6ad1-4323-a276-48ba96706e1a",
              "code": "C54129",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Comparator",
              "instanceType": "Code"
            },
            "role": {
              "id": "05a1e7a0-b05b-4aa3-8d21-b746f1fc3f71",
              "code": "C54129",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Comparator",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Second-line combination chemotherapy regimen (R-ICE, R-DHAP, R-ESHAP, or R-GDP) followed by HDT and ASCT for responders",
            "productIds": [
              "a5f03e71-58d4-45f8-b433-8b847def9bd3"
            ],
            "administrationIds": [
              "6d1b2e77-58df-4c51-87b3-dd2280d4cf52"
            ]
          },
          {
            "id": "e5ac739c-fcab-4a39-afff-bbff89936944",
            "name": "Fludarabine",
            "type": {
              "id": "b762861c-04e5-444c-a348-3d6875ac8f89",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "role": {
              "id": "b2085b93-c103-4f7f-b4e3-c00261de25bc",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Conditioning chemotherapy for lymphodepletion prior to axicabtagene ciloleucel",
            "productIds": [
              "510e4309-8f41-461a-8a0f-3671dfa69def"
            ],
            "administrationIds": [
              "6cfe7b2f-d8c0-47f6-afcc-60fa100a9d05",
              "ed4b865d-a4d8-46bf-9f26-687f587267e9"
            ]
          },
          {
            "id": "3ac8c4f0-43c4-41aa-a19b-88ad082507ea",
            "name": "Cyclophosphamide",
            "type": {
              "id": "70d1abf8-2b9a-4abb-a9ad-8386babce3fb",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "role": {
              "id": "04800222-3c86-4491-8c88-045428926909",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Conditioning chemotherapy for lymphodepletion prior to axicabtagene ciloleucel",
            "productIds": [
              "ca6f5df5-0671-4b1a-b1e1-5e58393795c4"
            ],
            "administrationIds": [
              "965ded5c-8511-47e0-8ae9-7fa5a0dc7476",
              "5076f1cc-6e47-482a-9611-27da931810ef"
            ]
          },
          {
            "id": "c77ff798-3c3a-45ab-83b5-731e62b357f2",
            "name": "Corticosteroids",
            "type": {
              "id": "bb5b4df3-a4c7-4c3e-a1e4-c8b37b66d600",
              "code": "C54127",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Background Therapy",
              "instanceType": "Code"
            },
            "role": {
              "id": "160c62a1-9ffe-4308-94bc-725d7ec57e8b",
              "code": "C54127",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Background Therapy",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Bridging therapy for subjects with high disease burden at screening",
            "administrationIds": [
              "55a5a011-4c3e-4d62-a271-a78ffd57e62f"
            ]
          },
          {
            "id": "dd3df252-5ba4-4137-9156-2085035829c1",
            "name": "Mesna",
            "type": {
              "id": "5c05e04c-386d-4a0e-b33b-53c5c8e10e88",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "94205795-2794-4ce1-900b-f3642352262f",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Detoxifying agent used to prevent hemorrhagic cystitis induced by chemotherapy"
          },
          {
            "id": "8fa70dab-771d-4e64-a5f4-0fa88bff99f0",
            "name": "G-CSF",
            "type": {
              "id": "7deabd44-7dc2-400e-bfcb-f582540215f8",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "67de0620-4da4-44ac-a2ea-f917ef76b72b",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Growth factor support for leukapheresis and prevention of chemotherapy delays/infection"
          },
          {
            "id": "196752d4-b3f3-4e58-855c-ce9182aec86e",
            "name": "Tocilizumab",
            "type": {
              "id": "ccc29ca1-9e16-4dea-bbb8-0dd3c7da20cb",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "3b57ec3a-ffc6-4fbb-b543-d748b94e2a9d",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Used for management of cytokine release syndrome (implied by hypersensitivity exclusion)"
          },
          {
            "id": "0f6aa867-7d6a-4003-bc94-28ccb1577c29",
            "name": "Systemic immunostimulatory agents",
            "type": {
              "id": "88db47ca-ca1e-4dd5-8bfa-a711a76db747",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "1d2a0da8-5491-4470-805f-fc351ff833a8",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Prohibited within 6 weeks or 5 half-lives prior to first dose (e.g., interferon, IL-2)"
          },
          {
            "id": "d1744b64-39e4-4c18-a3e8-94759e496de3",
            "name": "Live, attenuated vaccine",
            "type": {
              "id": "d8bb6c9a-1ea3-44e1-b3f9-d5c54f69cfe8",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "ac1c33e1-c618-40d5-92e2-5c4c60648e10",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Prohibited within 6 weeks prior to initiation of study treatment"
          }
        ],
        "administrableProducts": [
          {
            "id": "bdc36b27-75b3-411f-a3fe-d78a9a065eb3",
            "name": "Axicabtagene ciloleucel",
            "administrableDoseForm": {
              "id": "f577f888-9c54-4b0c-ae8f-3194dcaf24e9",
              "code": "C42945",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Injection",
              "instanceType": "Code",
              "standardCode": {
                "id": "054e3010-1e2e-4c1e-8736-0b839e636718",
                "code": "C42945",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Injection",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "a0f5a79c-c160-48fc-a28f-1b17ddb338be",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "Target dose 2 x 10^6 anti-CD19 CAR T cells/kg",
            "substanceIds": [
              "219e2ed4-a793-4c73-99cb-e0f07e629b88"
            ],
            "manufacturer": "Kite Pharma, Inc."
          },
          {
            "id": "a5f03e71-58d4-45f8-b433-8b847def9bd3",
            "name": "Fludarabine",
            "administrableDoseForm": {
              "id": "98529ee7-1972-49d9-9cc9-488a53d49478",
              "code": "C42945",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Injection",
              "instanceType": "Code",
              "standardCode": {
                "id": "89f11f4e-ca41-48cd-b543-fac87e9b4192",
                "code": "C42945",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Injection",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "383bfae7-24e4-41b7-a694-7b04a8f90a1b",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "30 mg/m2",
            "substanceIds": [
              "81ef5c92-5f12-4782-b010-45270590f010"
            ],
            "manufacturer": "Not specified"
          },
          {
            "id": "510e4309-8f41-461a-8a0f-3671dfa69def",
            "name": "Cyclophosphamide",
            "administrableDoseForm": {
              "id": "0fde00a9-a841-4c21-8599-849ed496488b",
              "code": "C42945",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Injection",
              "instanceType": "Code",
              "standardCode": {
                "id": "7c832d27-dcb0-44de-b646-58dfaa8a891a",
                "code": "C42945",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Injection",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "798330e8-d757-4f97-9757-39b5bf56bfe0",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "500 mg/m2",
            "substanceIds": [
              "3aabfe56-3773-4075-92ae-accd04ab8d8a"
            ],
            "manufacturer": "Not specified"
          },
          {
            "id": "ca6f5df5-0671-4b1a-b1e1-5e58393795c4",
            "name": "Rituximab",
            "administrableDoseForm": {
              "id": "53f8aaa3-82a1-41ae-bedb-1904e5db15fa",
              "code": "C42945",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Injection",
              "instanceType": "Code",
              "standardCode": {
                "id": "0722a9fd-cc96-460f-9d2a-6020f1a25eb3",
                "code": "C42945",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Injection",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "98232edf-310b-488d-b212-80bb7a4471a2",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "375 mg/m2",
            "substanceIds": [
              "66f2a355-2f74-48b2-b2ab-b5e8d2a943bf"
            ],
            "manufacturer": "Not specified"
          }
        ],
        "narrativeContents": [
          {
            "id": "18e5c4ea-118d-4e40-a7ef-5fc27736d418",
            "name": "PROTOCOL SYNOPSIS",
            "text": "PROTOCOL SYNOPSIS",
            "order": 0,
            "instanceType": "NarrativeContent",
            "sectionNumber": "0",
            "sectionTitle": "PROTOCOL SYNOPSIS",
            "sectionType": {
              "id": "9b366624-8581-4657-baa5-e1396a8fd644",
              "code": "Synopsis",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Synopsis",
              "instanceType": "Code"
            }
          },
          {
            "id": "841acb91-3419-439e-ba65-bd7ac6ef5ba4",
            "name": "STUDY SCHEMA",
            "text": "STUDY SCHEMA",
            "order": 1,
            "instanceType": "NarrativeContent",
            "sectionNumber": "0.1",
            "sectionTitle": "STUDY SCHEMA",
            "sectionType": {
              "id": "875bfaa7-d7b0-43d6-b41a-7b235a449562",
              "code": "Study Design",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Study Design",
              "instanceType": "Code"
            }
          },
          {
            "id": "8d69f4e4-d506-4e46-819a-d2218145bcee",
            "name": "OBJECTIVES",
            "text": "OBJECTIVES",
            "order": 2,
            "instanceType": "NarrativeContent",
            "sectionNumber": "1",
            "sectionTitle": "OBJECTIVES",
            "sectionType": {
              "id": "d911abd0-41c9-477c-aba5-e6a8ff3482fd",
              "code": "Objectives",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Objectives",
              "instanceType": "Code"
            },
            "childIds": [
              "1f81ba4c-ba5e-4e56-a0aa-ef991ea197d2",
              "f8275af3-ce53-4c60-9e0a-813fe2b5630f"
            ]
          },
          {
            "id": "37b02fed-cf66-4e9c-9e34-d3b24470ff71",
            "name": "DISEASE BACKGROUND AND RATIONALE",
            "text": "DISEASE BACKGROUND AND RATIONALE",
            "order": 3,
            "instanceType": "NarrativeContent",
            "sectionNumber": "2",
            "sectionTitle": "DISEASE BACKGROUND AND RATIONALE",
            "sectionType": {
              "id": "e6fb094d-2453-4f5a-a12d-28e260794861",
              "code": "Introduction",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Introduction",
              "instanceType": "Code"
            },
            "childIds": [
              "2ffb3e4c-af89-42bb-aa28-e693080eb92b",
              "06f1167e-cd4c-477a-8a5a-0fbfbba4e47f",
              "3dc449d0-bbb2-4249-bf0c-cceab013a2c7",
              "a3771de7-2173-42ff-9a27-9e37f75c3bfa",
              "f3b7b8c0-046d-49ed-92e7-8678073fd4e9"
            ]
          },
          {
            "id": "753e72c0-40fb-447a-b7b3-c5fb84919c78",
            "name": "STUDY DESIGN",
            "text": "STUDY DESIGN",
            "order": 4,
            "instanceType": "NarrativeContent",
            "sectionNumber": "3",
            "sectionTitle": "STUDY DESIGN",
            "sectionType": {
              "id": "3e674001-04ef-4d40-b204-b259abf7479c",
              "code": "Study Design",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Study Design",
              "instanceType": "Code"
            },
            "childIds": [
              "e6d43a10-7d25-463c-aeab-1ebfbee64586",
              "4bbfc932-9984-47dc-9698-20e4ff0d272e",
              "c7514825-bb8a-4f23-8cd0-b05e21ce170b",
              "eacca5f0-579a-427d-b144-e54d3fa5947c",
              "261615fe-52c1-4489-801d-47f89c8bb96a"
            ]
          },
          {
            "id": "e37328f4-9109-46da-a8be-696f5521291a",
            "name": "SUBJECT SCREENING AND ENROLLMENT",
            "text": "SUBJECT SCREENING AND ENROLLMENT",
            "order": 5,
            "instanceType": "NarrativeContent",
            "sectionNumber": "4",
            "sectionTitle": "SUBJECT SCREENING AND ENROLLMENT",
            "sectionType": {
              "id": "908503ab-2090-4d2f-ad6f-102c9e137cf1",
              "code": "Study Population",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Study Population",
              "instanceType": "Code"
            }
          },
          {
            "id": "f0f2f962-c55a-4152-8f23-0f5a45eaee0f",
            "name": "SUBJECT ELIGIBILITY",
            "text": "SUBJECT ELIGIBILITY",
            "order": 6,
            "instanceType": "NarrativeContent",
            "sectionNumber": "5",
            "sectionTitle": "SUBJECT ELIGIBILITY",
            "sectionType": {
              "id": "1edbb024-cb69-4907-bfe2-cfbb1cc709aa",
              "code": "Eligibility Criteria",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Eligibility Criteria",
              "instanceType": "Code"
            },
            "childIds": [
              "3a7eafa0-ca8e-4b23-94de-98e2f78268e3",
              "ec6dfe74-d91e-40e2-8158-f4f073245e45"
            ]
          },
          {
            "id": "84aa33b2-f73c-4930-925d-832115ff7637",
            "name": "PROTOCOL TREATMENT",
            "text": "PROTOCOL TREATMENT",
            "order": 7,
            "instanceType": "NarrativeContent",
            "sectionNumber": "6",
            "sectionTitle": "PROTOCOL TREATMENT",
            "sectionType": {
              "id": "80e840e4-7bc4-4f2f-b08a-fef8f0d99db5",
              "code": "Treatment",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Treatment",
              "instanceType": "Code"
            },
            "childIds": [
              "2b1714bf-85b3-48ef-ba2f-61bd9b9c07e6",
              "29fa6f59-2cbf-461e-b860-18d8d47c9369"
            ]
          }
        ],
        "narrativeContentItems": [
          {
            "id": "1f81ba4c-ba5e-4e56-a0aa-ef991ea197d2",
            "name": "Primary Objective",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "1.1",
            "sectionTitle": "Primary Objective"
          },
          {
            "id": "f8275af3-ce53-4c60-9e0a-813fe2b5630f",
            "name": "Secondary Objectives",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "1.2",
            "sectionTitle": "Secondary Objectives"
          },
          {
            "id": "2ffb3e4c-af89-42bb-aa28-e693080eb92b",
            "name": "Standard First-line Therapy",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.1",
            "sectionTitle": "Standard First-line Therapy"
          },
          {
            "id": "06f1167e-cd4c-477a-8a5a-0fbfbba4e47f",
            "name": "Standard Second-line Therapy",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.2",
            "sectionTitle": "Standard Second-line Therapy"
          },
          {
            "id": "3dc449d0-bbb2-4249-bf0c-cceab013a2c7",
            "name": "Study Rationale",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.3",
            "sectionTitle": "Study Rationale"
          },
          {
            "id": "a3771de7-2173-42ff-9a27-9e37f75c3bfa",
            "name": "Anti-CD19 Chimeric Antigen Receptor T Cells",
            "text": "",
            "order": 3,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.4",
            "sectionTitle": "Anti-CD19 Chimeric Antigen Receptor T Cells"
          },
          {
            "id": "f3b7b8c0-046d-49ed-92e7-8678073fd4e9",
            "name": "Prior Anti-CD19 CAR T-cell Study Designs and Results",
            "text": "",
            "order": 4,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.5",
            "sectionTitle": "Prior Anti-CD19 CAR T-cell Study Designs and Results"
          },
          {
            "id": "e6d43a10-7d25-463c-aeab-1ebfbee64586",
            "name": "General Study Design: ZUMA-7",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "3.1",
            "sectionTitle": "General Study Design: ZUMA-7"
          },
          {
            "id": "4bbfc932-9984-47dc-9698-20e4ff0d272e",
            "name": "Participating Sites",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "3.2",
            "sectionTitle": "Participating Sites"
          },
          {
            "id": "c7514825-bb8a-4f23-8cd0-b05e21ce170b",
            "name": "Number of Subjects",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "3.3",
            "sectionTitle": "Number of Subjects"
          },
          {
            "id": "eacca5f0-579a-427d-b144-e54d3fa5947c",
            "name": "Replacement of Subjects",
            "text": "",
            "order": 3,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "3.4",
            "sectionTitle": "Replacement of Subjects"
          },
          {
            "id": "261615fe-52c1-4489-801d-47f89c8bb96a",
            "name": "Duration of Study and Subject Participation",
            "text": "",
            "order": 4,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "3.5",
            "sectionTitle": "Duration of Study and Subject Participation"
          },
          {
            "id": "3a7eafa0-ca8e-4b23-94de-98e2f78268e3",
            "name": "Inclusion Criteria",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.1",
            "sectionTitle": "Inclusion Criteria"
          },
          {
            "id": "ec6dfe74-d91e-40e2-8158-f4f073245e45",
            "name": "Exclusion Criteria",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.2",
            "sectionTitle": "Exclusion Criteria"
          },
          {
            "id": "2b1714bf-85b3-48ef-ba2f-61bd9b9c07e6",
            "name": "Treatment Terminology",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "6.1",
            "sectionTitle": "Treatment Terminology"
          },
          {
            "id": "29fa6f59-2cbf-461e-b860-18d8d47c9369",
            "name": "Axicabtagene Ciloleucel Study Treatment Arm",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "6.2",
            "sectionTitle": "Axicabtagene Ciloleucel Study Treatment Arm"
          }
        ],
        "abbreviations": [
          {
            "id": "84adf042-830e-479c-8b79-3239eb76dd10",
            "abbreviatedText": "AE",
            "expandedText": "Adverse event",
            "instanceType": "Abbreviation"
          },
          {
            "id": "977bb731-34d7-4723-ab8a-40bb771b3f09",
            "abbreviatedText": "ALL",
            "expandedText": "Acute lymphoblastic leukemia",
            "instanceType": "Abbreviation"
          },
          {
            "id": "01bb26f2-baac-439a-a191-b9339c9c0830",
            "abbreviatedText": "ALT",
            "expandedText": "Alanine aminotransferase",
            "instanceType": "Abbreviation"
          },
          {
            "id": "f2e8fc04-9dc1-4e5f-8292-41e6720fbb8d",
            "abbreviatedText": "ANC",
            "expandedText": "Absolute neutrophil count",
            "instanceType": "Abbreviation"
          },
          {
            "id": "36ddaed8-7c4a-4ff9-81a1-b32b36b1c902",
            "abbreviatedText": "ASCT",
            "expandedText": "Autologous stem cell transplant",
            "instanceType": "Abbreviation"
          },
          {
            "id": "c73783b8-47c3-445a-ba37-c551641a68a8",
            "abbreviatedText": "AST",
            "expandedText": "Aspartate aminotransferase",
            "instanceType": "Abbreviation"
          },
          {
            "id": "acc4ea65-8c69-4351-8d5a-f5bbabf516f3",
            "abbreviatedText": "AUC",
            "expandedText": "Area under the curve",
            "instanceType": "Abbreviation"
          },
          {
            "id": "6b278e02-90d2-487c-83cc-00e2682a94c1",
            "abbreviatedText": "Axicabtagene ciloleucel",
            "expandedText": "Autologous T cells transduced with retroviral vector containing anti-CD19 CD28/CD3Î¶ chimeric antigen receptor",
            "instanceType": "Abbreviation"
          },
          {
            "id": "eed4f5aa-16aa-446e-968d-dacbc64e6824",
            "abbreviatedText": "CAR",
            "expandedText": "Chimeric antigen receptor",
            "instanceType": "Abbreviation"
          },
          {
            "id": "0abe6438-2406-4ddd-af1a-b27dc08d3fdf",
            "abbreviatedText": "CBC",
            "expandedText": "Complete blood count",
            "instanceType": "Abbreviation"
          },
          {
            "id": "b5a98316-ff40-4932-8586-8566ed884760",
            "abbreviatedText": "CD",
            "expandedText": "cluster of differentiation",
            "instanceType": "Abbreviation"
          },
          {
            "id": "312ec568-e037-4e0c-9964-60a0ee84afbd",
            "abbreviatedText": "CI",
            "expandedText": "confidence interval",
            "instanceType": "Abbreviation"
          },
          {
            "id": "19fec619-2a54-446e-9da3-678a21ed6f0e",
            "abbreviatedText": "CLL",
            "expandedText": "Chronic lymphocytic leukemia",
            "instanceType": "Abbreviation"
          },
          {
            "id": "2499c0ae-f814-4f35-a3ec-54c24d1b8576",
            "abbreviatedText": "CMR",
            "expandedText": "Complete metabolic response",
            "instanceType": "Abbreviation"
          },
          {
            "id": "7467c7dd-a44f-44e9-8b8d-55b83b7424cd",
            "abbreviatedText": "CNS",
            "expandedText": "Central nervous system",
            "instanceType": "Abbreviation"
          },
          {
            "id": "a32b9c20-3009-4fab-8e00-18667d98103f",
            "abbreviatedText": "CR",
            "expandedText": "Complete response",
            "instanceType": "Abbreviation"
          },
          {
            "id": "3d9e3122-d0c8-4210-866d-439dbc3eefc1",
            "abbreviatedText": "CRF",
            "expandedText": "Case Report Form",
            "instanceType": "Abbreviation"
          },
          {
            "id": "cfb7dba8-8df2-4ab8-9ba8-5e81b2f743c2",
            "abbreviatedText": "CRP",
            "expandedText": "C-reactive protein",
            "instanceType": "Abbreviation"
          },
          {
            "id": "528d625c-e9b0-42df-b29b-6152fa0da5bd",
            "abbreviatedText": "CRO",
            "expandedText": "Contract Research Organization",
            "instanceType": "Abbreviation"
          },
          {
            "id": "29e99897-56a2-4425-a962-a70afa785828",
            "abbreviatedText": "CRR",
            "expandedText": "Complete radiologic response",
            "instanceType": "Abbreviation"
          },
          {
            "id": "463421be-7a91-41ca-9d39-a6627a6d052d",
            "abbreviatedText": "CRS",
            "expandedText": "Cytokine release syndrome",
            "instanceType": "Abbreviation"
          },
          {
            "id": "27f16686-fe0b-4fcd-8173-31a4f325b3bf",
            "abbreviatedText": "CSF",
            "expandedText": "Cerebrospinal fluid",
            "instanceType": "Abbreviation"
          },
          {
            "id": "6b2ea581-1905-4890-acdc-f3850ee92f40",
            "abbreviatedText": "CSR",
            "expandedText": "Clinical Study Report",
            "instanceType": "Abbreviation"
          },
          {
            "id": "e3ed2b65-727f-4e61-8a54-7127c2fc3f4e",
            "abbreviatedText": "CT",
            "expandedText": "Computed tomography",
            "instanceType": "Abbreviation"
          },
          {
            "id": "2ad110b4-9cb3-4f5a-8b9c-4f160db14ac4",
            "abbreviatedText": "CTCAE",
            "expandedText": "Common Terminology Criteria for Adverse Events",
            "instanceType": "Abbreviation"
          },
          {
            "id": "9f2ed223-bc38-42c9-b224-bf6de90db019",
            "abbreviatedText": "DLBCL",
            "expandedText": "Diffuse large B-cell lymphoma",
            "instanceType": "Abbreviation"
          },
          {
            "id": "2283c363-273d-4f33-8fa6-42e5d81c3c91",
            "abbreviatedText": "DOR",
            "expandedText": "Duration of response",
            "instanceType": "Abbreviation"
          },
          {
            "id": "42f86082-3ea1-4af5-b1e4-f3804b53c47d",
            "abbreviatedText": "DSMB",
            "expandedText": "Data Safety Monitoring Board",
            "instanceType": "Abbreviation"
          },
          {
            "id": "2ec7b62d-3f7e-48eb-8478-993d38620a56",
            "abbreviatedText": "eCRF",
            "expandedText": "Electronic Case Report Form",
            "instanceType": "Abbreviation"
          },
          {
            "id": "739cb3c5-5c94-4108-add3-c91619ee6540",
            "abbreviatedText": "ECG",
            "expandedText": "Electrocardiogram",
            "instanceType": "Abbreviation"
          },
          {
            "id": "7c59c846-7b0b-4e04-9ec9-1639387497d4",
            "abbreviatedText": "ECHO",
            "expandedText": "Echocardiogram",
            "instanceType": "Abbreviation"
          },
          {
            "id": "46a94f22-3b58-4735-be34-6f1a89c0e13b",
            "abbreviatedText": "ECOG",
            "expandedText": "Eastern Cooperative Oncology Group",
            "instanceType": "Abbreviation"
          },
          {
            "id": "8263ddaa-df88-4cc5-b1e2-64259acf82ff",
            "abbreviatedText": "EEG",
            "expandedText": "Electroencephalogram",
            "instanceType": "Abbreviation"
          },
          {
            "id": "5a2adb92-d920-48d9-b533-389810632659",
            "abbreviatedText": "EFS",
            "expandedText": "Event-free survival",
            "instanceType": "Abbreviation"
          },
          {
            "id": "86e7f678-5d4f-4e46-b81e-ff715d0ebc82",
            "abbreviatedText": "EORTC QLQ-C30",
            "expandedText": "European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Cancer-30 (QLQ-C30)",
            "instanceType": "Abbreviation"
          },
          {
            "id": "fcce0c3e-3369-469b-bfde-6155076938f9",
            "abbreviatedText": "EQ-5D-5L",
            "expandedText": "Euro-QOL, Five Dimensions, Five Levels",
            "instanceType": "Abbreviation"
          },
          {
            "id": "180dc2a2-eb0f-43f7-818f-69199fd52b06",
            "abbreviatedText": "FAS",
            "expandedText": "Full analysis set",
            "instanceType": "Abbreviation"
          },
          {
            "id": "95d252f7-9654-4697-a183-7d87d751dea0",
            "abbreviatedText": "HDT",
            "expandedText": "high-dose therapy",
            "instanceType": "Abbreviation"
          },
          {
            "id": "696d14b5-f475-434a-9e88-9811aba97321",
            "abbreviatedText": "IB",
            "expandedText": "Investigatorâ€™s Brochure",
            "instanceType": "Abbreviation"
          },
          {
            "id": "d4752378-e5ca-4bdb-8904-47b563cf149b",
            "abbreviatedText": "IPI",
            "expandedText": "International Prognostic Index",
            "instanceType": "Abbreviation"
          },
          {
            "id": "327760c0-4800-48ad-9b58-bcd047516ccd",
            "abbreviatedText": "LTR",
            "expandedText": "long terminal repeat",
            "instanceType": "Abbreviation"
          },
          {
            "id": "59d8823f-6ccf-453f-9f16-c535768f6201",
            "abbreviatedText": "NCI",
            "expandedText": "National Cancer Institute",
            "instanceType": "Abbreviation"
          },
          {
            "id": "87bb4398-d6aa-47b0-9066-0d74ae2f13f9",
            "abbreviatedText": "NHL",
            "expandedText": "non-Hodgkin lymphoma",
            "instanceType": "Abbreviation"
          },
          {
            "id": "43a51901-1547-44dc-bf4f-168d27e333b2",
            "abbreviatedText": "ORR",
            "expandedText": "objective response rate",
            "instanceType": "Abbreviation"
          },
          {
            "id": "7bf47dab-4b1f-4557-856a-7dda7f2d4e8b",
            "abbreviatedText": "PMBCL",
            "expandedText": "primary mediastinal B-cell lymphoma",
            "instanceType": "Abbreviation"
          },
          {
            "id": "e7e23538-714d-4d41-93f4-b3b5d9ff5849",
            "abbreviatedText": "PR",
            "expandedText": "partial response",
            "instanceType": "Abbreviation"
          },
          {
            "id": "f902f626-464f-4b92-8bc6-fe1b46ad3773",
            "abbreviatedText": "r/r DLBCL",
            "expandedText": "relapsed/refractory diffuse large B-cell lymphoma",
            "instanceType": "Abbreviation"
          },
          {
            "id": "71af0e9e-5c9d-4ef7-a212-ced8f64be2e6",
            "abbreviatedText": "scFv",
            "expandedText": "single-chain variable fragment",
            "instanceType": "Abbreviation"
          },
          {
            "id": "8aabd83d-c904-4183-91eb-ca0696995c1e",
            "abbreviatedText": "SOA",
            "expandedText": "schedule of assessments",
            "instanceType": "Abbreviation"
          },
          {
            "id": "3baaa25e-8421-402d-9252-ab33ec491a03",
            "abbreviatedText": "SOC",
            "expandedText": "standard of care therapy",
            "instanceType": "Abbreviation"
          },
          {
            "id": "e628497a-0ef7-4613-aab6-0ae5b33c0f9e",
            "abbreviatedText": "TFL",
            "expandedText": "transformed follicular lymphoma",
            "instanceType": "Abbreviation"
          },
          {
            "id": "250fc533-ee72-44a1-93c9-fa85bb69817a",
            "abbreviatedText": "WBC",
            "expandedText": "white blood count",
            "instanceType": "Abbreviation"
          }
        ],
        "amendments": [
          {
            "id": "147f6696-75b8-4d1d-a058-7d0529661c1d",
            "number": "1",
            "name": "Amendment 1",
            "scope": {
              "id": "75d91184-1679-4317-be7a-4224162ae76a",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "7ec65679-ae22-4159-ae0d-1d487eb2023a",
              "code": {
                "id": "094953f9-005e-4e02-aa81-ccd8e3b61ee3",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "800987d0-9bce-48a0-8590-e22c657aac2a",
                "type": {
                  "id": "2a667b16-2b0d-4e28-a563-656c809d2f58",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The summary of changes for this amendment is available upon request as per the protocol amendment history section.",
            "effectiveDate": "2017-09-27",
            "reasonIds": [
              "7350f4e6-ea49-4241-9e6f-1bc9af355610",
              "44e79bc8-6a6d-4c4c-9df0-8336e903d258"
            ],
            "previousVersion": "Original Protocol",
            "newVersion": "2"
          },
          {
            "id": "9c894e30-a5fd-418b-b93b-7fc773d0018a",
            "number": "2",
            "name": "Amendment 2",
            "scope": {
              "id": "abf5a642-7165-4ca6-9393-6fbbc486c8bf",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "33b434fc-6405-421c-af1a-fc7e34883277",
              "code": {
                "id": "8a71ca01-0369-44cd-83e2-e6e7778a5efb",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "c977e014-f898-4fd6-966a-469e1eb12dd5",
                "type": {
                  "id": "99a1222c-0765-4aa9-96d6-4d1f6fc1a02a",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The summary of changes for this amendment is available upon request as per the protocol amendment history section.",
            "effectiveDate": "2017-11-21",
            "reasonIds": [
              "10e24543-a5b1-4f9a-a5fc-0f7c7d1e81ba",
              "7fe4e5df-ce8f-4d03-9e9f-324af407654f"
            ],
            "previousVersion": "2",
            "newVersion": "Amendment 2"
          },
          {
            "id": "5ecb0f56-d5d1-41d4-9dc1-87fddba08698",
            "number": "3",
            "name": "Amendment 3",
            "scope": {
              "id": "cf0ae547-d6c6-44b0-b732-bf1bf7a841fc",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "926ef6a5-c904-4c7e-a74a-4fe64f49187e",
              "code": {
                "id": "3cb43d4f-60d4-447d-b49b-8ccebc096fbc",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "86b90d05-2c2b-4867-bcdf-4cc6c9581363",
                "type": {
                  "id": "0e25a8e9-f3f8-4420-8904-de17a177f466",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The summary of changes for this amendment is available upon request as per the protocol amendment history section.",
            "effectiveDate": "2019-01-16",
            "reasonIds": [
              "30d449ab-deae-4ef0-8453-232dc8cee203",
              "92d61456-96af-4a9b-97c9-c555dc79d0f0"
            ],
            "previousVersion": "Amendment 2",
            "newVersion": "Amendment 3"
          },
          {
            "id": "029f48b3-ecf0-4822-bae9-e0b03055eb38",
            "number": "4",
            "name": "Amendment 4",
            "scope": {
              "id": "3116daeb-92b0-428d-a3e1-97dd3edaed50",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "bc2a0b28-63e8-4c71-a761-616447d71af3",
              "code": {
                "id": "32d3f6f4-07c2-4bc5-8153-e006b650a7d5",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "89b76dff-0c4c-4623-9e0e-42010885f9fa",
                "type": {
                  "id": "8f464c49-07f9-469a-8f16-106a29b65a97",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The summary of changes for this amendment is available upon request as per the protocol amendment history section.",
            "effectiveDate": "2019-03-19",
            "reasonIds": [
              "a7a0c7cd-1c9d-4aef-a533-6df5739ba3fc",
              "9125ae44-6a20-4fe9-8600-f47c186432f0"
            ],
            "previousVersion": "Amendment 3",
            "newVersion": "Amendment 4"
          },
          {
            "id": "b5c9659d-66fd-454e-91ce-ea7e25a3c0d0",
            "number": "5",
            "name": "Amendment 5",
            "scope": {
              "id": "87ad6f9b-7c3b-4a70-9ad4-18a16925e7b9",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "c68937ca-41ff-4e8b-9aba-b07720867612",
              "code": {
                "id": "ec8d995b-b4ff-4a92-b428-0a9cfd734569",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "49eb89a3-0d54-47eb-a3e1-beb0fe79b88a",
                "type": {
                  "id": "cf905bdb-b56e-44b6-8b72-af474a9d6dbc",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The summary of changes for this amendment is available upon request as per the protocol amendment history section.",
            "effectiveDate": "2020-06-25",
            "reasonIds": [
              "8f3c139b-aef0-4e06-8f32-516e7dd0c78c",
              "b41cd119-cd96-4cae-8368-1bfb06c44998"
            ],
            "previousVersion": "Amendment 4",
            "newVersion": "Amendment 5"
          },
          {
            "id": "0dcf7a1d-27a4-40dc-b955-1544caf21918",
            "number": "5.1 (USA)",
            "name": "Amendment 5.1 (USA)",
            "scope": {
              "id": "081dd977-4b14-472b-a5f7-8e2069ef8bbe",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "1257503b-06fb-4c3f-9b07-ba697597d227",
              "code": {
                "id": "13d2c971-d854-49cb-8026-6695880bfe33",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "9468deaa-1de2-4ace-9d62-28063bdb29a7",
                "type": {
                  "id": "1d93ba32-6d83-4de6-883f-8139654ee87a",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "This was a USA-specific version of the protocol; specific rationale details are available upon request.",
            "effectiveDate": "2020-09-16",
            "reasonIds": [
              "b72b3fe9-ef3d-4adb-8951-f5d5112abcdf"
            ],
            "previousVersion": "Amendment 5",
            "newVersion": "Amendment 5.1"
          },
          {
            "id": "d5c346fd-1482-4a4c-92fc-20726169e8dc",
            "number": "6",
            "name": "Amendment 6",
            "scope": {
              "id": "c1ccff72-e50f-4db1-b3f5-512389a2d885",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "5cd54950-54ab-444a-bece-0e45560d1eea",
              "code": {
                "id": "08b4a3c1-49f0-435e-9d0b-45b1ab675d05",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "98de150e-dad2-4d7c-99f1-48964613fc79",
                "type": {
                  "id": "eb38bfc4-05d8-4f6b-9582-bb60a9389663",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The main reasons for this amendment were to align with Kiteâ€™s latest protocol template, clarify study duration and long-term follow-up transitions, remove the lower limit for EFS events as requested by a regulatory agency, and harmonize country-specific requirements for the EU CTR transition.",
            "effectiveDate": "2023-04-14",
            "reasonIds": [
              "6a9f5c89-8bf7-4371-9724-6097954d8fbd",
              "a40a0df5-b1a0-4eea-af58-1e5d1217a206",
              "e3a42684-c8a5-42a0-91ee-c2599ef35625"
            ],
            "previousVersion": "Amendment 5 / 5.1",
            "newVersion": "Amendment 6"
          }
        ],
        "medicalDevices": [
          {
            "id": "c239f418-92e8-433a-a945-43b94b998730",
            "name": "Cryostorage Bag",
            "instanceType": "MedicalDevice",
            "label": "Cryostorage Bag",
            "description": "Bag used for the cryopreservation and infusion of axicabtagene ciloleucel",
            "deviceType": {
              "id": "406cef33-1a3f-4f1c-9560-7fb3c423c2b7",
              "code": "Drug Delivery Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Drug Delivery Device",
              "instanceType": "Code"
            }
          },
          {
            "id": "723c0a74-4e6c-4375-93d0-e3a6957274a0",
            "name": "Liquid Nitrogen Dry Shipper",
            "instanceType": "MedicalDevice",
            "label": "Dry Shipper",
            "description": "Device used for the transport of frozen cellular product",
            "deviceType": {
              "id": "184e8992-da90-40c3-8252-3807bf69554b",
              "code": "Diagnostic Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Diagnostic Device",
              "instanceType": "Code"
            }
          },
          {
            "id": "cd9fd4fb-2092-4e4b-b10d-f328ec71bccc",
            "name": "Apheresis Machine",
            "instanceType": "MedicalDevice",
            "label": "Apheresis System",
            "description": "Equipment used for the collection of mononuclear cells during leukapheresis",
            "deviceType": {
              "id": "e6d37010-03ff-4d36-8a6e-199eebc6fb20",
              "code": "Diagnostic Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Diagnostic Device",
              "instanceType": "Code"
            }
          }
        ],
        "conditions": [
          {
            "id": "9516a00a-bf2c-43a1-af61-e1451b98cd43",
            "name": "SOC Response Criteria",
            "instanceType": "Condition",
            "description": "Criteria to proceed to HDT and ASCT in SOC arm",
            "text": "Adequate disease response (CR or PR) demonstrated after the second or third cycle of chemotherapy"
          },
          {
            "id": "9b6ad367-720b-41fb-8150-c5f74c9208e7",
            "name": "Interim Futility Analysis",
            "instanceType": "Condition",
            "description": "Condition for early study assessment of EFS",
            "text": "Conducted after 135 EFS events have been observed"
          },
          {
            "id": "cec03200-7483-4485-9d3e-a7e59184a777",
            "name": "Primary OS Analysis",
            "instanceType": "Condition",
            "description": "Timing for final OS assessment",
            "text": "Approximately 210 deaths observed or no later than 5 years after first subject randomized"
          }
        ],
        "studySites": [
          {
            "id": "1af1cd5a-53a4-4158-b3f8-d83a52f5c894",
            "name": "Banner MD Anderson Cancer Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "1",
            "organizationId": "c049dba7-5199-450f-a84f-af9b541cd40a",
            "country": "United States"
          },
          {
            "id": "b1f5d4bf-ee84-4b1d-a5ea-6366d6642d99",
            "name": "Mayo Clinic Hospital",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "2",
            "organizationId": "2b42dd59-c961-416c-9b81-cd14b1a5cc2d",
            "country": "United States"
          },
          {
            "id": "8a4fdb6b-9fcd-4e85-8212-b2f9e94a0f25",
            "name": "UC San Diego Moores Cancer Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "3",
            "organizationId": "6488cec4-372b-4224-9202-b405c2b801ad",
            "country": "United States"
          },
          {
            "id": "603df930-994a-4ca7-90e2-9f8704c03038",
            "name": "UCLA",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "4",
            "organizationId": "b0691558-5f6f-4994-84f5-3e8ba2f30f65",
            "country": "United States"
          },
          {
            "id": "7b22fae8-b2b6-43cd-a9ab-50336d5f359f",
            "name": "Stanford Cancer Institute",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "5",
            "organizationId": "c6289dd2-fbbe-4099-9886-ff703f114e51",
            "country": "United States"
          },
          {
            "id": "c84ddce2-26af-449c-bbca-6640a9c47d1a",
            "name": "University of Miami Hospital/Sylvester Cancer Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "6",
            "organizationId": "b5961fc1-2edc-426a-b504-06913a892f5e",
            "country": "United States"
          },
          {
            "id": "aecc1910-956c-4e86-b252-ea6a0f69d504",
            "name": "Moffitt Cancer Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "7",
            "organizationId": "86818914-a17c-4b05-8d3c-999357e42850",
            "country": "United States"
          },
          {
            "id": "9e74f441-b9cc-4803-aa46-49f46ba4e312",
            "name": "Northwestern University",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "8",
            "organizationId": "3ac42d6c-f278-41ec-8d58-578046209165",
            "country": "United States"
          },
          {
            "id": "3f43ed99-8b47-4fce-9a67-6d04fbfbd6b8",
            "name": "University of Chicago Medical Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "9",
            "organizationId": "b3715214-7f5d-4db2-97df-900e2a248226",
            "country": "United States"
          },
          {
            "id": "f5de2680-dc2d-4c43-80a9-a3ff3dbbef44",
            "name": "University of Iowa Hospitals and Clinics",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "10",
            "organizationId": "e5011022-3887-4d4c-a4ea-076b048105d8",
            "country": "United States"
          },
          {
            "id": "91f08dbd-16e2-4ec9-88cd-22e04b3b20fc",
            "name": "The University of Kansas Cancer Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "11",
            "organizationId": "975e1cc8-9b92-4cb5-a067-7929c3798479",
            "country": "United States"
          },
          {
            "id": "ec4233b7-adab-45e4-bd99-d4c65b4ec460",
            "name": "University of Maryland Greenbaum Cancer Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "12",
            "organizationId": "3159e59d-7d15-4180-96c7-752fe6bb9fc0",
            "country": "United States"
          },
          {
            "id": "bcba7f49-bbc8-481d-ae92-0773f57c2573",
            "name": "Dana-Farber Cancer Institute",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "13",
            "organizationId": "9b7bc7e5-3830-4725-8aca-247da549fb45",
            "country": "United States"
          },
          {
            "id": "ac81f5f5-6a5e-4c63-b28d-0787f4b3c7c8",
            "name": "Barbara Ann Karmanos Cancer Institute",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "14",
            "organizationId": "b2492be0-e176-4744-8fe7-ef1765cadc8d",
            "country": "United States"
          },
          {
            "id": "3d57dc0a-09be-4a9d-90ac-82c3d06ec24e",
            "name": "Mayo Clinic Patient Location",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "15",
            "organizationId": "aa83dc21-fce1-460e-bcf7-89cf1e0f357a",
            "country": "United States"
          },
          {
            "id": "ca553bd7-a5d0-493f-abc1-608b23467161",
            "name": "Washington University School of Medicine",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "16",
            "organizationId": "38a3007d-d41d-4436-8851-1fcdd3695651",
            "country": "United States"
          },
          {
            "id": "0fb9265d-15d1-42b7-9bec-3321027b2cd8",
            "name": "John Theurer Cancer Center at Hackensack",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "17",
            "organizationId": "e7b289b2-600b-4275-a58b-a73700a9f261",
            "country": "United States"
          },
          {
            "id": "3d68678f-ed15-413c-ac79-d2c98d50cf95",
            "name": "Memorial Sloan Kettering Cancer Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "18",
            "organizationId": "f0c6210e-58f8-4a83-b7b7-3bb77b4e8800",
            "country": "United States"
          },
          {
            "id": "f4196974-0d00-425e-b14c-f5430a186f6b",
            "name": "Icahn School of Medicine at Mount Sinai",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "19",
            "organizationId": "2edceaeb-2393-40ff-ab20-0866ab2613c1",
            "country": "United States"
          },
          {
            "id": "03f2b3a7-8e64-4097-8683-503c338c20aa",
            "name": "University of Rochester Medical Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "20",
            "organizationId": "e13433f5-ef32-4696-9249-5848e70e9e8d",
            "country": "United States"
          },
          {
            "id": "e280661f-9b79-4576-9425-15158854b3e4",
            "name": "Cleveland Clinic",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "21",
            "organizationId": "5e975f18-4bce-4456-bd05-58f61dd522dc",
            "country": "United States"
          },
          {
            "id": "91c39650-c9b5-440d-81ca-fd0213a4833e",
            "name": "James Cancer Hospital at Ohio State",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "22",
            "organizationId": "30c29320-3a64-42b3-bdeb-b54609e50b45",
            "country": "United States"
          },
          {
            "id": "9f717699-ce71-41a5-9b22-8b82645f196f",
            "name": "Thomas Jefferson University",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "23",
            "organizationId": "ad3fb662-c508-4bac-8d13-c1b37d7a8181",
            "country": "United States"
          },
          {
            "id": "ff0f1ebb-d9ff-4c78-a097-29d05683dec9",
            "name": "UPMC Hillman Cancer Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "24",
            "organizationId": "871b6b4f-9f53-43d0-9c94-0c446bd61330",
            "country": "United States"
          },
          {
            "id": "44639673-6e91-40c0-b2f9-d623e9e9ae1c",
            "name": "Sarah Cannon Research Institute",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "25",
            "organizationId": "cda21e4d-0d87-4c1f-9af0-fd6c8e44723a",
            "country": "United States"
          },
          {
            "id": "66d1728f-4d11-4a46-b96d-77eeca204296",
            "name": "Henry-Joyce Cancer Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "26",
            "organizationId": "5f999fd0-d52f-4e8d-910e-c83ef1a79056",
            "country": "United States"
          },
          {
            "id": "f2672346-d108-484c-b525-ac20cfab79a4",
            "name": "MD Anderson Cancer Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "27",
            "organizationId": "84de371b-5ded-4ea4-b30a-c40c2c501e52",
            "country": "United States"
          },
          {
            "id": "c21402ef-92e1-42e4-99cb-dd91047ea469",
            "name": "University of Utah Huntsman Cancer Institute",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "28",
            "organizationId": "9729b906-67e8-404f-8d95-927df61ec774",
            "country": "United States"
          },
          {
            "id": "ce757642-bcb4-43f1-8fe3-7cff9f5d65e6",
            "name": "University of Virginia Health System",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "29",
            "organizationId": "b789099e-cc6c-46d6-a13f-827daedc661d",
            "country": "United States"
          },
          {
            "id": "a2ccfc4b-29d3-4ada-917f-b6ad90ffc4bf",
            "name": "Swedish Cancer Institute",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "30",
            "organizationId": "36f802c7-413f-4050-8c9c-bedd199a15fa",
            "country": "United States"
          },
          {
            "id": "292f047d-4c11-45d5-ada0-f549fd21abe8",
            "name": "Peter MacCallum Cancer Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "31",
            "organizationId": "903e31dd-abd6-4d65-9611-1299fdcf52a8",
            "country": "Australia"
          },
          {
            "id": "1a0cdd23-2484-4db0-b4a8-27282617cb6d",
            "name": "Universitatsklinikum Graz",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "32",
            "organizationId": "5701a2c3-614a-4025-b59c-394e22d2b0fa",
            "country": "Austria"
          },
          {
            "id": "81b0fc40-4282-443d-a662-c9dd2242045f",
            "name": "Medizinische Universitat Innsbruck",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "33",
            "organizationId": "0d8535e9-2831-4378-b38d-0009596dd621",
            "country": "Austria"
          },
          {
            "id": "b0e40f69-ae4c-4ea3-a593-19abfd51f931",
            "name": "Cliniques Universiaires Saint-Luc",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "34",
            "organizationId": "6cb09ef6-ea45-495a-bcbb-f28c8ad51a1d",
            "country": "Belgium"
          },
          {
            "id": "35ec9111-4202-4a26-90b7-d60e50ec20d4",
            "name": "UZ Gasthuisberg",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "35",
            "organizationId": "caba5ced-c510-4d04-82a6-551eec8001d6",
            "country": "Belgium"
          },
          {
            "id": "28cf35a0-e9ea-4a0d-bc9d-cf901bfe71d6",
            "name": "Vancouver General Hospital",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "36",
            "organizationId": "a79aef80-d9b3-4d53-8f0c-b9760ed2b504",
            "country": "Canada"
          },
          {
            "id": "30d02f0a-e88d-40e2-a1ac-a42d3c95db4b",
            "name": "CancerCare Manitoba",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "37",
            "organizationId": "dcc86ea9-5783-4918-a90b-1ca7a61f501a",
            "country": "Canada"
          },
          {
            "id": "67e7ea42-7d4e-40ce-bc3c-d8c0277fabb7",
            "name": "Princess Margaret Cancer Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "38",
            "organizationId": "e6b7516b-e04d-4fa2-883b-51bf36b5c7f7",
            "country": "Canada"
          },
          {
            "id": "2e08c00f-80b7-494a-b88f-e937eef80a17",
            "name": "McGill University Health Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "39",
            "organizationId": "cbe7dae0-0378-4a5d-ac9e-ba38c6d3aad1",
            "country": "Canada"
          },
          {
            "id": "fffc5684-dcee-4339-9ca0-dab212272e3a",
            "name": "QEII Health Sciences Centre",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "40",
            "organizationId": "9faf2bd6-01d1-42b3-941f-29b0e6271dba",
            "country": "Canada"
          }
        ],
        "administrations": [
          {
            "id": "ab679200-56c9-4d0d-b03b-c96ef4f83bd7",
            "name": "Administration of Axicabtagene ciloleucel",
            "description": "RouteOfAdministration.INTRAVENOUS DosingFrequency.SINGLE_DOSE",
            "instanceType": "Administration",
            "route": {
              "id": "154dee1c-48d7-417c-8512-ae74529207c9",
              "code": "C38276",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "Intravenous",
              "instanceType": "Code"
            }
          },
          {
            "id": "ed4b865d-a4d8-46bf-9f26-687f587267e9",
            "name": "Administration of Fludarabine",
            "description": "RouteOfAdministration.INTRAVENOUS DosingFrequency.ONCE_DAILY",
            "instanceType": "Administration",
            "route": {
              "id": "de1cd718-1d18-4ce6-9ac4-fb530d02e016",
              "code": "C38276",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "Intravenous",
              "instanceType": "Code"
            }
          },
          {
            "id": "5076f1cc-6e47-482a-9611-27da931810ef",
            "name": "Administration of Cyclophosphamide",
            "description": "RouteOfAdministration.INTRAVENOUS DosingFrequency.ONCE_DAILY",
            "instanceType": "Administration",
            "route": {
              "id": "6951a133-b4da-4747-abb1-babd20841580",
              "code": "C38276",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "Intravenous",
              "instanceType": "Code"
            }
          },
          {
            "id": "773c52d4-ad7f-415c-8b6e-902b195a1117",
            "name": "Administration of Standard of Care (SOC) - Platinum-based salvage combination chemotherapy (R-ICE, R-DHAP, R-ESHAP, or R-GDP)",
            "description": "RouteOfAdministration.INTRAVENOUS DosingFrequency.EVERY_THREE_WEEKS",
            "instanceType": "Administration",
            "route": {
              "id": "1a831b90-ac34-48b5-9614-d59e83c4e9a0",
              "code": "C38276",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "Intravenous",
              "instanceType": "Code"
            }
          }
        ],
        "rationale": "Protocol version"
      }
    ],
    "name": "A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy of Axicabtagene Ciloleucel versus Standard of Care Therapy in Subjects with Relapsed/Refractory Diffuse Large B Cell Lymphoma (ZUMA-7)"
  },
  "administrations": [
    {
      "id": "9444cc30-69a1-4e6b-90d2-247dac92af02",
      "name": "Axicabtagene ciloleucel infusion",
      "instanceType": "Administration",
      "dose": "2 x 10^6 anti-CD19 CAR T cells/kg",
      "doseFrequency": "Single infusion",
      "route": {
        "id": "c20ff90e-21d9-456b-bb31-56da8e584694",
        "code": "Intravenous",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Intravenous",
        "instanceType": "Code"
      },
      "duration": "Single dose on Treatment Day 0"
    },
    {
      "id": "6d1b2e77-58df-4c51-87b3-dd2280d4cf52",
      "name": "Conditioning Chemotherapy (Fludarabine)",
      "instanceType": "Administration",
      "dose": "30 mg/m2/day",
      "doseFrequency": "Once daily",
      "route": {
        "id": "2b191c3c-7a50-4262-9dfb-3f8bbd5e6060",
        "code": "Intravenous",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Intravenous",
        "instanceType": "Code"
      },
      "duration": "3 days (Day -5 to Day -3)"
    },
    {
      "id": "6cfe7b2f-d8c0-47f6-afcc-60fa100a9d05",
      "name": "Conditioning Chemotherapy (Cyclophosphamide)",
      "instanceType": "Administration",
      "dose": "500 mg/m2/day",
      "doseFrequency": "Once daily",
      "route": {
        "id": "a3784b97-e4ed-4ed2-aac5-0e32d3507c9f",
        "code": "Intravenous",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Intravenous",
        "instanceType": "Code"
      },
      "duration": "3 days (Day -5 to Day -3)"
    },
    {
      "id": "965ded5c-8511-47e0-8ae9-7fa5a0dc7476",
      "name": "Bridging Therapy (Dexamethasone)",
      "instanceType": "Administration",
      "dose": "20 to 40 mg",
      "doseFrequency": "Daily",
      "route": {
        "id": "65df1e50-6d85-4972-b15b-82d6b22b332e",
        "code": "Oral",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Oral",
        "instanceType": "Code"
      },
      "duration": "1 to 4 days"
    },
    {
      "id": "55a5a011-4c3e-4d62-a271-a78ffd57e62f",
      "name": "R-ICE Regimen",
      "instanceType": "Administration",
      "dose": "Rituximab 375mg/m2; Ifosfamide 5g/m2; Carboplatin AUC 5; Etoposide 100mg/m2",
      "doseFrequency": "Every 2-3 weeks",
      "route": {
        "id": "e75ffaea-bd5d-4673-98e7-2d04b83180c5",
        "code": "Intravenous",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Intravenous",
        "instanceType": "Code"
      },
      "duration": "2 or 3 cycles"
    }
  ],
  "substances": [
    {
      "id": "219e2ed4-a793-4c73-99cb-e0f07e629b88",
      "name": "Axicabtagene ciloleucel",
      "instanceType": "Substance",
      "description": "Autologous anti-CD19 CAR T cells"
    },
    {
      "id": "81ef5c92-5f12-4782-b010-45270590f010",
      "name": "Fludarabine phosphate",
      "instanceType": "Substance",
      "description": "Synthetic purine nucleoside antimetabolite"
    },
    {
      "id": "3aabfe56-3773-4075-92ae-accd04ab8d8a",
      "name": "Cyclophosphamide",
      "instanceType": "Substance",
      "description": "Nitrogen mustard-derivative alkylating agent"
    },
    {
      "id": "66f2a355-2f74-48b2-b2ab-b5e8d2a943bf",
      "name": "Sodium-2-mercaptoethane sulfonate",
      "instanceType": "Substance",
      "description": "Active ingredient in Mesna"
    }
  ],
  "studyDefinitionDocument": {
    "id": "e019ba3b-ada9-4a26-9bb1-c70e240d7e9f",
    "name": "A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy of Axicabtagene Ciloleucel versus Standard of Care Therapy in Subjects with Relapsed/Refractory Diffuse Large B Cell Lymphoma (ZUMA-7)",
    "documentType": "Protocol",
    "language": "en",
    "instanceType": "StudyDefinitionDocument",
    "version": "Amendment 6",
    "versionDate": "14 April 2023",
    "contentIds": [
      "18e5c4ea-118d-4e40-a7ef-5fc27736d418",
      "841acb91-3419-439e-ba65-bd7ac6ef5ba4",
      "8d69f4e4-d506-4e46-819a-d2218145bcee",
      "37b02fed-cf66-4e9c-9e34-d3b24470ff71",
      "753e72c0-40fb-447a-b7b3-c5fb84919c78",
      "e37328f4-9109-46da-a8be-696f5521291a",
      "f0f2f962-c55a-4152-8f23-0f5a45eaee0f",
      "84aa33b2-f73c-4930-925d-832115ff7637"
    ]
  },
  "geographicScope": {
    "id": "5ab2acd7-3320-433e-ad4c-9496b264f1d2",
    "name": "Study Geographic Scope",
    "scopeType": "Global",
    "instanceType": "GeographicScope",
    "countryIds": [
      "4eed7567-c620-43cf-a33d-68c4e8ab28d4"
    ],
    "regions": [
      "North America",
      "European Union"
    ]
  },
  "countries": [
    {
      "id": "4eed7567-c620-43cf-a33d-68c4e8ab28d4",
      "name": "United States",
      "instanceType": "Country",
      "code": "US"
    }
  ],
  "ingredients": [
    {
      "id": "1031408b-b113-4454-9cf3-e25d7d44f1b0",
      "name": "Fludarabine",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "77a006f4-0fe7-4172-80bd-4ce6220b4ee5"
    },
    {
      "id": "6f599800-fcbb-4dbe-8dac-765fe351d72b",
      "name": "Cyclophosphamide",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "0cafe671-b9b1-4350-85cf-a0b48271f9dc"
    },
    {
      "id": "2a0a4aa5-fd71-4433-b356-6977e1cf2cf6",
      "name": "Dexamethasone",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "791a7e2b-1947-4db5-95f1-c65ccd7a12b0"
    },
    {
      "id": "acd909a2-ca3d-4eaa-ac26-337ed2a180f6",
      "name": "Mesna",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "3a36a6f8-a886-4656-a167-e923f89796d3"
    },
    {
      "id": "925d36c9-8c50-4b42-b283-b1d01dbf1409",
      "name": "Rituximab",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "9d764851-4dab-4b4f-b90d-1b09d63792ce"
    }
  ],
  "strengths": [
    {
      "id": "e6bb6527-a3e7-429e-94ab-47d1b9cd60bf",
      "instanceType": "Strength",
      "value": 30,
      "unit": "mg/m2/day",
      "numerator": {
        "value": 30,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "m2"
      }
    },
    {
      "id": "f258d41b-4378-4b0b-9bea-02864329ea11",
      "instanceType": "Strength",
      "value": 500,
      "unit": "mg/m2/day",
      "numerator": {
        "value": 500,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "m2"
      }
    },
    {
      "id": "799777a3-c1fa-42ce-9693-01d44fde88c8",
      "instanceType": "Strength",
      "value": 2000000,
      "unit": "cells/kg",
      "numerator": {
        "value": 2000000,
        "unit": "anti-CD19 CAR T cells"
      },
      "denominator": {
        "value": 1,
        "unit": "kg"
      }
    }
  ],
  "transitionRules": [
    {
      "id": "33017b79-402d-43e6-a15b-9adca4cdcebe",
      "name": "SOC to HDT-ASCT",
      "instanceType": "TransitionRule",
      "transitionType": "Epoch Transition",
      "fromElementId": "c517b47a-a718-44d0-b918-8f71f3cbf6d7",
      "toElementId": "61f1283b-1f31-4da3-9f23-1f4cb7b0fb29",
      "text": "Subjects responding to second-line combination chemotherapy after 2 or 3 cycles should proceed with HDT and ASCT"
    },
    {
      "id": "87eb7f82-e350-4f1c-a6a6-3e149e2591a1",
      "name": "SOC Non-Response",
      "instanceType": "TransitionRule",
      "transitionType": "Discontinuation",
      "text": "Subjects who do not respond to second-line chemotherapy can receive additional treatment off protocol"
    },
    {
      "id": "7637732c-0cde-45be-a1cb-fc67fb075ce0",
      "name": "Transition to LTFU Study",
      "instanceType": "TransitionRule",
      "transitionType": "Epoch Transition",
      "fromElementId": "e4299960-1e14-4b47-8170-316e68c6db44",
      "toElementId": "251a88ed-b78f-43df-a93c-0fbeb14261ad",
      "text": "After completing at least 60 months of assessments, subjects who received axicabtagene ciloleucel transition to separate LTFU study for up to 15 years"
    }
  ],
  "documentContentReferences": [
    {
      "id": "c4287a33-f861-4318-abc1-f41b32c3373b",
      "name": "DSMB Details Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "9.9",
      "sectionTitle": "Data Safety Monitoring Board",
      "description": "Reference for further details on DSMB charter and meetings"
    },
    {
      "id": "3a8c061d-98fa-4238-a10d-96de8344af76",
      "name": "Study Requirements Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "7",
      "sectionTitle": "STUDY PROCEDURES",
      "description": "Reference for study requirements and procedures assigned to each arm"
    },
    {
      "id": "0d94923f-4412-4e75-8262-e3189c63c392",
      "name": "Eligibility Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "5",
      "sectionTitle": "SUBJECT ELIGIBILITY",
      "description": "Reference for complete list of inclusion and exclusion criteria"
    },
    {
      "id": "60ee2a50-627c-4b2c-bec4-f62c337d03c0",
      "name": "Country Requirements Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "Appendix D",
      "sectionTitle": "Country-specific Requirements",
      "description": "Reference for specific regulatory requirements by country"
    },
    {
      "id": "90bec483-406c-43f3-8118-c80495306bed",
      "name": "Statistical Methods Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "10",
      "sectionTitle": "STATISTICAL CONSIDERATIONS",
      "description": "Reference for full description of statistical analysis methods"
    },
    {
      "id": "f0b3957d-c4a4-4a3d-9ff0-2d269c5f55c7",
      "name": "Bridging Therapy Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "6.2.4.2",
      "sectionTitle": "Bridging Therapy",
      "description": "Reference for details on corticosteroid bridging therapy"
    },
    {
      "id": "a2d1ab8f-9218-4924-b9cf-67af02eca34f",
      "name": "Long-term Follow-up Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "3.5",
      "sectionTitle": "Duration of Study and Subject Participation",
      "description": "Reference for transition to separate LTFU study"
    }
  ],
  "commentAnnotations": [
    {
      "id": "c186c26c-49bb-474e-99f2-263db9eaf432",
      "text": "Bridging therapy: At the discretion of the investigator, corticosteroid bridging therapy may be considered for subjects with high disease burden at screening.",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "STUDY SCHEMA",
      "pageNumber": 8
    },
    {
      "id": "8f18cfa3-8eb8-48bb-935d-8b6fa30fea6d",
      "text": "Disease Assessments: Calculated from the day of randomization and not the date of dosing with axicabtagene ciloleucel or SOC therapy.",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "STUDY SCHEMA",
      "pageNumber": 8
    },
    {
      "id": "6301651e-fa15-412c-951a-e6e428a7887d",
      "text": "After completing at least 60 months of assessments in Study KTE-C19-107, subjects who received at least one dose of axicabtagene ciloleucel as protocol therapy will complete the remainder of the 15-year follow-up assessments in a separate LTFU study.",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "STUDY SCHEMA",
      "pageNumber": 8
    },
    {
      "id": "040b7cd2-8bc0-48b7-9df8-93e597087f6e",
      "text": "Minimum observation period: 7 days unless otherwise required by country regulatory agencies (refer to Appendix D).",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "STUDY SCHEMA",
      "pageNumber": 8
    }
  ],
  "studyDefinitionDocumentVersions": [
    {
      "id": "bbdcf8cd-837a-4080-a12b-f629ce9cb9ce",
      "versionNumber": "1.0",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2017-05-22",
      "description": "Original Protocol",
      "amendmentNumber": "Original"
    },
    {
      "id": "f3bd9017-7cdc-4113-ad5a-e616ab60716d",
      "versionNumber": "2.0",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2017-09-27",
      "description": "Amendment 1",
      "amendmentNumber": "Amendment 1"
    },
    {
      "id": "8bcf1e5c-7bbc-42ca-b872-3885cde75304",
      "versionNumber": "3.0",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2019-01-16",
      "description": "Amendment 3",
      "amendmentNumber": "Amendment 3"
    },
    {
      "id": "94a7aa37-6db8-4432-b5ac-1c0028cbf858",
      "versionNumber": "6.0",
      "status": "Final",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2023-04-14",
      "description": "Current version of the protocol",
      "amendmentNumber": "Amendment 6"
    }
  ],
  "studyAmendmentImpacts": [
    {
      "id": "e1444305-b468-493e-96fd-1737c5103a61",
      "amendmentId": "0dcf7a1d-27a4-40dc-b955-1544caf21918",
      "affectedSection": "Protocol Title / Synopsis",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "The study remains a Phase 3 randomized trial evaluating axicabtagene ciloleucel versus SOC in r/r DLBCL."
    },
    {
      "id": "86c8711f-5889-4c31-ab3b-0ca065339891",
      "amendmentId": "0dcf7a1d-27a4-40dc-b955-1544caf21918",
      "affectedSection": "Section 10 - Statistical Considerations",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Updates to primary and secondary analysis methods for EFS, ORR, and OS."
    }
  ],
  "studyAmendmentReasons": [
    {
      "id": "c25e376c-31d9-4953-8060-6162ffa8eed3",
      "amendmentId": "0dcf7a1d-27a4-40dc-b955-1544caf21918",
      "reasonText": "To provide updated clinical data and refine statistical analysis plans based on study progression.",
      "category": "Scientific",
      "isPrimary": true,
      "instanceType": "StudyAmendmentReason"
    }
  ],
  "studyChanges": [
    {
      "id": "3c4810c4-7237-4cb4-9928-53e6e34468c1",
      "amendmentId": "0dcf7a1d-27a4-40dc-b955-1544caf21918",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "3.0",
      "beforeText": "Original: 22 May 2017",
      "afterText": "Amendment 6: 14 April 2023",
      "summary": "Updated protocol version and date to reflect Amendment 6."
    },
    {
      "id": "321fd496-3ba2-4e46-b247-c9421d0a0e0a",
      "amendmentId": "0dcf7a1d-27a4-40dc-b955-1544caf21918",
      "changeType": "Clarification",
      "instanceType": "StudyChange",
      "sectionNumber": "Primary Endpoint",
      "beforeText": "Not explicitly detailed in provided snippet",
      "afterText": "EFS is defined as the time from randomization to the earliest date of disease progression per the Lugano Classification, commencement of new lymphoma therapy, or death from any cause.",
      "summary": "Defined the specific events constituting an EFS event and the use of blinded central review."
    },
    {
      "id": "f44883c3-c592-4a5d-b2e3-b908d7f5b8d3",
      "amendmentId": "0dcf7a1d-27a4-40dc-b955-1544caf21918",
      "changeType": "Addition",
      "instanceType": "StudyChange",
      "sectionNumber": "6.3.1",
      "beforeText": "Not provided",
      "afterText": "Rituximab + gemcitabine, dexamethasone and cisplatin/carboplatin (R-GDP) suggested dosing",
      "summary": "Added specific suggested dosing regimens for the Standard of Care arm."
    }
  ],
  "computationalExecution": {
    "ready": true,
    "supportedSystems": [
      "EDC",
      "ePRO",
      "CTMS",
      "RTSM"
    ],
    "validationStatus": "complete"
  }
}